Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009214	s-lh	u/l (u/l)	4612	5920	1.81%
3009214	s-lh	iu/l (u/l)	4024	5254	0.00%
3009214	p-lh	u/l (u/l)	3313	4368	0.00%
3009214	s-lh	— (—)	2782	3659	100.00%	Distribution not available
3009214	p-lh	— (—)	839	1017	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Polycystic ovarian syndrome

633

1053

7.84

307.65

1.4

1.2

9.85

8.96

u/l

1.32

544

878

Ovarian dysfunction

788

1309

7.61

307.65

1.4

1.2

13.38

9.27

u/l

7.06

670

1093

Benign neoplasm of other and unspecified endocrine glands

680

872

8.84

307.65

1.9

1.3

7.84

10.25

u/l

3.62

565

710

Polycystic ovarian syndrome, broad definition

1192

2022

7.39

307.65

1.3

1.2

9.58

9.92

u/l

0.31

1023

1695

Female infertility, cervigal, vaginal, other or unspecified origin

1827

1623

8.43

307.65

1.2

8.25

14.08

u/l

32.12

1557

1298

Noninflammatory disorders of female genital tract

1760

2155

4.33

307.65

1.4

1.3

9.78

13.02

u/l

9.87

1467

1710

Exclusions for E4_PCOS_CONSORTIUM

2740

6742

2.65

307.65

1.8

1.3

9.27

11.27

u/l

9.21

2200

5499

Benign neoplasm of other and unspecified endocrine glands

680

989

7.78

307.65

1.9

1.3

7.84

11.19

u/l

6.49

565

808

Endocrine, nutritional and metabolic diseases

3594

6422

2.97

307.65

1.6

1.3

8.41

9.15

u/l

2.26

2957

5249

Amenorrhoea

794

663

15.52

307.65

1.8

1.4

8.35

10.87

u/l

3.71

636

533

Benign neoplasm: Pituitary gland, craniopharyngeal duct

604

503

16.92

307.65

2.0

1.3

7.07

9.74

u/l

3.49

497

408

Exclusions for E4_PCOS_BROAD

1858

2094

11.46

307.65

2.1

1.4

7.63

9.37

u/l

4.98

1482

1634

Hypopituitarism

1110

797

22.59

307.65

2.2

1.4

5.83

6.93

u/l

1.83

869

599

Benign neoplasm: Pituitary gland, craniopharyngeal duct

604

448

19.05

307.65

2.0

1.3

7.07

9.17

u/l

2.32

497

368

Hyperfunction of pituitary gland

437

549

9.89

307.65

2.0

1.3

8.10

10.51

u/l

2.58

360

431

Hypothyroidism (congenital or acquired)

1543

2672

3.53

307.65

1.5

1.3

8.29

7.90

u/l

0.44

1255

2249

Medical treatment for female infertility

1272

3537

3.97

307.65

1.2

8.89

12.58

u/l

13.87

1147

2879

Testicular dysfunction

528

385

22.05

307.65

2.1

1.3

7.66

4.88

u/l

6.15

434

316

Hypothyroidism and >3 levothyroxin purchases

1521

2657

3.50

307.65

1.5

1.3

8.33

7.91

u/l

0.47

1235

2240

Hypothyroidism, levothyroxine purchases

1521

2657

3.50

307.65

1.5

1.3

8.33

7.91

u/l

0.47

1235

2240

Testicular hypofunction

482

332

23.92

307.65

2.1

1.3

7.86

4.65

u/l

7.23

397

273

Female infertility

2246

1705

9.22

307.65

1.2

8.72

13.82

u/l

24.75

1932

1361

Female infertility, associated with anovulation

947

844

14.57

307.65

1.3

1.2

9.53

11.78

u/l

2.69

813

681

Irregular menses

1952

5133

3.26

307.65

1.4

1.2

10.63

13.05

u/l

9.61

1591

4263

Disorders of other endocrine glands

3184

4781

7.48

307.65

1.9

1.3

9.27

9.62

u/l

0.56

2586

3874

Polycystic ovarian syndrome, consortium definition

2495

5343

2.94

307.65

1.4

1.2

11.03

13.29

u/l

10.00

2051

4431

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1781

3408

5.77

307.65

2.0

1.3

7.97

11.12

u/l

15.03

1430

2723

Used for control exclusion in common control thyroid runs

3455

8718

2.06

281.34

1.6

1.3

8.47

9.18

u/l

2.12

2805

7088

Genitourinary diseases

2180

4595

2.45

264.63

1.6

1.5

7.39

7.23

u/l

0.29

1757

3658

Hyperprolactinaemia

320

386

10.48

256.03

1.7

1.2

7.96

11.41

u/l

3.42

260

318

Disorders of the thyroid gland

2730

8965

2.04

231.30

1.4

1.3

10.59

10.07

u/l

0.89

2211

7364

Anxiety disorders, excluding more controls

2505

8164

2.09

226.30

1.4

9.83

9.86

u/l

0.04

1979

6848

Mood disorders, excluding more controls

2737

8397

2.03

225.70

1.4

9.32

9.85

u/l

1.16

2161

7044

Depression

2888

10364

1.97

223.30

1.4

9.17

9.66

u/l

1.18

2274

8616

Recurrent or chronic depression

1421

4031

2.64

221.40

1.4

1.3

9.47

9.99

u/l

0.67

1134

3395

Medical observation and evaluation for suspected diseases and conditions

2181

5107

2.24

220.68

1.6

1.3

8.72

8.99

u/l

0.41

1754

4159

Sleep apnoea

2191

7013

2.17

220.43

1.5

1.4

8.43

11.34

u/l

15.10

1780

5713

Procreative management

1375

4601

2.66

220.41

1.6

1.5

9.00

8.93

u/l

0.05

1075

3689

Mood [affective] disorders

3016

10503

1.93

220.17

1.4

9.35

9.66

u/l

0.59

2384

8729

Other antidepressants

2992

8081

1.97

220.06

1.4

8.76

9.56

u/l

2.59

2371

6711

Mood disorders

3017

10504

1.93

219.39

1.4

9.35

9.66

u/l

0.60

2385

8728

Hypothyroidism, other/unspecified

2532

8349

2.05

218.56

1.4

1.3

10.81

10.31

u/l

0.77

2044

6858

Depression or dysthymia

1991

5025

2.27

213.07

1.4

8.61

9.76

u/l

3.17

1603

4195

Hypothyreosis and Thyroxine purchase for inclusion criteria

2567

8597

2.02

212.06

1.4

1.3

10.89

10.43

u/l

0.69

2074

7062

Male infertility

377

666

6.75

211.44

1.8

1.6

6.43

4.39

u/l

7.17

293

560

Neurotic, stress-related and somatoform disorders

2750

10295

1.95

207.98

1.4

9.57

9.63

u/l

0.07

2177

8523

Anxiety disorders

2759

10330

1.94

206.52

1.4

9.56

9.62

u/l

0.08

2182

8548

Sleep apnoea, including avohilmo

2323

7509

2.05

200.70

1.5

1.4

8.71

11.17

u/l

11.56

1883

6131

Oligomenorrhoea

225

230

11.31

200.67

1.4

1.3

9.27

13.06

u/l

2.35

180

178

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

834

2325

3.25

200.06

1.6

1.3

15.83

9.64

u/l

18.57

689

1859

Oxycodone

751

2207

3.39

198.30

1.4

12.63

11.06

u/l

1.77

608

1778

Sleep disorders (combined)

2525

8551

1.98

197.48

1.4

8.74

10.69

u/l

8.67

2042

6998

Neoplasms

2868

8411

1.87

181.22

1.7

1.3

8.38

8.07

u/l

0.68

2312

6862

Anxiety (asthma-related co-morbidities)

2056

8259

2.02

175.75

1.4

9.05

9.64

u/l

1.22

1617

6887

Excessive, frequent and irregular menstruation

1018

2038

2.86

172.46

1.2

1.3

11.16

13.33

u/l

3.92

838

1616

Depression medications

1391

2935

2.47

171.30

1.5

1.3

8.08

7.69

u/l

0.57

1123

2469

General symptoms and signs

3184

9145

1.78

168.88

1.5

1.4

9.81

9.21

u/l

1.51

2574

7465

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

196

224

11.65

165.03

2.9

1.6

7.42

4.09

u/l

7.14

165

188

Malignant neoplasm of testis

183

206

12.24

156.71

3.0

1.5

7.32

4.50

u/l

4.85

162

175

All anxiety disorders

2093

9031

1.92

154.62

1.4

9.01

9.47

u/l

0.86

1645

7487

Selective serotonin reuptake inhibitors

2756

8228

1.79

153.29

1.4

8.54

9.46

u/l

3.29

2202

6819

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

316

588

5.27

148.37

1.3

14.43

9.67

u/l

4.98

260

466

Other nutritional deficiencies

1813

9354

1.94

144.74

1.4

1.3

8.60

10.50

u/l

10.08

1481

7671

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

452

1225

3.82

143.90

1.7

1.3

15.68

9.94

u/l

9.69

376

976

Non-small cell lung cancer

316

661

4.97

141.56

1.3

14.43

10.97

u/l

2.87

260

526

Lung cancer and mesothelioma

369

722

4.52

140.57

1.3

1.4

14.39

10.27

u/l

4.34

303

570

Hypertrichosis

210

318

8.48

139.18

1.5

1.3

9.16

11.22

u/l

1.38

181

259

Other disorders of adrenal gland

231

377

6.94

138.68

1.7

1.4

13.83

9.17

u/l

3.07

183

274

Pain and other conditions associated with female genital organs and menstrual cycle

580

1806

3.20

137.94

1.2

1.3

10.17

12.95

u/l

5.02

473

1437

Hirsutism in women

196

280

9.21

137.48

1.4

1.3

9.03

11.31

u/l

1.48

167

229

Hypothyroidism, strict autoimmune

1885

6623

1.92

136.78

1.3

11.39

10.37

u/l

1.70

1528

5438

Obesity and other hyperalimentation

1713

8986

1.94

135.44

1.4

1.3

8.63

10.57

u/l

9.92

1401

7391

Obesity

1706

8964

1.93

134.53

1.4

1.3

8.64

10.56

u/l

9.79

1398

7371

Episodal and paroxysmal disorders

3073

9601

1.67

131.13

1.4

9.00

9.75

u/l

2.06

2515

7770

Adrenocortical insufficiency

180

240

8.54

130.20

1.6

1.3

14.86

9.94

u/l

2.49

154

184

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

425

959

3.83

129.69

1.4

1.3

13.74

9.12

u/l

6.79

352

761

Headache

1803

8172

1.88

128.54

1.4

1.3

9.56

9.60

u/l

0.05

1490

6695

Use of cabergoline

141

146

13.30

128.26

1.9

1.3

6.01

10.03

u/l

2.27

116

121

Neurological diseases

2677

8050

1.70

123.20

1.5

1.4

8.78

9.36

u/l

1.23

2178

6513

General examination and investigation of persons without complaint and reported diagnosis

1799

5107

1.91

122.13

1.4

1.3

9.71

8.99

u/l

1.40

1502

4159

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

360

759

4.07

119.54

1.3

14.61

9.69

u/l

5.80

295

599

Diseases of male genital organs

1526

3966

1.99

114.50

1.7

1.6

5.59

5.29

u/l

1.10

1219

3217

Other endocrine disorders

296

683

4.67

113.73

2.3

1.5

6.52

7.03

u/l

0.29

201

484

Opioids

2743

8861

1.65

113.73

1.4

9.51

9.40

u/l

0.15

2243

7284

Psychiatric diseases

2749

8476

1.65

112.19

1.4

9.30

9.89

u/l

1.39

2186

7059

GASTRO-related operations

2509

7590

1.69

111.43

1.5

1.4

9.37

8.47

u/l

2.82

2069

6174

Any gastric operation

2509

7590

1.69

111.43

1.5

1.4

9.37

8.47

u/l

2.82

2069

6174

Obesity due to excess calories

1274

6557

2.00

110.61

1.4

1.3

8.70

10.36

u/l

5.51

1047

5392

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

351

964

3.80

110.18

1.7

1.4

15.17

8.78

u/l

9.36

289

771

Any mental disorder

2750

8561

1.63

107.98

1.5

1.4

9.32

9.87

u/l

1.28

2185

7127

Other special examinations and investigations of persons without complaint or reported diagnosis

1818

5108

1.83

107.50

1.5

1.3

8.97

8.99

u/l

0.02

1504

4159

Malignant melanoma, excluding all cancers (controls excluding all cancers)

342

941

3.77

106.72

1.3

14.04

10.14

u/l

4.43

284

747

Other anxiety disorders

1566

7702

1.85

106.11

1.4

9.09

9.15

u/l

0.06

1235

6400

Parasetamol

2473

7754

1.66

102.74

1.4

8.95

8.72

u/l

0.39

2054

6356

Benign neoplasms

2425

8445

1.65

102.68

1.5

1.3

8.52

8.18

u/l

0.66

1978

6931

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

305

802

3.96

101.79

1.4

1.3

14.39

9.99

u/l

4.84

252

634

Neurological diseases, wide definition

1279

3243

2.03

100.88

1.6

1.4

8.11

8.46

u/l

0.48

1037

2567

Malignant neoplasm of respiratory system and intrathoracic organs

345

900

3.62

100.30

1.4

1.3

12.97

10.72

u/l

1.83

284

709

Fever of other and unknown origin

1293

6409

1.91

98.13

1.6

1.4

10.64

9.40

u/l

2.31

1071

5235

Seminoma of testis, excluding all cancers (controls excluding all cancers)

106

108

13.46

97.49

3.1

1.5

7.31

4.13

u/l

3.37

Osteoporosis

344

960

3.50

96.07

1.5

1.4

13.23

14.56

u/l

0.62

275

781

Behavioural syndromes associated with physiological disturbances and physical factors

1128

5875

1.99

95.33

1.6

1.4

8.18

9.19

u/l

2.28

881

4823

Endometriosis

671

1628

2.50

91.36

1.2

12.89

14.52

u/l

1.65

577

1308

Malignant neoplasm of bronchus and lung

284

707

3.85

90.99

1.3

13.94

11.13

u/l

2.05

231

559

Seminoma of testis

106

119

12.18

90.93

3.1

1.5

7.31

4.67

u/l

2.24

102

Deposits [accretions] on teeth

298

818

3.80

89.57

2.5

1.6

7.86

7.82

u/l

0.02

228

588

Examination and observation for other reasons

1487

5070

1.81

89.18

1.4

1.3

10.01

9.01

u/l

1.80

1193

4129

Persons encountering health services in other circumstances, wide

2959

10175

1.53

89.04

1.5

1.4

9.53

9.49

u/l

0.04

2406

8272

Codeine

2447

8568

1.59

88.97

1.4

1.3

9.55

9.49

u/l

0.08

2014

7063

Other diseases of hard tissues of teeth

1588

6862

1.76

88.91

1.6

1.4

10.07

9.50

u/l

0.84

1274

5603

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1057

5063

1.97

88.48

1.4

12.89

10.63

u/l

4.79

875

4056

Anaemias

755

2234

2.32

88.32

1.5

1.3

11.02

8.13

u/l

5.75

612

1868

Primary_lymphoid and hematopoietic malignant neoplasms

434

1558

2.86

86.83

1.9

1.4

10.93

8.58

u/l

2.59

343

1236

Dental caries

729

3312

2.25

86.46

1.9

1.5

9.21

8.60

u/l

0.62

572

2670

Malignant melanoma of skin

253

657

4.03

86.22

1.4

1.3

13.95

11.24

u/l

1.81

209

531

Tramadol

1658

6260

1.73

85.57

1.4

9.97

10.25

u/l

0.32

1334

5153

Ovarian cyst

717

1802

2.35

84.56

1.2

12.61

13.92

u/l

1.35

607

1441

Malignant melanoma

294

856

3.56

84.46

1.4

1.3

13.72

11.16

u/l

1.94

245

689

Malignant neoplasm

1863

6723

1.67

82.94

1.7

1.3

13.48

9.91

u/l

16.10

1486

5462

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

132

202

6.87

82.93

1.3

1.4

14.55

9.04

u/l

3.05

106

164

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1951

7102

1.65

82.84

1.7

1.3

13.36

9.52

u/l

19.43

1555

5787

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1950

7102

1.65

82.60

1.7

1.3

13.36

9.52

u/l

19.43

1555

5788

Malignant neoplasm, wide definition for exclusion

1950

7103

1.65

82.57

1.7

1.3

13.36

9.52

u/l

19.43

1555

5788

Disorders of puberty

151

280

6.80

82.01

3.3

1.6

5.04

5.91

u/l

0.71

119

206

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

15.57

81.51

3.2

1.6

8.66

4.22

u/l

3.73

Malaise and fatigue

962

4110

1.99

81.18

1.4

1.3

11.27

9.99

u/l

1.72

777

3338

Hypothyroidism, strict autoimmune, 3 medication purchases required

1876

7903

1.64

81.07

1.3

11.69

10.81

u/l

1.35

1523

6504

L02BG Aromatase inhibitors

355

1185

3.06

80.80

1.5

1.2

15.83

19.99

u/l

4.31

306

973

Personal history of malignant neoplasm

148

264

6.16

80.77

2.4

1.4

9.37

11.46

u/l

0.94

120

202

First line medication for Crohn's disease

2863

10562

1.50

79.14

1.5

1.4

10.36

8.99

u/l

5.48

2336

8581

Symptoms and signs involving the circulatory and respiratory systems

2800

9441

1.51

78.14

1.4

9.36

9.40

u/l

0.06

2275

7701

Benign neoplasms

2682

10034

1.51

78.07

1.5

1.4

8.73

8.98

u/l

0.44

2184

8211

Primary ovarian failure

126

203

7.31

77.50

1.7

1.2

30.58

12.65

u/l

5.21

105

160

Obesity related asthma

726

3471

2.15

77.30

1.4

9.07

10.72

u/l

2.98

587

2831

Disorders of puberty, all

179

410

5.53

76.84

3.5

1.7

5.33

6.89

u/l

1.59

145

298

Benzodiazepine use

2274

10656

1.54

75.17

1.4

10.18

9.79

u/l

0.63

1792

8812

Non-seminoma of testis

13.59

74.33

3.2

1.5

8.66

4.82

u/l

2.75

Other medical care

732

3473

2.10

73.97

1.8

1.4

11.90

9.91

u/l

3.04

595

2793

Any reimbursement code in KELA

1999

6350

1.61

73.31

1.5

1.3

9.15

8.32

u/l

1.55

1616

5238

Abnormal findings on diagnostic imaging of lung

669

3083

2.15

72.18

1.3

13.11

10.65

u/l

3.87

560

2464

Acute upper respiratory infections of multiple and unspecified sites

1936

9347

1.58

71.56

1.5

1.4

9.37

9.73

u/l

0.54

1575

7595

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2618

10144

1.49

71.31

1.5

1.4

10.14

9.50

u/l

1.23

2139

8247

Persons encountering health services for examination and investigation

1668

5108

1.66

70.49

1.5

1.3

8.93

8.99

u/l

0.06

1354

4159

Codeine or tramadol medication

2688

10183

1.48

70.47

1.4

1.3

9.84

9.79

u/l

0.07

2212

8371

Special screening examination for infectious and parasitic diseases

941

3749

1.93

70.40

1.4

1.3

7.55

8.07

u/l

0.76

718

3083

Medicines for HER+ breast cancer

456

1814

2.49

69.80

1.5

1.2

16.09

19.30

u/l

3.50

390

1477

Bronchitis

2487

11088

1.49

69.49

1.4

9.67

9.83

u/l

0.22

2028

9033

Endometriosis diagnosis and infertility diagnosis occurring together

360

1333

2.85

69.22

1.2

1.3

9.65

13.24

u/l

5.94

313

1099

Obesity, other/unspecified

848

4464

1.95

69.07

1.4

1.3

8.90

11.18

u/l

7.00

693

3674

Personality disorders, excluding more controls

812

4224

1.98

68.89

1.4

1.3

9.14

9.03

u/l

0.08

604

3591

Impotence

179

429

4.49

68.84

1.6

1.4

5.22

5.28

u/l

0.05

141

352

Primary_lymphoid and hematopoietic malignant neoplasms

434

1755

2.54

68.64

1.9

1.4

10.93

9.78

u/l

0.86

343

1398

Non-small cell lung cancer, adenocarcinoma

132

244

5.68

68.52

1.3

14.55

10.43

u/l

1.90

106

191

Non-small cell lung cancer, adenocarcinoma, helper endpoint

132

244

5.68

68.52

1.3

14.55

10.43

u/l

1.90

106

191

Dentinal caries

613

2868

2.19

68.48

1.8

1.5

9.52

8.51

u/l

1.14

491

2315

Complications associated with artificial fertilization

131

8.30

68.13

1.2

9.26

13.63

u/l

1.62

105

Female infertility, tubal origin

146

309

4.99

65.18

1.2

1.3

8.91

17.82

u/l

9.28

125

242

Unspecified/other endometriosis

245

754

3.38

64.79

1.2

1.3

10.51

13.70

u/l

2.73

205

609

Symptoms and signs involving the digestive system and abdomen

2520

8655

1.48

64.04

1.5

1.4

9.10

8.85

u/l

0.43

2059

7024

Abdominal and pelvic pain

2512

8654

1.48

63.94

1.4

9.32

8.85

u/l

1.00

2052

7024

Endometriosis of pelvic peritoneum

320

1140

2.84

63.42

1.2

12.22

15.80

u/l

3.71

282

911

Other reaction to severe stress, and adjustment disorders

1081

6308

1.76

62.84

1.4

10.25

9.58

u/l

0.91

868

5252

Acromegaly and pituitary gigantism

15.29

62.55

2.5

1.1

7.80

7.76

u/l

0.01

Dysplasia of cervi uteri

466

1532

2.40

62.50

1.2

11.96

14.14

u/l

2.19

393

1224

Any event in cancer register

2046

8074

1.52

62.40

1.7

1.3

12.78

9.55

u/l

15.63

1655

6624

Pain, not elsewhere classified

627

3087

2.08

61.84

1.4

1.3

11.02

9.86

u/l

1.11

519

2522

KRA_PSY_EATING, excluding more controls

443

1922

2.46

61.52

1.7

1.3

7.37

8.94

u/l

2.16

354

1633

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

209

601

3.59

61.26

1.5

1.4

16.16

8.11

u/l

6.76

158

486

Pain in joint

1438

5903

1.64

61.17

1.4

10.38

8.89

u/l

3.68

1199

4801

Other headache syndromes

942

5318

1.80

61.02

1.4

1.3

9.89

11.54

u/l

3.25

768

4379

Pain (limb, back, neck, head abdominally)

1876

6138

1.55

60.14

1.4

8.62

8.75

u/l

0.18

1527

4943

Persons encountering health services in circumstances related to reproduction

1522

6545

1.60

59.44

1.6

1.5

8.74

8.55

u/l

0.24

1185

5259

Non-selective monoamine reuptake inhibitors

574

2679

2.11

59.39

1.4

1.3

11.59

12.77

u/l

0.97

453

2222

Acute upper respiratory infections

2309

9990

1.46

59.06

1.4

9.89

10.09

u/l

0.27

1906

8095

Endometriosis of ovary

293

1047

2.86

58.97

1.1

1.2

12.09

17.06

u/l

5.76

251

834

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

259

869

3.06

58.79

1.6

1.3

18.62

9.68

u/l

10.17

221

684

Other menopausal disorders

357

770

2.72

57.11

1.2

22.73

21.54

u/l

0.42

276

612

Delayed puberty

128

8.67

57.00

3.3

1.7

4.92

5.88

u/l

0.53

106

Factors influencing health status and contact with health services

758

1952

1.98

56.85

1.5

1.4

7.52

7.84

u/l

0.30

604

1593

L01XE Protein kinase inhibitors

134

298

4.75

56.38

1.5

1.3

15.12

10.40

u/l

2.02

112

238

Autoimmune diseases

2799

10244

1.41

56.19

1.4

9.35

8.95

u/l

0.75

2282

8314

Intestinal infectious diseases

2180

11792

1.46

56.12

1.5

1.4

9.17

9.53

u/l

0.63

1793

9572

Other dorsopathies, not elsewhere classified

2572

9596

1.43

56.10

1.4

9.39

9.30

u/l

0.14

2118

7835

Migraine

1336

7180

1.61

55.34

1.4

10.69

10.57

u/l

0.12

1109

5867

Short stature, not elsewhere classified

164

413

4.33

54.84

2.6

1.7

3.90

5.89

u/l

3.62

110

266

Asthma (mode)

1814

6622

1.52

54.80

1.4

10.02

9.50

u/l

0.82

1475

5435

Dorsalgia

2481

9495

1.43

54.66

1.4

9.89

9.34

u/l

1.18

2018

7763

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1146

3412

1.71

54.29

1.5

1.4

8.91

8.10

u/l

1.20

919

2817

Asthma, excluding more controls

1826

6489

1.52

54.07

1.4

9.92

9.51

u/l

0.61

1481

5327

Habitual aborter

172

6.23

53.47

1.2

1.3

7.44

13.51

u/l

3.77

138

Asthma

1833

6586

1.51

53.12

1.4

9.95

9.52

u/l

0.65

1485

5405

Dental caries 2

1952

10590

1.47

52.42

1.4

9.69

9.71

u/l

0.02

1559

8664

Dentofacial anomalies [including malocclusion]

733

3991

1.86

52.00

1.8

1.4

9.94

10.19

u/l

0.20

584

3254

Disorders of adult personality and behaviour

904

5306

1.75

51.87

1.4

8.52

9.11

u/l

0.75

681

4437

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

183

541

3.49

51.50

1.5

1.4

15.63

7.98

u/l

5.50

140

443

Osteopathies and chondropathies

986

5599

1.69

51.18

1.5

1.4

10.32

10.35

u/l

0.02

788

4539

Disorders of skin appendages

1195

7538

1.61

51.02

1.4

9.95

9.46

u/l

0.67

980

6203

Endocrine disorders, other/unspecified

150

6.52

50.60

1.5

1.3

11.53

9.09

u/l

0.61

121

Dental caries 2 and operation codes

1918

10571

1.46

50.34

1.4

9.71

9.73

u/l

0.02

1533

8644

Use of hypnotics and sedatives

2217

9032

1.43

50.25

1.4

9.79

10.11

u/l

0.47

1764

7427

Continuous positive airway pressure

358

1309

2.41

49.66

1.4

1.5

8.20

8.93

u/l

0.49

283

1024

Substance abuse, excluding more controls

1206

6684

1.60

49.42

1.4

8.88

8.81

u/l

0.06

930

5586

Certain infectious and parasitic diseases

2448

8779

1.41

49.23

1.5

1.4

9.96

9.43

u/l

1.09

2009

7161

Bacterial infection, other or unspecified

819

4238

1.77

49.21

1.5

1.4

11.77

9.95

u/l

2.63

617

3431

Drug-induced adrenocortical insufficiency

127

7.01

48.31

1.5

1.4

14.86

11.21

u/l

0.90

104

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1084

6618

1.63

48.27

1.4

9.33

9.75

u/l

0.47

860

5413

Nonorganic sleeping disorders, excluding more controls

501

2505

2.06

47.86

1.4

1.3

8.73

9.48

u/l

0.72

385

2096

Asthma (only as main-diagnosis)

1625

6586

1.51

47.66

1.4

9.79

9.52

u/l

0.34

1328

5405

Asthma (only as main-diagnosis), excluding more controls

1622

6489

1.51

47.56

1.4

9.79

9.51

u/l

0.36

1327

5327

Other functional intestinal disorders

811

4478

1.75

47.46

1.4

1.5

11.07

10.28

u/l

0.84

647

3544

Hypertrophy of breast in women and men

425

2006

2.18

47.17

1.5

1.3

11.28

14.16

u/l

3.88

346

1643

Malignant neoplasm of urinary organs

170

508

3.46

47.10

1.5

1.4

16.72

8.65

u/l

5.43

131

405

Abnormalities of heart beat

688

3790

1.83

46.98

1.4

10.92

10.52

u/l

0.28

567

3101

Diseases of the skin and subcutaneous tissue

2465

8950

1.39

46.49

1.5

1.4

9.13

9.36

u/l

0.40

2003

7295

Abnormalities of breathing

2198

9349

1.41

45.97

1.4

9.60

9.44

u/l

0.22

1808

7628

Menorrhagia

504

1346

2.10

45.79

1.2

1.3

15.16

15.91

u/l

0.38

416

1075

Malignant neoplasm of kidney, except renal pelvis

160

469

3.53

45.73

1.5

1.4

16.24

8.69

u/l

4.59

123

377

Symptoms and signs involving the skin and subcutaneous tissue

1339

8827

1.53

45.66

1.4

10.86

10.55

u/l

0.35

1087

7213

Eating disorder

445

2191

2.15

45.54

1.7

1.4

7.37

9.20

u/l

2.84

354

1815

Soft tissue disorders

2624

10020

1.37

45.49

1.4

9.22

9.10

u/l

0.19

2150

8138

Diseases of oral cavity, salivary glands and jaws

1957

7012

1.45

45.43

1.4

9.31

9.54

u/l

0.31

1570

5715

Polyp of the female genital tract

415

1088

2.25

45.31

1.2

1.3

16.40

17.83

u/l

0.72

341

873

Gastrointestinal diseases

1832

6341

1.47

45.17

1.5

1.4

9.31

8.76

u/l

0.79

1503

5160

Care involving use of rehabilitation procedures

1194

7339

1.56

44.93

1.6

1.4

10.18

10.19

u/l

0.00

983

5915

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

108

245

4.78

44.83

2.8

1.6

7.57

7.37

u/l

0.07

194

Dorsopathies

2599

9756

1.37

44.76

1.4

9.17

9.24

u/l

0.10

2142

7944

COPD differential diagnosis

1899

6627

1.45

44.53

1.4

9.98

9.50

u/l

0.76

1545

5437

ILD differential diagnosis

1897

6622

1.45

44.40

1.4

9.99

9.50

u/l

0.77

1542

5435

Symptoms and signs concerning food and fluid intake

241

909

2.74

44.39

1.7

1.5

8.20

9.23

u/l

0.69

203

694

Supervision of high-risk pregnancy

675

2253

1.87

43.69

1.2

1.3

11.23

12.75

u/l

1.98

615

1779

Other diseases of blood and blood-forming organs, wide

414

1992

2.13

43.65

1.6

1.4

10.87

10.55

u/l

0.15

335

1593

Excluding asthma or asthma-COPD overlap

1903

6669

1.44

43.65

1.4

9.91

9.57

u/l

0.50

1545

5473

Other pulmonary diagnosis

1902

6669

1.44

43.51

1.4

9.88

9.57

u/l

0.43

1544

5473

Antihypertensive medication - note that there are other indications

2052

8021

1.42

43.13

1.5

1.4

8.70

8.95

u/l

0.40

1693

6529

Fentanyl

144

409

3.60

42.96

1.4

15.94

10.89

u/l

2.05

118

330

Eating disorders

464

2362

2.06

42.95

1.6

1.4

7.42

9.16

u/l

2.67

368

1952

Testicular dysfunction, other/unspecified

13.47

42.69

2.3

1.5

6.09

4.24

u/l

1.27

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

141

5.80

42.53

1.3

14.16

7.56

u/l

3.39

117

Low back pain

1644

8799

1.46

42.49

1.4

10.36

9.51

u/l

1.67

1342

7230

Mouth breathing

834

5040

1.68

42.34

1.5

7.59

9.03

u/l

3.73

685

4020

Personality disorders

812

4893

1.70

42.31

1.4

9.14

9.08

u/l

0.04

604

4098

Any operation in hilmo

163

224

3.82

41.99

1.6

1.3

6.53

6.46

u/l

0.03

140

171

Type 2 diabetes, definitions combined

1742

7266

1.44

41.56

1.4

1.3

9.18

11.07

u/l

8.24

1415

6015

Complications of medical and surgical care

1278

8105

1.51

41.56

1.5

1.3

11.71

10.91

u/l

1.08

1040

6616

Lymphoid leukaemia

126

339

3.89

41.19

2.6

1.6

8.30

7.20

u/l

0.52

271

Coxibs

697

2078

1.82

41.16

1.4

7.76

8.67

u/l

1.35

583

1668

Oedema, not elsewhere classified

478

2455

1.97

41.10

1.4

1.3

12.53

10.65

u/l

1.77

386

1999

Viral hepatitis, IBD co-morbidity

185

635

3.06

41.08

1.4

7.81

8.02

u/l

0.09

130

529

Anorexia (incl.atypical)

281

1198

2.50

41.05

1.7

1.4

6.20

9.04

u/l

5.92

219

982

Type 2 diabetes, strict (exclude DM1)

1743

7292

1.44

41.02

1.4

1.3

9.16

11.10

u/l

8.67

1416

6037

Other soft tissue disorders, not elsewhere classified

2152

9684

1.39

40.93

1.4

10.78

9.22

u/l

5.14

1747

7872

Diabetes insipidus

9.20

40.86

2.3

1.1

8.08

8.91

u/l

0.18

Dental caries 2, only avohilmo

1877

10642

1.41

40.44

1.4

9.66

9.69

u/l

0.04

1514

8686

Type 2 diabetes

1931

8208

1.41

40.31

1.4

1.3

9.30

10.69

u/l

5.14

1569

6794

Persons encountering health services in other circumstances

880

5471

1.63

39.97

1.4

9.95

9.46

u/l

0.49

707

4453

Symptoms and signs involving the nervous and musculoskeletal systems

1061

6890

1.56

39.74

1.5

1.4

11.08

10.30

u/l

0.98

887

5564

Sciatica+with lumbago

933

5579

1.61

39.70

1.3

11.08

10.86

u/l

0.17

768

4594

Rare circulating lymphoid malignancy

108

270

4.32

39.58

2.8

1.7

7.57

8.15

u/l

0.22

208

Dermatitis and eczema

2396

11719

1.35

39.49

1.5

1.4

9.98

9.51

u/l

0.93

1966

9518

Specific personality disorders

709

4212

1.73

39.09

1.4

1.3

8.99

9.26

u/l

0.22

523

3502

Type 2 diabetes, definitions combined, including avohilmo

1766

7409

1.42

39.02

1.4

1.3

9.11

11.06

u/l

8.98

1435

6138

Hodgkin lymphoma

116

310

4.08

38.94

1.7

1.5

11.83

7.89

u/l

1.85

259

Nausea and vomiting

538

2894

1.86

38.88

1.6

1.5

10.63

9.23

u/l

1.17

426

2269

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

437

2237

1.99

38.83

1.4

1.3

8.60

10.84

u/l

4.17

358

1823

Molar incisor enamel hypoplasia, with caries

201

6.02

38.82

3.3

2.4

4.82

4.63

u/l

0.07

113

Other disorders of fluid, electrolyte and acid-base balance

397

1886

2.06

38.79

1.5

1.4

12.49

10.95

u/l

1.00

318

1531

Diseases of pulp and periapical tissues

700

4141

1.72

38.66

1.5

1.4

9.58

9.42

u/l

0.12

552

3423

Somatoform disorder

378

1846

2.10

38.55

1.4

1.3

10.31

10.35

u/l

0.02

295

1521

Disorders of pituitary gland, other and/or unspecified

11.75

38.15

2.1

1.2

4.58

7.98

u/l

1.21

Lower back pain or/and sciatica

2182

11215

1.36

37.99

1.4

10.45

9.63

u/l

1.92

1781

9226

Other diseases of upper respiratory tract

2407

9375

1.35

37.70

1.4

9.71

9.57

u/l

0.20

1964

7597

Other noninflammatory disorders of vulva and perineum

163

544

3.08

37.65

1.2

1.3

13.36

15.36

u/l

0.70

136

431

Substance use, excluding alcohol

540

3003

1.85

37.53

1.5

1.4

8.63

8.18

u/l

0.36

396

2479

Metabolic disorders

1737

7693

1.41

37.47

1.6

1.4

10.18

10.25

u/l

0.07

1387

6270

Ovarian hyperstimulation (induction)

224

4.73

37.26

1.2

1.3

9.29

14.21

u/l

2.60

179

Ovarian dysfunction, other/unspecified

10.74

37.21

1.5

1.1

20.72

9.62

u/l

3.08

Asthma, hospital admission 2, infections

1196

7953

1.50

37.09

1.5

1.4

9.34

9.66

u/l

0.38

956

6479

Asthma-related infections

1196

7953

1.50

37.09

1.5

1.4

9.34

9.66

u/l

0.38

956

6479

Other diseases of intestines

2484

10903

1.34

36.99

1.4

10.23

9.28

u/l

2.72

2008

8874

Cushing syndrome

8.09

36.93

2.6

1.3

10.59

11.16

u/l

0.09

Complications of procedures, not elsewhere classified

1497

9103

1.43

36.75

1.4

1.3

11.24

10.36

u/l

1.53

1222

7439

Acute lymphocytic leukaemia, helper endpoint

114

7.32

36.68

3.0

1.9

6.80

8.00

u/l

0.33

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

114

7.32

36.68

3.0

1.9

6.80

8.00

u/l

0.33

Secondary uncertain malignant neoplasm

208

802

2.66

36.65

1.6

1.4

13.57

9.67

u/l

2.82

169

646

Sleep disorders

567

3221

1.81

36.65

1.4

9.09

9.31

u/l

0.17

438

2636

Hyperkinetic disorders, excluding more controls

436

2233

1.99

36.54

1.5

6.85

7.76

u/l

1.02

323

1837

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1011

6599

1.54

36.39

1.4

1.3

11.36

11.05

u/l

0.28

818

5386

Irritable bowel syndrome

579

3310

1.78

36.30

1.3

10.14

10.83

u/l

0.56

467

2728

340

1635

2.14

36.29

1.5

1.4

10.47

10.13

u/l

0.16

269

1352

Diarrhoea and gastroenteritis of presumed infectious origin

1615

10514

1.41

36.19

1.5

1.4

9.14

9.11

u/l

0.03

1323

8546

Chronic rhinitis, nasopharyngitis and pharyngitis

660

3919

1.71

36.06

1.4

9.61

10.44

u/l

0.84

521

3175

Triptan medication for migraine, single purchase ok

1895

9379

1.38

36.04

1.3

1.4

10.80

9.75

u/l

2.46

1587

7680

Migraine, single triptan purchase ok & required. ICD-code if available is included

1895

9379

1.38

36.04

1.3

1.4

10.80

9.75

u/l

2.46

1587

7680

Other (not insulin) diabetes medications

1740

7532

1.40

35.85

1.4

1.3

8.74

11.01

u/l

13.28

1415

6230

Non-small cell lung cancer, squamous

165

4.95

35.75

1.3

1.2

14.16

8.53

u/l

2.53

131

Non-small cell lung cancer, squamous, helper endpoint

165

4.95

35.75

1.3

1.2

14.16

8.53

u/l

2.53

131

Chronic diseases of tonsils and adenoids

1919

8892

1.38

35.72

1.4

9.60

9.51

u/l

0.11

1587

7240

Diseases of the musculoskeletal system and connective tissue

1679

5989

1.42

35.60

1.4

8.33

8.63

u/l

0.48

1372

4825

Myalgia

499

2748

1.85

35.57

1.4

1.3

11.27

10.66

u/l

0.36

393

2241

Gingivitis and periodontal diseases

1866

6977

1.39

35.48

1.4

9.37

9.54

u/l

0.21

1487

5709

COPD/asthma related infections

2305

8639

1.35

35.38

1.4

10.41

9.98

u/l

0.71

1901

7032

COPD/asthma/ILD related infections

2305

8639

1.35

35.38

1.4

10.41

9.98

u/l

0.71

1901

7032

Symptoms and signs involving the urinary system

1267

6714

1.47

35.18

1.4

10.46

9.82

u/l

0.84

1014

5432

Visual disturbances and blindness

914

5910

1.57

35.11

1.6

1.4

10.51

10.13

u/l

0.34

722

4801

Disorders of parathyroid gland

209

812

2.58

34.99

1.5

1.3

12.67

14.28

u/l

0.71

176

645

Lumbar disc prolapse

1182

6371

1.49

34.89

1.4

9.94

10.31

u/l

0.42

980

5232

1006

6602

1.53

34.89

1.5

9.09

9.33

u/l

0.22

803

5381

Hodgkin lymphoma, hilmo

116

335

3.76

34.82

1.7

1.5

11.83

8.14

u/l

1.69

274

Haemorrhage from respiratory passages

494

2522

1.84

34.56

1.4

10.52

9.81

u/l

0.53

375

2006

Biguanides

1668

7385

1.40

34.40

1.4

1.3

8.78

11.08

u/l

13.14

1363

6090

Acute lymphocytic leukaemia

122

6.82

34.21

3.0

2.0

6.80

7.99

u/l

0.34

Routine general health check-up of defined subpopulation

207

4.54

34.08

2.1

1.3

8.35

10.76

u/l

0.82

176

Enlarged lymph nodes

337

1652

2.09

34.00

1.5

1.4

11.72

9.47

u/l

1.99

275

1334

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

741

4609

1.64

33.96

1.3

9.87

9.44

u/l

0.39

568

3906

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1867

9859

1.37

33.93

1.5

1.4

11.39

9.97

u/l

3.58

1493

8022

Hypoplasia of dental enamel, including avohilmo

239

5.08

33.68

3.3

2.6

4.12

4.06

u/l

0.03

141

2380

9535

1.33

33.66

1.4

10.35

10.03

u/l

0.48

1973

7733

Cystitis

1755

7813

1.39

33.45

1.3

11.68

10.93

u/l

1.24

1397

6410

Persistent mood disorders

414

2198

1.92

33.18

1.3

10.65

10.10

u/l

0.33

325

1809

Polyuria

346

1731

2.04

32.85

1.4

8.14

9.92

u/l

2.60

278

1398

Lymphoid leukaemia

126

394

3.34

32.83

2.6

1.6

8.30

8.26

u/l

0.01

307

ILD medications

2614

11082

1.31

32.79

1.5

1.4

10.19

9.17

u/l

3.14

2154

8986

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

201

4.36

32.28

1.5

1.4

15.34

7.04

u/l

3.74

167

Visual disturbances

855

5559

1.56

32.13

1.6

1.4

10.74

10.10

u/l

0.62

677

4517

Mental and behavioural disorders due to sedatives or hypnotics

213

894

2.50

31.99

1.5

1.4

8.26

8.16

u/l

0.03

147

733

Exposure to unspecified factor

2073

12178

1.33

31.88

1.5

1.4

9.14

9.65

u/l

1.00

1659

9917

Hypo-osmolality and hyponatraemia

212

879

2.45

31.74

1.6

1.4

12.59

11.04

u/l

0.63

168

710

Other joint disorders

2349

9566

1.32

31.70

1.4

9.33

9.09

u/l

0.40

1947

7785

Pain in throat and chest

1804

8151

1.36

31.33

1.4

9.87

9.73

u/l

0.17

1475

6665

Adenomyosis (Endometriosis of uterus)

157

568

2.81

31.25

1.2

1.3

15.57

19.45

u/l

2.00

141

452

Other/unspecified dorsalgia

698

4342

1.62

31.06

1.4

11.25

10.46

u/l

0.70

553

3547

Cervical disc disorders

526

3065

1.74

30.68

1.4

1.3

11.18

11.54

u/l

0.21

423

2498

Deviated nasal septum

616

3754

1.66

30.42

1.4

8.06

8.39

u/l

0.28

483

3064

Persons encountering health services for specific procedures and health care

2317

11051

1.31

30.42

1.6

1.4

11.09

9.33

u/l

6.69

1885

8998

Pregnancy examination and test

589

2182

1.74

30.39

1.2

1.3

10.56

11.61

u/l

1.10

505

1729

Panic disorder

478

2738

1.80

30.35

1.4

8.63

9.07

u/l

0.34

370

2271

Infections of the skin and subcutaneous tissue

1287

9138

1.42

30.23

1.6

1.4

8.59

8.75

u/l

0.18

1042

7454

Hypothyroidism, drug reimbursement

320

1121

2.08

30.22

1.4

1.3

14.32

9.90

u/l

4.03

259

943

Asthma, including avohilmo

2576

11680

1.29

30.19

1.4

9.58

9.54

u/l

0.05

2092

9506

Other metabolic disorders

271

1282

2.17

30.18

2.0

1.3

13.90

12.50

u/l

0.64

219

1057

Diseases of the eye and adnexa

2308

8868

1.32

30.09

1.5

1.4

9.25

8.87

u/l

0.57

1880

7249

1838

8603

1.35

29.98

1.5

1.4

10.14

9.98

u/l

0.19

1458

7002

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1838

8603

1.35

29.98

1.5

1.4

10.14

9.98

u/l

0.19

1458

7002

Spondylosis

696

3736

1.61

29.98

1.3

12.26

11.84

u/l

0.27

555

3034

Secondary and unspecified malignant neoplasm of lymph nodes

161

608

2.74

29.83

1.6

1.4

11.41

9.25

u/l

1.05

130

492

Gastro-oesophageal reflux disease

1144

7072

1.45

29.63

1.4

10.49

10.64

u/l

0.13

908

5736

Benign neoplasm of colon, rectum, anus and anal canal

656

2877

1.64

29.61

1.4

1.3

11.48

10.11

u/l

1.56

535

2310

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

916

6143

1.51

29.59

1.4

1.3

11.28

11.12

u/l

0.12

743

5003

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

181

725

2.55

29.52

1.7

1.4

10.76

8.74

u/l

1.30

152

580

Bipolar affective disorders

510

2998

1.74

29.33

1.4

1.3

9.05

9.42

u/l

0.28

408

2501

Infections, IBD-co-morbidities

311

1113

2.07

29.27

1.5

1.4

10.39

10.54

u/l

0.06

257

896

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

584

2378

1.69

29.23

1.4

1.3

13.97

10.57

u/l

5.56

470

1899

Disorders of lacrimal system

630

3911

1.63

28.89

1.5

1.4

12.86

11.85

u/l

0.76

512

3185

Diabetes, varying definitions

2106

9626

1.32

28.87

1.4

9.23

10.08

u/l

2.45

1708

7890

Diabetes mellitus

2122

9702

1.32

28.76

1.4

9.24

10.06

u/l

2.32

1720

7957

Benign neoplasm: Colon

535

2415

1.71

28.64

1.4

1.3

11.56

9.94

u/l

1.61

436

1924

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

9.95

28.64

3.0

1.5

12.40

3.71

u/l

4.27

ILD medications: prednisolone, methylprednisolone, prednisone

2410

10605

1.29

28.60

1.5

1.4

10.70

9.25

u/l

5.22

1986

8628

Insomnia

415

2321

1.84

28.50

1.4

8.60

9.58

u/l

1.04

321

1905

Cardiovascular diseases

2002

8295

1.33

28.47

1.5

1.4

8.72

u/l

0.00

1646

6750

Asthma, unspecified (mode)

959

5155

1.49

28.44

1.4

11.09

10.32

u/l

0.84

768

4240

Postprocedural endocrine and metabolic disorders, not elsewhere classified

248

1161

2.19

28.41

2.0

1.3

14.54

12.87

u/l

0.74

201

965

Other intervertebral disc disorders

1584

7134

1.37

28.40

1.4

10.39

9.99

u/l

0.54

1312

5878

Hypoparathyroidism

165

4.50

28.39

1.5

1.3

12.83

11.81

u/l

0.19

125

Generalized anxiety disorder

486

2856

1.75

28.21

1.4

9.33

8.93

u/l

0.24

358

2399

Complications of surgical and medical care, not elsewhere classified

1831

9933

1.33

28.03

1.4

11.20

10.02

u/l

2.87

1496

8136

Asthma, unspecified (mode), excluding more controls

956

5102

1.49

28.01

1.4

11.05

10.29

u/l

0.83

766

4196

Mental and behavioural disorders due to opioids

167

672

2.67

27.97

1.6

1.4

7.22

7.09

u/l

0.05

112

555

Rotator cuff syndrome

894

4450

1.51

27.75

1.4

1.3

10.71

11.26

u/l

0.54

746

3614

Hypertensive diseases (excluding secondary)

1233

5075

1.43

27.68

1.5

1.4

10.10

10.08

u/l

0.02

1019

4156

Dysphagia

339

1788

1.92

27.62

1.4

12.08

10.65

u/l

0.92

273

1432

Other bacterial diseases

1674

8653

1.35

27.59

1.6

1.4

10.54

9.69

u/l

1.54

1319

7056

Concussion

1080

6544

1.44

27.56

1.5

1.4

9.07

9.48

u/l

0.51

861

5313

Other disorders of lacrimal gland

518

3100

1.69

27.53

1.5

1.3

13.22

12.01

u/l

0.82

414

2544

Benign neoplasm of meninges

123

419

3.00

27.48

1.6

1.3

11.82

12.16

u/l

0.08

332

Acetic acid derivatives and related substances

634

2023

1.65

27.27

1.4

8.26

8.73

u/l

0.44

522

1622

Nonorganic sleeping disorders

501

2994

1.71

27.20

1.4

8.73

9.22

u/l

0.43

385

2463

Other symptoms and signs involving the nervous and musculoskeletal systems

778

5146

1.53

27.11

1.5

1.4

11.23

10.16

u/l

1.23

657

4156

Disorders of tooth development and eruption

213

940

2.33

26.97

2.6

1.6

5.50

7.59

u/l

3.75

164

710

Tonsillectomy and adenotomy

1741

9177

1.34

26.94

1.5

1.4

8.74

9.33

u/l

1.26

1463

7454

Hypertension, essential

1440

5994

1.38

26.92

1.4

10.24

10.90

u/l

0.93

1175

4939

Inflammatory diseases of prostate (prostatitis)

238

1122

2.17

26.77

1.5

1.4

6.48

5.91

u/l

0.59

197

920

Other problems related to primary support group, including family circumstances

397

2182

1.84

26.74

1.8

1.5

9.23

8.90

u/l

0.20

304

1716

Disorders of thyroid, IBD co-morbidities

425

1745

1.81

26.72

1.4

1.3

12.00

10.16

u/l

1.68

350

1425

Weight loss

188

806

2.40

26.70

1.6

1.5

9.04

9.38

u/l

0.14

159

638

Poisoning by drugs, medicaments and biological substances

643

4106

1.60

26.65

1.4

9.73

9.02

u/l

0.65

484

3389

Direct fill therapy

332

1770

1.93

26.61

2.0

1.6

10.28

8.59

u/l

1.26

264

1378

Mental and behavioural disorders due to psychoactive substance use

1246

8511

1.40

26.60

1.4

8.92

8.38

u/l

0.84

963

7036

Emotionally unstable personality disorder

425

2451

1.79

26.59

1.4

1.3

9.38

9.53

u/l

0.08

304

2045

Polyneuropathies and other disorders of the peripheral nervous system

305

1578

1.97

26.41

1.6

1.4

11.81

9.62

u/l

1.48

237

1271

Cough

702

4378

1.56

26.32

1.5

10.27

10.72

u/l

0.32

556

3507

Chronic sinusitis

797

5330

1.51

26.28

1.4

1.3

10.40

10.67

u/l

0.20

655

4397

Aplastic and other anaemias

546

3171

1.65

26.19

1.6

1.4

13.51

10.47

u/l

3.80

441

2531

Other diseases of urinary system

2113

9209

1.30

26.17

1.3

1.4

11.28

10.07

u/l

3.19

1686

7543

Sexual dysfunction

184

4.35

26.05

1.6

1.4

5.42

7.70

u/l

1.42

157

Substance abuse

1206

8335

1.40

25.97

1.4

8.88

8.32

u/l

0.86

930

6885

Spinal stenosis

537

2551

1.66

25.96

1.4

1.3

11.69

12.00

u/l

0.18

442

2037

Viral Sepsis

315

1661

1.93

25.84

1.4

9.09

9.33

u/l

0.13

256

1325

Precocious central puberty

101

6.15

25.82

3.6

1.4

6.54

7.83

u/l

0.45

Implicit viral Sepsis

314

1655

1.93

25.79

1.4

9.07

9.35

u/l

0.15

255

1319

Clear cell adenocarcinoma of kidney

237

3.69

25.74

1.5

1.3

15.34

7.83

u/l

3.18

189

Oxicams

414

1308

1.82

25.67

1.4

9.36

9.45

u/l

0.05

346

1061

Hernia of abdominal wall, postoperative

263

1305

2.05

25.66

1.3

10.08

9.18

u/l

0.54

215

1050

Type 2 diabetes, wide definition

1129

5214

1.42

25.62

1.4

1.3

9.31

10.90

u/l

3.91

883

4302

Benign neoplasm of colon, rectum, anus and anal canal

680

3972

1.56

25.61

1.4

1.3

11.72

11.50

u/l

0.14

553

3200

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

803

4947

1.52

25.52

1.6

1.5

7.32

7.76

u/l

0.62

611

4021

Injuries to the wrist and hand

2117

11994

1.29

25.52

1.4

8.96

9.69

u/l

1.89

1724

9775

Certain disorders involving the immune mechanism

359

1984

1.85

25.49

1.9

1.4

10.31

9.96

u/l

0.16

296

1600

Other and unspecified anaemias

490

2847

1.68

25.47

1.5

1.4

13.67

10.67

u/l

3.25

392

2281

Other abnormal uterine and vaginal bleeding

240

805

2.15

25.12

1.2

1.3

16.21

17.56

u/l

0.48

188

638

Other specific joint derangements/joint disorders

1799

9243

1.32

25.08

1.4

10.73

9.19

u/l

4.78

1506

7541

Constipation

1388

7343

1.36

24.95

1.4

11.40

10.89

u/l

0.59

1058

5923

Benign neoplasm: Cerebral meninges

112

383

2.99

24.91

1.6

1.3

12.30

12.44

u/l

0.03

304

Acute sinusitis

1185

8025

1.39

24.83

1.4

9.22

9.80

u/l

0.91

978

6579

Other anaemias

492

2875

1.67

24.77

1.5

1.4

13.63

10.64

u/l

3.26

394

2301

Influenza and pneumonia

2230

11559

1.28

24.73

1.5

1.4

9.64

9.56

u/l

0.11

1780

9429

Hyperhidrosis

105

353

3.16

24.58

1.4

1.3

10.95

9.68

u/l

0.44

295

Other noninflammatory disorders of uterus, except cervix

178

506

2.42

24.41

1.2

1.3

14.94

22.87

u/l

7.51

148

402

Other disorders of teeth and supporting structures

361

2025

1.81

24.33

1.4

13.26

9.89

u/l

2.95

294

1656

Disorders of mineral metabolism

146

582

2.58

24.30

1.7

1.4

11.91

10.67

u/l

0.35

119

473

Vasomotor and allergic rhinitis

935

6465

1.44

24.26

1.5

1.4

9.11

9.68

u/l

0.71

761

5235

Congenital malformations, deformations and chromosomal abnormalities

1458

10526

1.34

24.19

1.6

1.4

10.07

9.32

u/l

1.24

1183

8604

Asthma, hospital admissions , main diagnosis only

1691

11637

1.31

23.99

1.4

9.68

9.86

u/l

0.22

1363

9469

Pain in limb

1594

8757

1.33

23.89

1.4

11.21

9.48

u/l

4.69

1293

7125

Nerve, nerve root and plexus disorders

1950

9533

1.29

23.79

1.4

1.3

10.90

10.01

u/l

1.95

1609

7837

Other diseases of blood and blood-forming organs

130

496

2.71

23.73

1.6

1.4

8.12

9.13

u/l

0.46

100

407

Other septicaemia

490

2946

1.65

23.71

1.9

1.4

11.23

9.80

u/l

1.16

382

2340

Diseases of the ear and mastoid process

2654

10803

1.25

23.67

1.4

9.57

9.62

u/l

0.07

2155

8836

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

150

600

2.49

23.54

1.5

1.2

24.25

17.14

u/l

4.36

131

479

Diseases of the respiratory system

1423

5286

1.36

23.52

1.4

10.25

9.81

u/l

0.52

1149

4308

Other sleep disorders

211

1000

2.16

23.50

1.4

8.87

10.02

u/l

0.73

170

802

Gender identity disorders

269

3.63

23.45

2.0

1.5

5.74

8.41

u/l

2.66

220

Diabetes medication

2041

9733

1.28

23.25

1.4

8.99

10.13

u/l

4.23

1651

7983

Disorders of lipoprotein metabolism and other lipidaemias

1134

5142

1.40

23.13

1.4

9.19

10.40

u/l

2.20

904

4232

Poisoning by medicine

578

3729

1.58

23.02

1.4

9.72

8.91

u/l

0.76

440

3069

Disorders of puberty, other/unspecified

7.79

22.84

3.6

1.7

5.19

5.99

u/l

0.20

Asthma-related pneumonia

542

3434

1.59

22.84

1.5

9.92

9.84

u/l

0.05

428

2755

Shoulder lesions

1250

5619

1.37

22.83

1.4

10.83

10.59

u/l

0.22

1024

4592

Other eating disorders

237

1201

2.09

22.80

1.7

1.4

6.39

8.93

u/l

4.15

196

975

Dental caries 1 and operation codes

1621

6318

1.33

22.78

1.4

9.68

9.49

u/l

0.23

1315

5128

Monoamine oxidase A inhibitors

190

875

2.22

22.69

1.4

1.3

8.69

11.75

u/l

2.59

150

720

Thyroiditis, ILD-related definition

261

1357

1.97

22.62

1.5

1.4

13.30

11.53

u/l

0.85

210

1106

Atopic dermatitis

1412

9109

1.34

22.62

1.5

1.4

9.15

9.74

u/l

0.93

1136

7405

Chronic periapical parodontitis

344

1945

1.80

22.62

1.5

1.4

10.65

9.74

u/l

0.54

267

1585

Erosion of teeth, including avohilmo

505

3059

1.63

22.59

1.5

1.4

8.65

9.19

u/l

0.42

399

2531

Cervicalgia

326

1814

1.82

22.58

1.3

1.4

10.63

11.32

u/l

0.37

268

1481

Other maternal disorders predominantly related to pregnancy

1184

5443

1.38

22.50

1.2

12.46

13.09

u/l

0.75

1016

4452

Anomalies of dental arch relationship, including avohilmo

551

3168

1.60

22.45

1.7

1.5

7.88

9.02

u/l

1.70

434

2541

Temporomandibular joint disorders

334

1878

1.81

22.45

1.4

1.3

12.98

11.14

u/l

1.20

267

1543

Asthma, hospital admissions 3, pneumonia

543

3456

1.59

22.44

1.5

9.96

9.83

u/l

0.07

429

2774

Asthma-related pneumonia or sepsis

543

3456

1.59

22.44

1.5

9.96

9.83

u/l

0.07

429

2774

Dental caries 3 and operation codes

1753

6925

1.31

22.40

1.4

9.61

9.41

u/l

0.26

1422

5607

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

132

519

2.58

22.33

1.3

13.02

8.11

u/l

3.62

108

414

Abnormal weight loss

158

680

2.39

22.31

1.7

1.5

9.46

9.27

u/l

0.07

135

540

Fibromyalgia

189

878

2.21

22.26

1.2

1.3

15.19

13.45

u/l

0.58

149

731

Secondary polycythaemia

185

3.91

22.25

1.7

1.4

6.02

8.36

u/l

1.01

150

Other and unspecified iron deficiency

491

3066

1.62

22.14

1.4

11.20

10.73

u/l

0.26

393

2463

Schizophrenia or delusion, excluding more controls

631

4145

1.53

22.06

1.3

1.4

8.64

8.92

u/l

0.25

475

3471

Pneumonia, organism unspecified

1733

9736

1.30

22.03

1.5

1.4

9.97

9.58

u/l

0.57

1366

7943

Benign neoplasm: Colon

545

3415

1.58

21.97

1.4

1.3

11.63

11.50

u/l

0.07

443

2741

Arthropathies

2361

9629

1.26

21.93

1.4

8.96

9.07

u/l

0.16

1945

7815

Premenstrual syndrome

6.01

21.73

1.3

1.2

9.14

15.21

u/l

1.22

Unspecified haematuria

551

3028

1.57

21.62

1.4

11.54

9.28

u/l

3.03

450

2423

Hypoplasia of dental enamel , including avohilmo

155

677

2.47

21.58

2.7

2.0

5.12

6.86

u/l

2.04

108

465

Chromosomal abnormalities, not elsewhere classified

109

407

2.94

21.50

2.8

1.8

9.18

7.45

u/l

0.79

293

Hypertension

1503

6467

1.32

21.47

1.5

1.4

10.28

10.66

u/l

0.45

1232

5290

Molar incisor enamel hypoplasia

163

723

2.41

21.41

2.7

2.0

5.25

6.84

u/l

1.81

111

497

Asthma (diagnoses ohter than nonallergic)

1717

11475

1.29

21.35

1.4

9.90

9.92

u/l

0.02

1377

9337

Speech and linguistic disorders, excluding more controls

288

1489

1.89

21.24

2.1

1.6

6.92

7.40

u/l

0.39

207

1178

Benign neoplasm: Sigmoid colon

190

898

2.15

21.18

1.4

1.3

10.47

9.62

u/l

0.37

149

715

Transport accidents

1068

6942

1.38

21.10

1.4

8.22

9.24

u/l

2.40

873

5740

Hypertensive diseases

1503

6485

1.32

21.10

1.5

1.4

10.28

10.65

u/l

0.43

1232

5299

Gestational diabetes (for exclusion)

1063

5494

1.39

21.09

1.2

10.36

12.00

u/l

3.63

901

4544

Intracranial trauma

1223

6814

1.35

21.03

1.5

1.4

8.93

9.50

u/l

0.87

972

5529

Other and unspecified polyneuropathies, also in other diseases

245

1275

1.95

20.98

1.4

12.27

9.55

u/l

1.81

191

1024

Iron deficiency anaemia

587

3842

1.53

20.59

1.4

11.62

10.98

u/l

0.43

470

3093

Triptan medication for migraine, min. 3 purchases

1343

8058

1.33

20.54

1.3

11.51

10.75

u/l

1.08

1139

6618

Hyperparathyroidism

151

649

2.32

20.53

1.5

1.2

13.21

14.79

u/l

0.55

128

517

Transplanted organ and tissue status

207

1028

2.07

20.52

2.0

1.5

11.74

7.45

u/l

2.94

172

803

Septicaemia

544

3401

1.55

20.48

1.8

1.4

11.16

9.62

u/l

1.48

429

2706

Spondylopathies

1220

5514

1.35

20.45

1.4

11.15

10.69

u/l

0.48

997

4492

Benign neoplasm: Colon, unspecified

231

1181

1.97

20.43

1.4

1.3

11.52

9.49

u/l

1.22

190

940

Migraine without aura

549

3599

1.56

20.41

1.4

11.01

10.49

u/l

0.35

442

2954

Endometriosis of rectovaginal septum and vagina

107

399

2.74

20.35

1.2

1.3

11.78

16.61

u/l

2.73

321

Other disorders of male genital organs

108

409

2.77

20.29

2.0

1.5

5.87

4.75

u/l

1.17

341

Non-follicular lymphoma, hilmo, excluding all cancers

120

477

2.57

20.09

1.7

1.4

10.45

8.80

u/l

0.75

104

391

Psychotic depression

141

606

2.40

20.07

1.5

1.3

8.62

9.18

u/l

0.24

118

508

Disturbances of skin sensation

570

3779

1.53

19.97

1.4

1.3

10.18

10.15

u/l

0.02

460

3116

Benign neoplasm of meninges

123

496

2.53

19.97

1.6

1.3

11.82

14.56

u/l

1.13

393

Excessive attrition of teeth

920

3560

1.42

19.94

1.4

9.85

9.30

u/l

0.60

744

2925

Other disorders of penis

199

985

2.07

19.91

1.6

1.5

5.67

5.33

u/l

0.30

160

778

Exposure to other specified factors

1563

11449

1.29

19.85

1.4

8.99

9.33

u/l

0.54

1250

9353

Melanocytic naevi

543

3573

1.54

19.66

1.4

1.3

10.17

9.39

u/l

0.65

439

2919

Other symptoms and signs involving the digestive system and abdomen

243

1290

1.91

19.64

1.5

1.4

13.67

12.43

u/l

0.58

200

1023

Osteoporosis with pathological fracture (FG)

148

3.92

19.58

1.2

19.61

21.50

u/l

0.25

119

Other abnormal products of conception

863

4101

1.42

19.52

1.2

11.06

12.00

u/l

1.11

735

3401

Follow-up examination after treatment for malignant neoplasms

105

396

2.69

19.48

1.5

1.2

13.54

14.26

u/l

0.17

320

Nutritional anaemias

649

4309

1.48

19.39

1.4

11.85

11.06

u/l

0.60

521

3467

Dental operations

1077

4050

1.37

19.34

1.4

9.23

9.63

u/l

0.45

880

3283

Agranulocytosis

182

880

2.11

19.32

1.6

1.5

13.08

11.13

u/l

0.78

153

709

Visual field defects

138

598

2.36

19.22

2.0

1.4

9.53

9.90

u/l

0.10

103

487

Pure hypercholesterolaemia

899

4330

1.40

19.18

1.4

9.55

10.36

u/l

0.97

714

3547

Other disorders of optic [2nd] nerve and visual pathways

144

640

2.33

19.08

2.1

1.5

9.87

9.32

u/l

0.17

111

503

Benign neoplasm: Cerebral meninges

112

442

2.59

19.05

1.6

1.3

12.30

14.32

u/l

0.66

348

Spontaneous abortion

918

4519

1.40

18.96

1.2

11.86

12.58

u/l

0.77

769

3737

Inflammatory diseases of female pelvic organs

1148

6500

1.34

18.90

1.2

1.3

13.61

12.57

u/l

1.26

932

5389

All pneumoniae

2007

11152

1.25

18.86

1.5

1.4

9.77

9.59

u/l

0.23

1597

9104

Pneumonias (Asthma/COPD co-morbidities)

1989

11084

1.25

18.86

1.5

1.4

9.75

9.61

u/l

0.18

1583

9045

Persons with potential health hazards related to communicable diseases

1085

8082

1.35

18.85

1.4

8.92

8.91

u/l

0.01

917

6573

Other obstetric conditions, not elsewhere classified

1088

5273

1.36

18.78

1.2

9.95

11.17

u/l

2.31

920

4360

Localized swelling, mass and lump of skin and subcutaneous tissue

507

3319

1.55

18.77

1.4

11.23

10.27

u/l

0.80

410

2685

Convulsions, not elsewhere classified

511

3314

1.54

18.68

1.5

1.4

8.73

8.11

u/l

0.51

404

2690

Syncope and collapse

651

3963

1.47

18.59

1.4

1.3

10.54

9.41

u/l

1.37

525

3236

Dermatitis

1015

7548

1.36

18.55

1.5

1.4

10.42

10.53

u/l

0.09

843

6158

Pain in thoracic spine

277

1562

1.81

18.55

1.4

1.3

9.55

10.97

u/l

1.18

226

1274

Mixed and other personality disorders

222

1175

1.95

18.49

1.4

1.3

8.74

9.34

u/l

0.27

168

976

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1078

5230

1.36

18.41

1.2

9.81

11.02

u/l

2.34

912

4327

Drug-induced osteoporosis with pathological fracture

6.02

18.28

1.2

1.3

15.25

11.52

u/l

0.40

Injuries to the ankle and foot

1595

11501

1.27

18.22

1.4

9.46

9.30

u/l

0.20

1319

9360

Explicit Sepsis

620

4072

1.47

18.21

1.8

1.4

11.05

9.70

u/l

1.38

493

3250

Emotional disorders starting during childhood or adolecense, excluding more controls

212

1094

1.99

18.18

1.8

1.5

7.15

7.87

u/l

0.75

165

892

Disorders of ocular muscles, binocular movement, accommodation and refraction

1025

7609

1.35

18.07

1.6

1.4

10.17

9.56

u/l

0.49

828

6182

344

2.88

18.06

1.3

1.2

11.18

10.09

u/l

0.36

286

Use of pramipexole

252

1390

1.84

18.05

1.3

9.90

12.08

u/l

1.54

200

1128

Falls/tendency to fall

2549

10530

1.22

18.02

1.4

9.76

9.47

u/l

0.51

2057

8585

Unspecified mental disorder

891

6537

1.38

17.93

1.3

1.4

8.99

9.01

u/l

0.01

707

5394

Nonalcoholic fatty liver disease

177

873

2.08

17.93

1.5

1.4

9.83

9.74

u/l

0.03

143

706

Radiculopathy

207

1076

1.95

17.84

1.3

12.53

11.84

u/l

0.26

166

878

Other specified and unspecified personality disorders

241

1325

1.87

17.81

1.4

1.3

8.49

9.30

u/l

0.53

170

1089

Implicit Sepsis

1112

6525

1.33

17.73

1.4

10.31

9.65

u/l

0.87

896

5296

Propionic acid derivatives

723

2526

1.45

17.69

1.5

1.6

7.67

8.13

u/l

0.55

588

1994

Cardiovascular diseases (excluding rheumatic etc)

1830

8471

1.26

17.61

1.5

1.4

9.77

9.00

u/l

1.59

1505

6913

Dyspnoea

1480

8896

1.28

17.60

1.4

10.93

10.31

u/l

0.91

1207

7246

Other symptoms and signs involving cognitive functions and awareness

525

3283

1.51

17.58

1.4

10.37

10.60

u/l

0.14

420

2665

Disturbance of activity and attention

413

2609

1.62

17.57

1.5

1.6

6.69

7.46

u/l

0.89

312

2089

Inflammatory bowel disease treatment related agents

2426

11368

1.22

17.56

1.4

10.61

9.28

u/l

4.60

1987

9259

Disorders of psychological development

431

2573

1.60

17.52

2.0

1.6

6.87

7.01

u/l

0.13

321

2026

Constitutional tall stature

103

5.04

17.51

2.7

1.6

4.70

6.19

u/l

0.91

Post-traumatic stress disorder

276

1595

1.79

17.39

1.4

1.3

9.46

8.82

u/l

0.37

214

1330

Fissure and fistula of anal and rectal regions

399

2521

1.60

17.33

1.3

1.4

10.22

9.90

u/l

0.16

326

2051

Disorders of calcium metabolism

381

2.64

17.31

1.6

1.4

14.79

11.92

u/l

0.71

311

Other general symptoms and signs

128

559

2.35

17.25

1.5

10.69

9.48

u/l

0.37

423

Precocious puberty

109

4.92

17.23

3.4

1.6

4.63

6.88

u/l

2.11

Diabetes mellitus in pregnancy

984

4749

1.36

17.22

1.2

10.62

11.91

u/l

2.23

834

3895

Hyperkinetic disorders

439

2825

1.58

17.22

1.5

1.6

6.83

7.41

u/l

0.60

324

2254

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1906

10837

1.24

17.22

1.5

1.4

9.84

9.63

u/l

0.29

1517

8847

Cerebral cysts

141

650

2.25

17.19

1.6

1.4

9.24

8.99

u/l

0.08

120

523

Brain meningioma, excluding all cancers (controls excluding all cancers)

207

3.27

17.18

1.5

1.3

13.27

11.39

u/l

0.40

161

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

229

1261

1.88

17.01

1.6

1.5

7.31

7.19

u/l

0.06

161

1032

Covid-19 confirmed case

539

3653

1.50

17.01

1.4

10.13

9.22

u/l

0.78

430

2988

Disorders of vestibular function (Vertigo)

545

3673

1.49

16.90

1.3

11.58

12.34

u/l

0.60

446

2974

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

441

2879

1.56

16.87

1.3

1.4

9.74

8.91

u/l

0.64

325

2379

TMD related pain

395

2.63

16.85

1.4

1.3

15.00

12.01

u/l

0.88

325

Abnormal findings on examination of blood, without diagnosis

665

4383

1.43

16.83

1.5

1.4

9.36

9.08

u/l

0.20

542

3514

Restless leg syndrome

181

920

2.01

16.80

1.3

1.4

10.60

11.10

u/l

0.16

142

750

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

215

3.18

16.76

1.9

1.3

21.50

17.96

u/l

0.88

164

Chronic lower respiratory diseases

2575

11605

1.21

16.67

1.4

9.66

9.50

u/l

0.24

2083

9461

Viral infections characterized by skin and mucous membrane lesions

785

5715

1.39

16.55

1.6

1.4

8.77

9.14

u/l

0.34

640

4592

Chronic laryngitis and laryngotracheitis

198

1043

1.93

16.50

1.4

1.3

12.99

11.98

u/l

0.40

163

865

Paralytic ileus and intestinal obstruction

286

1679

1.72

16.50

1.4

12.32

10.82

u/l

0.94

235

1358

Redundant prepuce, phimosis and paraphimosis

419

2700

1.57

16.48

1.6

4.79

4.94

u/l

0.30

342

2209

Other acute lower respiratory infections

1001

7216

1.34

16.47

1.5

8.90

8.82

u/l

0.07

802

5828

Melanocytic naevi of trunk

226

1247

1.85

16.41

1.4

1.3

10.98

9.39

u/l

0.87

185

1021

Abnormal results of function studies

164

814

2.07

16.37

1.6

1.5

13.20

8.88

u/l

2.34

131

663

Other disorders starting during childhood or adolecense, excluding more controls

195

998

1.97

16.31

1.8

1.6

6.19

7.76

u/l

2.48

142

776

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

113

4.09

16.30

1.3

22.24

8.14

u/l

2.87

Diseases of salivary glands

310

1870

1.68

16.30

1.5

1.3

11.72

10.91

u/l

0.45

253

1536

Carpal tunnel syndrome

846

5625

1.37

16.28

1.4

1.3

12.26

11.98

u/l

0.21

709

4606

Internal derangement of knee

690

4924

1.41

16.18

1.4

9.29

9.82

u/l

0.58

553

4026

Anti-inflammatory and antirheumatic products, non-steroids

713

2528

1.43

16.17

1.5

1.6

7.92

8.13

u/l

0.19

581

1994

Dental caries 3

1525

6156

1.27

16.17

1.4

9.79

9.42

u/l

0.49

1236

5006

Hypokalaemia

146

696

2.13

16.10

1.5

1.4

12.01

11.99

u/l

0.00

117

570

Dental pulpitis 4

2312

9933

1.22

16.08

1.4

9.53

9.32

u/l

0.32

1868

8092

Diseases of pulp and periapical tissues, including avohilmo

2309

9922

1.22

16.04

1.4

9.52

9.33

u/l

0.30

1865

8082

Dental pulpitis 1

2311

9934

1.22

16.02

1.4

9.53

9.32

u/l

0.32

1867

8093

Other and unspecified nerve root and plexus disorders, also in other diseases

311

1888

1.67

16.00

1.4

1.3

10.23

10.36

u/l

0.06

263

1564

Oral corticosteroids

2073

10295

1.22

16.00

1.4

11.26

9.50

u/l

6.30

1707

8423

Other and unspecified dermatitis

832

6152

1.36

15.92

1.5

1.4

10.43

10.80

u/l

0.33

683

5004

Vocal cord dysfunction

232

1203

1.82

15.91

1.3

1.4

13.43

11.18

u/l

1.20

186

989

Spondylolisthesis/Spondylolysis

242

1372

1.79

15.91

1.4

12.85

12.04

u/l

0.33

206

1118

Venous thromboembolism

629

4307

1.43

15.84

1.5

1.3

12.29

11.16

u/l

1.04

517

3486

Malignant neoplasm of skin

548

2815

1.47

15.83

1.4

1.3

13.64

12.13

u/l

1.42

438

2241

Immunodeficiencies

113

492

2.38

15.83

1.7

1.6

9.69

9.94

u/l

0.06

381

Dissociative [conversion] disorders

125

570

2.29

15.82

1.4

10.02

9.42

u/l

0.19

102

469

Other diseases of liver

279

1652

1.72

15.79

1.5

1.4

10.95

10.84

u/l

0.04

223

1349

Rheumatism, unspecified

166

836

2.01

15.75

1.2

1.3

17.49

16.06

u/l

0.47

137

688

Non-follicular lymphoma

120

534

2.29

15.75

1.7

1.4

10.45

9.64

u/l

0.30

104

432

Other disorders of skin and subcutaneous tissue

947

6541

1.33

15.65

1.4

11.24

11.00

u/l

0.19

738

5341

Benign paroxysmal vertigo

328

2027

1.63

15.62

1.3

11.85

12.51

u/l

0.33

268

1648

Dental caries, including avohilmo

1370

5484

1.28

15.58

1.4

9.97

9.52

u/l

0.58

1105

4475

Follow-up examination after treatment for conditions other than malignant neoplasms

805

3856

1.38

15.52

1.3

12.58

10.03

u/l

4.52

660

3163

Erosion of teeth

208

3.26

15.51

2.2

1.7

5.53

7.46

u/l

1.16

159

Sequelae of external causes of morbidity and mortality

353

2227

1.60

15.49

1.4

10.84

10.48

u/l

0.18

281

1813

COPD (mode)

304

1451

1.68

15.48

1.4

9.85

9.29

u/l

0.33

228

1156

Dental caries 1

1371

5493

1.28

15.46

1.4

9.97

9.52

u/l

0.58

1106

4483

Diseases of liver

482

3259

1.49

15.37

1.5

1.4

10.32

10.14

u/l

0.09

380

2639

Diseases of middle ear and mastoid

1453

9506

1.26

15.33

1.5

1.4

8.53

8.64

u/l

0.12

1189

7762

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

741

5428

1.38

15.30

1.3

1.4

9.87

9.44

u/l

0.39

568

4520

Other extrapyramidal and movement disorders in other diseases

287

1726

1.68

15.27

1.4

1.3

10.54

11.28

u/l

0.38

231

1392

Migraine without aura and triptan purchases

435

2896

1.53

15.26

1.3

11.50

10.44

u/l

0.74

354

2385

Viral hepatitis

198

1079

1.89

15.19

1.4

7.85

7.81

u/l

0.02

139

873

Other hypertrichosis

7.57

15.17

1.6

1.3

10.21

8.80

u/l

0.23

Haemorrhoids and perianal venous thrombosis

337

2111

1.61

15.12

1.3

10.82

10.59

u/l

0.12

292

1727

Orchitis and epididymitis

166

851

1.99

15.12

1.7

1.5

6.39

5.69

u/l

0.64

140

695

Hyperplasia of prostate

522

2014

1.49

15.12

1.4

6.55

6.31

u/l

0.29

414

1642

Implicit bacterial Sepsis

432

2619

1.52

15.09

1.4

10.74

9.78

u/l

0.70

343

2093

Uterine polyps

388

2.48

15.08

1.1

1.3

19.32

21.40

u/l

0.44

302

Other complications of surgical and medical care, not elsewhere classified

171

887

1.97

15.06

1.4

11.67

10.85

u/l

0.29

144

723

Abnormal involuntary movements

219

1229

1.81

15.04

1.4

10.17

9.91

u/l

0.12

183

979

Kela-code for severe mental illness

765

5650

1.37

14.89

1.3

1.4

8.85

8.84

u/l

0.01

600

4656

Motor disorders, excluding more controls

300

2.82

14.89

2.8

2.0

4.56

5.79

u/l

1.16

202

Brachial plexus disorders

198

1083

1.87

14.88

1.4

1.3

12.20

11.40

u/l

0.31

172

902

Bulimia nervosa (incl. atypical)

147

736

2.11

14.82

1.3

9.15

10.13

u/l

0.39

116

600

Missing teeth due to accident, extraction or parodontitis

156

787

2.02

14.82

1.4

1.3

15.02

10.47

u/l

2.18

124

636

Deforming dorsopathies

467

3164

1.49

14.80

1.5

1.4

11.66

10.37

u/l

1.01

388

2560

Paracetamol of NSAID medication

520

1771

1.50

14.80

1.6

7.63

7.60

u/l

0.03

411

1370

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

117

530

2.26

14.79

2.2

1.5

7.49

8.11

u/l

0.22

427

Diaphragmatic hernia

380

2462

1.56

14.78

1.3

11.49

12.20

u/l

0.43

303

2006

DVT of lower extremities and pulmonary embolism

457

3071

1.49

14.72

1.5

1.3

12.37

10.85

u/l

1.26

384

2489

Postmenopausal bleeding

179

498

1.99

14.69

1.2

29.09

25.86

u/l

1.08

149

395

Non-invasive ventilation

353

2115

1.59

14.68

1.5

1.4

9.35

9.98

u/l

0.38

311

1762

Contact with and exposure to communicable diseases

939

7149

1.33

14.63

1.4

9.03

8.84

u/l

0.19

811

5803

Other diseases of pleura

477

2873

1.48

14.51

1.4

11.20

9.94

u/l

1.14

378

2283

Benign lipomatous neoplasm

355

2278

1.57

14.47

1.4

1.3

10.95

10.14

u/l

0.50

289

1847

Other enthesopathies

439

2952

1.50

14.41

1.4

1.3

11.27

11.95

u/l

0.43

367

2405

Secondary hypertension

145

714

2.05

14.40

1.9

1.5

10.81

8.44

u/l

1.04

122

577

Voice disturbances

359

2314

1.57

14.39

1.3

12.87

12.34

u/l

0.26

284

1890

Lack of expected normal physiological development

116

464

2.33

14.38

2.5

1.8

5.39

6.61

u/l

1.07

334

Disorders of adrenal gland, other and/or unspecified

7.82

14.32

1.4

1.2

9.75

9.73

u/l

0.00

Undescended testicle

182

3.41

14.31

2.9

2.0

6.94

4.08

u/l

1.55

124

Cluster headache, wide

395

2.47

14.30

1.4

11.48

9.67

u/l

0.59

325

Zoster [herpes zoster]

213

1202

1.79

14.29

1.7

1.4

10.71

11.44

u/l

0.30

179

982

Abnormal findings on diagnostic imaging of central nervous system

106

470

2.34

14.28

1.6

1.4

9.58

9.76

u/l

0.05

373

Functional dyspepsia

405

2685

1.53

14.28

1.3

11.24

11.33

u/l

0.04

333

2195

Other follicular disorders

172

914

1.94

14.26

1.4

1.3

11.38

9.15

u/l

1.15

145

767

Intestinal stricture

343

2191

1.58

14.25

1.4

12.37

10.59

u/l

1.27

283

1773

Other adrenocortical overactivity

101

4.48

14.23

2.3

1.6

10.52

7.30

u/l

0.53

Benign neoplasm: Sigmoid colon

190

1037

1.85

14.21

1.4

1.3

10.47

11.06

u/l

0.24

149

841

Disorders of optic nerve and visual pathways

201

1123

1.83

14.15

1.9

1.4

9.88

9.89

u/l

0.00

159

907

Dental operations, only avohilmo

1122

4446

1.30

14.08

1.4

9.49

9.71

u/l

0.22

920

3597

Obsessive-compulsive disorder

229

1337

1.77

14.08

1.5

1.4

7.35

7.66

u/l

0.24

181

1096

Suicide or other Intentional self-harm

555

3931

1.43

14.04

1.3

1.4

9.79

9.21

u/l

0.48

412

3233

Endometriosis of intestine

113

3.91

14.01

1.2

7.98

14.38

u/l

2.13

Other external causes of accidental injury

1856

7632

1.22

13.93

1.4

10.12

9.79

u/l

0.46

1513

6241

Chronic gastritis

270

1636

1.66

13.92

1.4

1.3

12.27

12.02

u/l

0.10

217

1320

Oter anti-inflammatory and antirheumatic agents, non-steroids

252

807

1.75

13.91

1.4

9.84

11.13

u/l

0.75

198

659

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

344

2.52

13.87

1.8

1.4

16.27

9.00

u/l

2.59

272

Acute bronchitis

671

4808

1.38

13.83

1.4

9.66

9.28

u/l

0.31

543

3850

Elevated blood glucose level

153

789

1.99

13.80

1.5

8.79

8.50

u/l

0.09

124

631

Dental pulpitis 1, only avohilmo

2318

10167

1.20

13.77

1.4

9.55

9.36

u/l

0.28

1870

8297

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

774

5742

1.35

13.77

1.6

1.4

9.37

9.58

u/l

0.18

595

4679

Cluster headache, strict

384

2.46

13.76

1.4

11.41

9.58

u/l

0.59

317

Temporomandibular joint disorders, including avohilmo

949

7308

1.31

13.75

1.4

1.3

11.03

10.59

u/l

0.42

768

6036

Chronic periodontitis

199

1115

1.81

13.72

1.5

1.4

12.44

9.85

u/l

1.23

160

916

Dental caries 3, only avohilmo

1537

6340

1.25

13.68

1.4

9.79

9.45

u/l

0.44

1244

5154

Other bacterial intestinal infections

244

1450

1.70

13.66

1.5

1.4

10.34

10.03

u/l

0.13

199

1170

Dental pulpitis 4, only avohilmo

2313

10151

1.20

13.63

1.4

9.52

9.36

u/l

0.23

1866

8283

Undetermined asthma

209

1191

1.78

13.60

1.5

1.4

11.22

10.10

u/l

0.47

168

963

Bacterial Sepsis

533

3337

1.43

13.55

1.5

1.4

10.90

9.69

u/l

1.16

422

2675

Benign neoplasm of brain and other parts of central nervous system

108

492

2.25

13.54

2.0

1.4

7.61

8.49

u/l

0.31

400

Cellulitis

383

2544

1.53

13.49

1.6

1.5

8.55

8.96

u/l

0.29

294

2044

Undetermined asthma, excluding more controls

209

1196

1.77

13.41

1.5

1.4

11.22

10.14

u/l

0.45

168

967

Accidents

1849

7632

1.22

13.39

1.4

10.04

9.79

u/l

0.31

1499

6241

Impingement syndrome of shoulder

309

1957

1.59

13.39

1.4

1.3

11.30

11.51

u/l

0.09

255

1572

Other disorders involving the immune mechanism, not elsewhere classified

347

2.53

13.38

3.0

1.6

9.81

7.97

u/l

0.59

280

Malignant neoplasm of heart, mediastinum and pleura

5.19

13.29

1.7

1.2

8.39

8.06

u/l

0.05

Crossbite

233

1285

1.74

13.26

2.0

1.9

7.12

7.14

u/l

0.01

177

963

Phobic anxiety disorders

395

2658

1.52

13.25

1.5

1.4

7.91

8.31

u/l

0.31

294

2190

Drug-induced polyneuropathy

4.74

13.24

3.2

2.1

8.33

7.76

u/l

0.07

External causes of morbidity and mortality

1551

6300

1.24

13.19

1.4

9.66

9.75

u/l

0.10

1264

5164

Other viral hepatitis

179

991

1.87

13.16

1.4

7.57

7.77

u/l

0.09

124

805

Melanocytic naevi of trunk

226

1334

1.73

13.13

1.4

10.98

9.90

u/l

0.51

185

1095

Spermatocele

117

557

2.14

13.11

1.5

1.4

6.35

6.22

u/l

0.07

461

Thyrotoxicosis, other and/or unspecified

293

1845

1.61

13.08

1.3

12.34

11.75

u/l

0.26

237

1516

Benign neoplasm of mouth and pharynx

148

768

1.96

13.04

1.4

11.70

8.87

u/l

1.33

123

626

Mixed hyperlipidaemia

227

2.85

13.01

1.6

1.3

7.39

7.45

u/l

0.02

187

All influenza

438

3010

1.47

13.01

1.5

8.67

8.30

u/l

0.24

350

2433

Turner's syndrome

7.34

12.98

2.7

1.7

6.56

11.86

u/l

0.77

Dental pulpitis 2, only avohilmo

1235

5008

1.27

12.87

1.4

9.70

9.52

u/l

0.17

987

4090

Symptoms and signs involving speech and voice

422

2884

1.48

12.84

1.4

1.3

12.41

12.04

u/l

0.20

330

2337

Bacterial intestinal infections, IBD co-morbidities

244

1475

1.67

12.83

1.5

1.4

10.27

10.29

u/l

0.01

201

1192

Disorders of refraction and accommodation

591

4286

1.39

12.76

1.6

1.5

9.88

9.31

u/l

0.44

461

3427

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1047

6710

1.28

12.75

1.3

12.09

12.12

u/l

0.02

852

5556

Allergic rhinitis

797

6012

1.33

12.75

1.5

8.66

9.25

u/l

0.72

648

4867

Brain meningioma

235

2.79

12.74

1.5

1.2

12.80

14.23

u/l

0.28

180

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

151

797

1.93

12.72

1.5

1.4

13.37

10.58

u/l

1.04

128

654

Epilepsy

509

3600

1.42

12.69

1.5

10.13

9.35

u/l

0.62

410

2852

Mycoses

420

2878

1.48

12.68

1.5

1.4

11.74

9.97

u/l

1.42

328

2342

Colonic or urogenital fistula

415

2838

1.48

12.64

1.3

1.4

10.16

10.18

u/l

0.01

339

2311

Other benign neoplasms of skin

420

2821

1.47

12.59

1.5

1.3

12.10

10.38

u/l

1.39

323

2286

Melanocytic naevi

543

3905

1.41

12.58

1.4

10.17

10.13

u/l

0.02

439

3196

Candidiasis

228

1364

1.70

12.57

1.4

1.3

13.35

10.66

u/l

1.30

170

1133

Pain associated with micturition

182

1022

1.81

12.56

1.3

1.4

10.11

10.58

u/l

0.16

144

817

Cervicobrachial syndrome

325

2116

1.55

12.54

1.3

10.77

12.05

u/l

0.95

262

1741

Pulmonary embolism

306

1963

1.57

12.53

1.5

1.3

12.78

10.98

u/l

1.18

257

1594

Intracranial injury

1046

7974

1.28

12.53

1.5

1.4

8.93

9.05

u/l

0.11

836

6474

Provisional assignment of new diseases of uncertain etiology

922

7171

1.30

12.52

1.4

10.65

9.39

u/l

1.82

734

5921

Migraine with aura

553

3995

1.40

12.52

1.4

1.3

10.03

10.51

u/l

0.40

467

3303

Dental caries 1, only avohilmo

1388

5720

1.25

12.51

1.4

9.89

9.50

u/l

0.49

1126

4653

Immunodeficiency with predominantly antibody defects

286

2.64

12.50

1.9

1.6

10.07

9.70

u/l

0.07

228

Codes for special purposes

922

7176

1.30

12.46

1.4

10.65

9.38

u/l

1.82

734

5925

Pulmonary heart disease

306

1966

1.57

12.45

1.5

1.3

12.78

10.97

u/l

1.20

257

1597

L04AD Calcineurin inhibitors

220

1310

1.72

12.44

1.8

1.6

11.18

8.34

u/l

1.70

182

1025

TMD related operations

335

2205

1.54

12.43

1.5

1.3

12.47

10.50

u/l

0.73

286

1818

Problems related to lifestyle

247

1517

1.66

12.41

1.5

1.4

8.25

8.23

u/l

0.01

195

1257

Benign neoplasm of other and ill-defined parts of digestive system

176

980

1.82

12.40

1.4

1.3

14.21

10.86

u/l

1.84

139

785

Misadventures to patients during surgical and medical care

202

1173

1.75

12.39

1.5

1.3

12.79

11.16

u/l

0.84

168

970

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

4.12

12.33

1.8

1.4

9.29

7.60

u/l

0.40

Gingival hyperplasia

293

2.59

12.32

1.8

1.6

8.10

8.17

u/l

0.01

216

Hernia of abdominal wall

645

4781

1.36

12.29

1.4

8.84

9.63

u/l

1.02

533

3886

Benign neoplasm: Colon, unspecified

231

1392

1.67

12.27

1.4

1.3

11.52

11.04

u/l

0.18

190

1118

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

410

2.30

12.23

2.4

1.5

6.19

7.53

u/l

0.73

335

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

415

1717

1.49

12.21

2.2

1.4

7.57

6.10

u/l

2.87

336

1388

Sequelae with surgical and medical care as external cause

251

1549

1.64

12.20

1.4

11.24

10.85

u/l

0.16

197

1263

Allergic asthma (mode)

573

4104

1.39

12.17

1.4

9.10

9.40

u/l

0.23

469

3358

Allergic asthma (mode), excluding more controls

573

4104

1.39

12.16

1.4

9.10

9.36

u/l

0.20

469

3356

Cutaneous abscess, furuncle and carbuncle

500

3570

1.42

12.13

1.5

1.4

9.06

8.76

u/l

0.23

418

2915

Renal cell carcinoma of kidney

139

3.32

12.12

1.3

22.24

9.19

u/l

2.55

104

Cervicocranial syndrome

162

888

1.85

12.10

1.3

10.45

12.49

u/l

0.98

129

724

Other diseases of anus and rectum

361

2419

1.50

12.08

1.4

10.29

10.49

u/l

0.10

294

1951

Dental pulpitis 2

1206

4920

1.26

12.04

1.4

9.60

9.51

u/l

0.08

962

4014

Subjective visual disturbances

383

2607

1.49

12.00

1.5

1.4

11.24

10.33

u/l

0.62

312

2143

Other or unspecified ileus, impaction or obstruction

190

1093

1.75

11.96

1.4

11.69

10.27

u/l

0.71

161

879

Other pleural conditions

103

484

2.16

11.91

1.4

12.95

9.97

u/l

1.02

384

Other and unspecified drugs and medicaments

140

738

1.94

11.88

1.6

1.4

13.58

10.40

u/l

1.18

121

601

Other disorders of skin and subcutaneous tissue, not elsewhere classified

190

1099

1.75

11.82

1.4

10.69

10.22

u/l

0.20

157

898

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

331

2.46

11.78

3.2

1.6

9.98

8.05

u/l

0.60

268

Erysipelas

695

4774

1.34

11.76

1.4

9.21

9.41

u/l

0.17

569

3909

Early onset COPD, excluding more controls

238

1462

1.64

11.73

1.4

1.3

9.44

9.07

u/l

0.18

179

1184

Chronic viral hepatitis

157

869

1.87

11.65

1.4

6.81

7.85

u/l

0.73

108

711

Tinnitus

314

2064

1.54

11.64

1.4

9.76

10.66

u/l

0.46

253

1704

Collagenous colitis

131

680

1.96

11.62

1.3

1.4

12.61

10.83

u/l

0.58

104

552

Postprocedural disorders of nervous system

185

1075

1.77

11.55

1.4

1.3

11.85

10.10

u/l

0.81

157

895

Pulmonary heart disease, diseases of pulmonary circulation

324

2145

1.52

11.54

1.5

1.4

12.92

10.90

u/l

1.50

270

1738

Injuries to the neck

491

3534

1.41

11.44

1.3

1.4

9.94

8.76

u/l

1.32

413

2911

In situ neoplasms

403

2662

1.45

11.40

1.3

11.70

11.00

u/l

0.47

329

2176

Other diseases of jaws

128

665

1.97

11.38

1.4

1.3

11.06

10.18

u/l

0.21

103

533

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

114

567

2.04

11.36

1.4

1.3

13.98

8.13

u/l

3.09

464

Optic atrophy

162

3.12

11.35

2.8

1.5

6.54

9.15

u/l

0.68

131

Other noninfective gastroenteritis and colitis

428

3007

1.44

11.33

1.4

1.5

10.40

9.61

u/l

0.53

351

2378

Other diseases of intestine

137

728

1.91

11.27

1.2

1.4

12.79

10.86

u/l

0.63

589

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1749

9963

1.20

11.23

1.5

1.4

10.72

9.98

u/l

1.34

1431

8085

Diseases of inner ear

627

4596

1.34

11.15

1.4

1.3

11.21

11.78

u/l

0.47

512

3732

Migraine with aura and triptan purchases

383

2657

1.47

11.07

1.4

1.3

10.12

10.22

u/l

0.05

325

2195

Diverticular disease of intestine

759

3851

1.31

11.06

1.4

1.3

11.60

11.72

u/l

0.07

620

3130

Extrapyramidal and movement disorders

400

2787

1.45

11.05

1.4

10.18

10.96

u/l

0.57

324

2245

Stomatitis and related lesions

160

902

1.81

11.02

1.4

11.16

9.59

u/l

0.71

123

728

Asthma and allergy

363

2463

1.48

11.01

1.5

1.4

8.49

8.97

u/l

0.32

296

2008

Specific development disorders of scholastic skills

178

1033

1.78

10.97

2.2

1.7

6.72

6.66

u/l

0.03

131

789

Abnormal findings on diagnostic imaging of other body structures

152

843

1.83

10.96

1.6

1.3

15.29

12.39

u/l

1.11

123

689

Emotional disorders and disorders of social functioning with onset specific to childhood

232

1440

1.65

10.95

1.7

6.99

7.23

u/l

0.20

180

1146

Speech and linguistic disorders

301

1920

1.55

10.91

2.1

1.7

6.75

6.77

u/l

0.01

214

1480

Sleep disorders, other/unspecified

473

2.16

10.90

1.4

1.5

10.82

10.00

u/l

0.20

374

Preparation and fitting of bite rail to mouth

269

1741

1.57

10.86

1.5

1.3

12.43

10.44

u/l

0.58

230

1439

Alcohol use disorder, Swedish definition

977

7224

1.26

10.85

1.4

9.04

8.31

u/l

1.13

766

5929

Other shoulder lesions

167

960

1.77

10.75

1.4

11.15

10.59

u/l

0.19

133

790

Asthma and allergy, excluding more controls

363

2477

1.47

10.71

1.5

1.4

8.49

8.96

u/l

0.31

296

2015

Other neurological diseases

910

5771

1.27

10.71

1.5

1.4

11.07

10.59

u/l

0.45

736

4653

Other inflammation of eyelid

186

1103

1.71

10.66

1.4

12.67

10.93

u/l

0.55

136

887

Benign neoplasm of brain and other parts of central nervous system

108

542

2.04

10.64

2.0

1.4

7.61

9.64

u/l

0.92

436

Unspecified misadventure during surgical and medical care

409

2.21

10.62

1.8

1.3

12.19

9.92

u/l

0.83

330

Diseases of the digestive system

626

4716

1.33

10.59

1.5

1.4

11.16

9.52

u/l

1.93

518

3762

Other congenital malformations

227

1425

1.63

10.56

2.0

1.6

8.93

u/l

0.00

161

1100

Other disorders of bladder

152

854

1.81

10.53

1.3

1.4

8.16

8.86

u/l

0.36

122

696

Other CVD

171

992

1.74

10.52

1.4

12.93

10.44

u/l

1.19

142

798

Malignant neoplasm of mesothelium and soft tissue

242

2.58

10.52

1.7

1.3

13.57

9.02

u/l

1.33

186

Injury of muscle and tendon at shoulder and upper arm level

448

3218

1.40

10.48

1.3

1.4

8.00

9.32

u/l

1.81

373

2595

Urticaria and erythema

685

5260

1.31

10.37

1.5

1.4

10.76

10.27

u/l

0.41

576

4243

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

158

2.94

10.33

1.2

24.18

21.80

u/l

0.34

116

Other disorders of eye and adnexa

250

1610

1.58

10.33

1.5

1.4

13.66

10.18

u/l

1.06

190

1310

Myeloid leukaemia

138

3.14

10.32

2.5

1.5

12.79

7.44

u/l

0.95

114

Dental caries 2 and operation codes, only avohilmo

1561

8101

1.20

10.31

1.4

9.91

9.56

u/l

0.46

1259

6617

Benign neoplasm: Rectum, anus and anal canal

174

1021

1.72

10.30

1.4

1.3

11.98

9.61

u/l

1.23

142

810

Noninfectious colitis NAS

239

1525

1.59

10.27

1.4

1.5

9.86

9.52

u/l

0.14

201

1223

Congenital malformations and deformations of the musculoskeletal system

256

1657

1.58

10.27

1.7

1.6

8.37

8.19

u/l

0.08

191

1285

Disorders of synovium and tendon

883

6300

1.27

10.25

1.3

10.83

10.35

u/l

0.49

731

5178

Condition for Implicit Sepsis (Organ dysfunction codes)

1351

8113

1.22

10.21

1.4

10.10

9.72

u/l

0.47

1084

6637

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

4.16

10.21

1.9

1.7

10.26

7.52

u/l

0.49

Diplopia

184

1102

1.69

10.19

1.4

12.24

10.08

u/l

0.95

148

906

Specific developmental disorder of motor function

371

2.32

10.12

2.8

2.2

4.56

5.53

u/l

0.93

244

Anankastic personality disorder

486

2.09

10.12

1.4

1.3

8.90

10.37

u/l

0.43

399

Wide developmental disorders, excluding more controls

111

572

2.01

10.09

1.9

1.6

7.51

7.29

u/l

0.08

444

Umbilical hernia

429

3084

1.41

10.07

1.4

7.52

8.75

u/l

1.87

346

2538

Social phobias

258

1691

1.56

10.03

1.5

1.4

7.60

7.89

u/l

0.20

192

1388

1110

8101

1.23

10.02

1.4

8.96

8.38

u/l

0.88

874

6678

Mental and behavioural disorders due to alcohol

930

7247

1.26

9.99

1.4

9.00

8.18

u/l

1.36

726

5980

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

405

2.16

9.98

1.3

11.96

11.28

u/l

0.14

324

Volume depletion

107

547

1.98

9.95

1.5

11.29

8.80

u/l

0.94

439

Thyrotoxicosis

348

2415

1.45

9.94

1.3

12.52

12.18

u/l

0.15

282

1964

Recurring oral aphthae

421

2.15

9.93

1.5

1.6

12.61

9.22

u/l

1.13

323

Diseases of oesophagus, stomach and duodenum

1919

9948

1.18

9.88

1.4

10.54

9.85

u/l

1.34

1555

8127

Neuromuscular dysfunction of bladder

128

697

1.87

9.88

1.5

1.4

12.46

9.59

u/l

1.01

109

575

Cluster headache, wide,, including avohilmo

119

636

1.92

9.87

1.5

1.4

10.76

9.50

u/l

0.47

108

523

Cerebral palsy and other paralytic syndromes

189

1151

1.67

9.85

1.8

1.5

10.21

9.56

u/l

0.29

145

909

Disorders of continuity of bone

163

955

1.74

9.85

1.6

1.4

9.81

10.40

u/l

0.20

131

779

Autoimmune diseases related-to ILD

1563

11587

1.19

9.85

1.4

10.60

9.59

u/l

2.04

1271

9491

Endometriosis ASRM stages 3,4

365

2562

1.44

9.83

1.2

12.02

13.48

u/l

1.17

312

2114

ILD medications: immunosuppressive drugs

1101

8621

1.23

9.83

1.5

1.4

10.86

9.62

u/l

2.08

920

6989

Melanoma in situ

147

2.99

9.83

1.1

1.3

11.59

10.91

u/l

0.11

123

Benign neoplasm: Ascending colon

109

563

1.96

9.81

1.5

1.3

12.37

9.82

u/l

0.82

452

Later onset COPD, excluding more controls

127

531

1.88

9.73

1.2

1.4

10.75

10.92

u/l

0.05

413

Conjunctivitis

1488

10900

1.20

9.70

1.5

1.4

10.33

9.89

u/l

0.46

1203

8861

Ectopic pregnancy

278

1857

1.52

9.69

1.2

15.02

14.15

u/l

0.37

239

1534

Anosmia

3.64

9.67

1.4

1.2

13.46

13.10

u/l

0.04

Drug-induced neutropenia

479

2.04

9.62

1.7

1.3

13.67

11.44

u/l

0.73

390

Other symptoms and signs involving the urinary system

148

849

1.77

9.62

1.6

1.4

8.80

8.31

u/l

0.20

127

697

Atypical facial pain

360

2.22

9.60

1.4

1.3

12.58

12.89

u/l

0.05

296

Salpingitis and oophoritis

191

1175

1.64

9.50

1.2

15.62

17.73

u/l

0.90

145

962

Coagulation defects, purpura and other haemorrhagic conditions

316

2175

1.47

9.50

1.5

1.4

11.09

9.81

u/l

0.78

246

1753

Other arthrosis

656

3600

1.31

9.50

1.4

1.3

11.16

11.64

u/l

0.34

545

2924

Other hearing loss

236

1498

1.56

9.50

1.5

1.4

10.77

11.52

u/l

0.34

185

1220

Injuries to the head

2143

12065

1.16

9.49

1.5

1.4

9.04

9.68

u/l

1.54

1725

9838

Dizziness and giddiness

1083

7177

1.23

9.46

1.4

11.94

10.86

u/l

1.43

874

5867

Haemorrhage in early pregnancy

532

3901

1.34

9.45

1.2

11.48

13.32

u/l

2.44

456

3215

Retention of urine

361

2143

1.43

9.42

1.4

10.66

9.29

u/l

0.98

280

1718

Cluster headache, strict, including avohilmo

116

625

1.91

9.42

1.4

10.70

9.38

u/l

0.50

106

514

Abnormalities of gait and mobility

140

795

1.78

9.41

1.6

1.5

11.00

9.27

u/l

0.72

107

616

Mental and behavioural disorders due to use of other stimulants, including caffeine

105

551

2.00

9.41

1.5

1.4

6.06

7.13

u/l

0.69

465

Nontoxic multinodular goitre

156

912

1.72

9.39

1.3

1.2

15.55

15.90

u/l

0.08

121

744

Adrenogenital disorders

5.82

9.39

2.6

1.2

7.63

7.18

u/l

0.05

Postpartum care and examination

448

2080

1.40

9.36

1.2

1.3

9.90

11.36

u/l

1.70

396

1652

Bleeding

1146

6843

1.22

9.34

1.4

10.49

9.49

u/l

1.67

915

5524

Enterocolitis due to Clostridium difficile

119

645

1.87

9.30

1.4

11.92

10.30

u/l

0.51

524

Non-allergic asthma (mode)

295

1991

1.48

9.30

1.6

1.5

7.93

9.55

u/l

1.84

227

1602

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

350

2.19

9.30

1.2

1.3

14.80

9.70

u/l

1.83

277

Non-allergic asthma (mode), excluding more controls

295

1991

1.48

9.29

1.6

1.5

7.93

9.53

u/l

1.80

227

1602

Special screening examination for other diseases and disorders

158

933

1.72

9.29

1.3

1.4

10.37

8.75

u/l

0.78

126

771

Benign neoplasm: Adrenal gland

371

2.16

9.28

1.5

1.3

10.85

9.92

u/l

0.25

303

Benign neoplasm: Stomach

411

2.09

9.23

1.3

13.58

10.96

u/l

0.75

326

Injury, poisoning and certain other consequences of external causes

1252

5175

1.22

9.22

1.4

9.80

9.81

u/l

0.01

1026

4202

Dislocation, sprain and strain of joints and ligaments at neck level

357

2533

1.43

9.21

1.3

1.4

10.26

8.87

u/l

1.24

299

2086

Benign neoplasm of mouth and pharynx

148

860

1.75

9.21

1.4

11.70

10.00

u/l

0.64

123

697

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

181

2.71

9.18

1.4

1.3

11.22

8.59

u/l

0.69

146

Mental and behavioural disorders due to alcohol, excluding acute intoxication

781

6189

1.27

9.18

1.4

9.17

7.97

u/l

2.12

603

5096

Hypermetropia

158

939

1.72

9.17

1.9

1.7

9.12

8.01

u/l

0.55

122

709

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

160

955

1.72

9.16

1.5

1.4

10.72

8.56

u/l

0.90

127

774

Other diseases of lip and oral mucosa

196

1226

1.62

9.15

1.5

1.4

12.66

11.17

u/l

0.63

154

998

Hypotension

136

771

1.78

9.14

1.4

1.3

11.56

10.13

u/l

0.51

116

623

Cardiac arrhythmias

1226

6708

1.21

9.12

1.4

10.59

10.06

u/l

0.62

1000

5531

Enthesopathies of lower limb, excluding foot

325

2266

1.45

9.10

1.4

9.63

11.17

u/l

1.32

255

1840

Congenital malformations of genital organs

252

1669

1.53

9.08

1.7

1.5

10.51

9.87

u/l

0.29

200

1334

Astigmatism

153

905

1.73

9.06

1.8

1.7

8.70

7.89

u/l

0.39

117

678

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

136

776

1.78

9.04

1.6

1.3

11.55

10.06

u/l

0.50

110

630

Alcohol use disorder, ICD-based

723

5695

1.28

9.04

1.4

9.27

7.99

u/l

2.18

562

4694

Other and unspecified trigeminal disorders

3.43

9.02

1.3

1.1

4.87

12.66

u/l

3.87

Other and unspecified nonorganic psychotic disorders

464

3449

1.36

9.00

1.3

1.5

8.06

8.20

u/l

0.12

352

2856

Bell's palsy

175

1071

1.66

8.98

1.3

1.4

11.22

9.95

u/l

0.58

137

880

Abnormal findings in secretions and smears from cervix uteri vagina vulva

905

5734

1.25

8.96

1.2

12.58

12.97

u/l

0.30

748

4765

Noninfective enteritis and colitis

847

6795

1.25

8.95

1.4

1.5

9.56

9.31

u/l

0.22

698

5499

Inflammatory disease of uterus

293

2015

1.48

8.94

1.2

1.3

15.05

11.61

u/l

2.69

238

1677

Drug-induced cataract

179

2.72

8.92

1.4

1.5

14.51

9.69

u/l

0.80

145

Assault

337

2385

1.44

8.87

1.4

1.5

8.51

7.43

u/l

0.94

256

1954

Other and unspecified mood [affective] disorders

197

1253

1.61

8.79

1.4

8.14

8.77

u/l

0.36

153

1042

Acne

344

2451

1.43

8.79

1.5

7.76

7.68

u/l

0.05

278

2038

Delayed milestone in childhood

423

2.09

8.79

2.7

2.4

5.16

5.27

u/l

0.05

256

Papilloedema, unspecified

267

2.39

8.71

2.1

1.4

10.11

9.35

u/l

0.17

215

Other noninflammatory disorders of vagina

387

2.09

8.71

1.3

11.63

17.42

u/l

2.50

303

Other disorders of gingiva or/and edentulous alveolar ridge

443

2.03

8.69

1.7

1.5

7.89

9.45

u/l

0.53

337

Open bite

170

1051

1.67

8.66

1.7

1.6

7.48

8.41

u/l

0.61

134

818

Paroxysmal tachycardia

381

2323

1.40

8.64

1.4

11.12

10.12

u/l

0.62

305

1890

Other disorders of bone

369

2662

1.40

8.60

1.5

1.4

8.70

9.48

u/l

0.64

296

2179

Malignant neoplasm of head and neck

471

1.98

8.59

1.3

1.4

14.11

8.16

u/l

2.70

382

Other and unspecified visual disturbances

139

811

1.74

8.58

1.5

1.4

10.46

10.20

u/l

0.08

116

668

Benign neoplasm: Rectum

151

900

1.69

8.54

1.4

1.3

10.99

9.37

u/l

0.78

124

712

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

127

3.03

8.52

1.9

1.7

10.75

6.62

u/l

1.02

110

Protozoal diseases

207

2.55

8.52

1.7

1.4

13.20

9.51

u/l

0.78

160

Symptoms and signs involving cognition, perception, emotional state and behaviour

1638

9816

1.17

8.50

1.4

11.05

10.10

u/l

1.77

1327

8032

Carcinoma in situ of other and unspecified sites

132

2.94

8.49

1.3

9.12

7.09

u/l

0.63

111

Other CVD (FINNGEN)

127

563

1.79

8.46

1.4

1.3

10.93

10.23

u/l

0.21

110

461

Pruritus

165

1012

1.65

8.44

1.4

9.91

11.42

u/l

0.80

142

821

Other peripheral vascular diseases

118

660

1.82

8.43

1.5

1.3

9.55

11.20

u/l

0.66

539

Personal history of other diseases and conditions

292

2025

1.46

8.43

1.6

1.5

8.80

9.39

u/l

0.38

230

1603

Other and unspecified follicular disorders

429

2.04

8.41

1.5

1.4

11.76

8.30

u/l

1.04

357

Sequelae of injuries, of poisoning and of other consequences of external causes

396

2900

1.38

8.41

1.4

9.13

9.06

u/l

0.03

313

2380

Cramp and spasm

477

1.98

8.41

1.4

10.27

8.49

u/l

0.77

389

Diseases of external ear

509

3869

1.33

8.40

1.5

1.4

9.19

9.69

u/l

0.44

408

3100

Other diseases of the digestive system

356

2559

1.40

8.39

1.4

10.93

9.31

u/l

1.44

305

2042

Motor disorders

407

2.13

8.38

2.8

2.1

4.56

5.78

u/l

1.20

258

Nontoxic goitre/thyroid nodule

266

1815

1.48

8.34

1.2

1.3

14.83

15.19

u/l

0.12

213

1491

Other disorders of breast

188

1195

1.59

8.30

1.3

13.23

13.98

u/l

0.28

159

977

Thyroiditis

115

642

1.82

8.30

1.6

1.3

14.46

12.41

u/l

0.63

522

Melanocytic naevi, other sites/unspecified

129

745

1.76

8.30

1.4

1.3

10.28

9.46

u/l

0.31

111

616

Seborrhoeic dermatitis

149

895

1.69

8.28

1.6

1.4

10.36

8.75

u/l

0.71

122

719

Varicella [chickenpox]

129

749

1.78

8.28

1.8

1.5

4.67

6.44

u/l

4.05

108

593

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

100

385

1.93

8.27

1.4

11.36

11.76

u/l

0.08

320

Injuries to the abdomen, lower back, lumbar spine and pelvis

609

4717

1.29

8.27

1.4

10.00

9.06

u/l

0.95

482

3848

Benign neoplasm: Brain, supratentorial

141

2.89

8.23

2.6

1.4

7.68

8.95

u/l

0.20

113

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

210

1102

1.55

8.22

1.2

23.97

20.37

u/l

2.03

174

869

Intestinal adhesions without obstruction

451

1.98

8.21

1.5

1.3

12.48

11.50

u/l

0.23

358

Benign neoplasm of other and ill-defined parts of digestive system

176

1104

1.61

8.17

1.4

1.3

14.21

12.52

u/l

0.66

139

895

Artificial opening status

351

2.12

8.16

1.4

1.5

10.39

8.48

u/l

0.61

272

Autism spe, excluding more controls

416

2.06

8.15

1.6

8.31

7.57

u/l

0.24

336

Benign neoplasm: Tongue

147

2.79

8.11

1.4

1.3

12.90

8.47

u/l

0.94

118

Early lumbar disc prolapse, operated

248

1687

1.50

8.10

1.4

8.62

8.52

u/l

0.04

206

1400

Pleural effusion

139

823

1.70

8.09

1.4

12.94

10.03

u/l

1.28

112

655

Emotional disorders starting during childhood or adolescence

212

1395

1.56

8.08

1.8

1.7

7.15

7.21

u/l

0.04

165

1092

Medial epicondylitis

281

2.26

8.06

1.6

1.4

16.44

11.09

u/l

1.33

229

Fracture of rib(s), sternum and thoracic spine

363

2638

1.39

8.06

1.4

8.75

9.01

u/l

0.16

290

2136

Other viral diseases

683

5415

1.27

8.04

1.6

1.5

9.80

8.69

u/l

1.35

559

4381

All influenza (not pneumonia)

283

1974

1.45

8.03

1.5

8.88

7.67

u/l

0.86

235

1590

Heart failure, not strict

860

4800

1.24

8.02

1.5

1.4

12.16

10.34

u/l

2.90

689

3867

Malignant neoplasm of bladder

287

2.22

8.01

1.2

1.3

15.57

8.55

u/l

3.29

227

Hyperlipidaemia, other/unspecified

350

2390

1.39

8.01

1.4

1.3

9.88

10.21

u/l

0.19

271

1936

Fenamates

258

1178

1.49

8.00

1.3

9.70

9.76

u/l

0.02

211

966

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

4.05

7.99

3.5

2.3

14.03

9.22

u/l

0.56

Arthrosis

1102

5018

1.21

7.94

1.4

1.3

10.70

10.83

u/l

0.10

905

4091

Diagnoses used for exclusion with ILD

298

2099

1.43

7.94

1.4

11.80

10.09

u/l

1.02

245

1698

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1580

8261

1.17

7.94

1.4

9.02

10.35

u/l

4.13

1253

6751

Rash and other nonspecific skin eruption

144

868

1.68

7.91

1.4

10.58

11.22

u/l

0.22

112

696

Other disorders of patella

326

2338

1.41

7.91

1.4

1.3

9.79

10.63

u/l

0.53

259

1906

Disorders of endocrine glands in diseases classified elsewhere

7.97

7.91

2.8

1.8

5.38

8.25

u/l

0.37

Gonarthrosis

840

3886

1.24

7.90

1.4

1.3

11.02

11.81

u/l

0.81

681

3165

Disorder of lipoprotein metabolism, unspecified

127

739

1.74

7.89

1.5

1.3

10.16

10.13

u/l

0.01

101

602

Lesion of ulnar nerve

197

1281

1.56

7.89

1.4

1.3

10.47

9.73

u/l

0.29

168

1060

Disorders of conjunctiva

1577

11353

1.17

7.88

1.5

1.4

10.53

9.77

u/l

1.04

1280

9224

Other heart diseases

1011

5511

1.22

7.88

1.5

1.4

10.89

9.54

u/l

1.93

813

4465

Dislocation, sprain and strain of joints and ligaments of knee

1223

9580

1.19

7.88

1.4

9.15

9.43

u/l

0.32

1018

7875

Other and unspecified local infections of skin and subcutaneous tissue

152

931

1.66

7.87

1.7

1.4

7.96

9.23

u/l

0.75

121

752

Disorders of eyelid, lacrimal system and orbit

1248

8251

1.19

7.86

1.5

1.4

12.24

10.86

u/l

2.24

981

6736

Viral and other specified intestinal infections

606

4658

1.29

7.81

1.7

1.5

7.18

7.46

u/l

0.35

504

3759

malignant neoplasm of female genital organs

515

1.88

7.79

1.6

1.2

24.94

20.43

u/l

1.42

410

1024

7810

1.21

7.78

1.4

8.87

8.27

u/l

0.91

804

6428

Acne vulgaris

276

1939

1.46

7.75

1.5

7.66

7.35

u/l

0.23

227

1608

GI-bleeding

355

2587

1.38

7.74

1.4

11.11

9.20

u/l

1.87

306

2063

Other and unspecified tonsillitis

975

6850

1.22

7.70

1.5

1.4

7.37

7.72

u/l

0.47

802

5592

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

211

1391

1.54

7.69

1.7

1.8

6.91

7.30

u/l

0.22

150

1073

Other skin changes

195

1272

1.55

7.69

1.4

11.84

11.12

u/l

0.30

166

1026

Lateral epicondylitis

192

1249

1.55

7.68

1.4

1.3

12.10

12.19

u/l

0.02

161

1021

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

6.95

7.67

1.2

1.3

16.83

5.51

u/l

—

Childhood asthma (age<16), excluding more controls

516

3157

1.32

7.66

1.5

1.4

8.17

7.69

u/l

0.42

404

2573

Other local infections of skin and subcutaneous tissue

159

992

1.63

7.65

1.7

1.4

8.40

9.23

u/l

0.39

126

800

Alcohol abuse, main dg, excluding more controls

259

1794

1.46

7.65

1.4

8.64

7.88

u/l

0.50

198

1500

Schizophrenia, schizotypal and delusional disorders

632

5010

1.27

7.62

1.3

1.4

8.63

8.60

u/l

0.02

476

4133

Childhood asthma (age<16)

516

3162

1.31

7.60

1.5

1.4

8.17

7.68

u/l

0.43

404

2580

Systemic connective tissue disorders

418

3135

1.34

7.59

1.4

1.3

12.53

11.99

u/l

0.28

339

2549

Neuralgia and neuritis, unspecified

417

1.98

7.55

1.3

1.4

10.17

9.79

u/l

0.10

338

Melanocytic naevi of lower limb, including hip

397

2.01

7.55

1.4

11.44

9.44

u/l

0.47

323

Myeloid leukaemia

165

2.62

7.52

2.5

1.4

12.79

8.17

u/l

0.77

132

Small fibre neuropathy

183

2.53

7.52

1.4

12.71

8.93

u/l

0.63

147

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

589

4641

1.28

7.50

1.4

9.64

9.15

u/l

0.39

478

3813

Schizophrenia or delusion

631

5012

1.27

7.49

1.3

1.4

8.64

8.60

u/l

0.03

475

4133

Urolithiasis

406

3039

1.35

7.49

1.4

9.48

9.37

u/l

0.06

341

2465

Glucagon-like peptide-1 (GLP-1) analogues

519

3294

1.30

7.47

1.3

9.74

11.11

u/l

1.76

392

2679

Benign lipomatous neoplasm

355

2606

1.37

7.44

1.4

10.95

10.99

u/l

0.02

289

2128

Gout

256

1616

1.45

7.40

1.5

1.3

9.09

8.89

u/l

0.10

199

1278

Meniscus derangement

790

4379

1.24

7.40

1.4

9.88

10.77

u/l

1.10

660

3565

Pure hyperglyceridaemia

149

2.70

7.39

1.6

1.2

7.75

8.59

u/l

0.19

124

Sarcoidosis

177

1143

1.57

7.34

1.4

11.54

10.60

u/l

0.31

149

935

In situ neoplasms

403

3022

1.34

7.34

1.3

11.70

12.17

u/l

0.29

329

2475

Malnutrition

168

2.60

7.31

2.3

1.9

7.06

8.67

u/l

0.35

124

Dialysis, with operation codes

183

1193

1.55

7.30

1.6

1.5

12.75

7.54

u/l

3.14

147

948

Vulvovaginal ulceration/inflammation in other diseases

142

876

1.66

7.28

1.2

1.3

11.69

11.22

u/l

0.10

108

724

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

162

1027

1.60

7.28

1.4

1.3

12.12

9.82

u/l

1.18

137

846

Carcinoma in situ, bladder

127

2.82

7.28

1.3

8.87

6.60

u/l

0.71

107

Endometriosis ASRM stages 1,2

327

2384

1.39

7.25

1.2

12.44

13.06

u/l

0.33

287

1959

Parodontitis and operation codes

1247

8233

1.18

7.22

1.4

11.22

10.35

u/l

1.28

1000

6772

Correction of physiology of bite - demanding therapy visit

137

838

1.67

7.22

1.6

1.3

13.75

10.94

u/l

1.08

119

685

Torsion of testis

317

2.14

7.22

1.6

1.7

5.07

4.46

u/l

0.48

259

Other disorders of eyelid

355

2527

1.36

7.20

1.3

12.82

13.35

u/l

0.26

272

2043

Trigeminal neuralgia

403

1.97

7.19

1.4

1.3

15.69

12.02

u/l

0.87

328

Unspecified kidney failure

480

1.87

7.17

1.8

1.4

12.72

8.40

u/l

1.39

391

Chronic periodontitis, complicated

120

709

1.72

7.15

1.3

1.4

14.30

8.31

u/l

2.52

569

Nontoxic single thyroid nodule

432

1.92

7.13

1.2

1.3

13.57

14.13

u/l

0.12

350

Pollen allergy

522

4044

1.29

7.10

1.5

8.20

8.60

u/l

0.36

419

3235

Benign neoplasm of male genital organs

135

2.75

7.09

1.7

1.4

6.26

4.85

u/l

0.44

113

Schizoaffective disorder

158

1007

1.60

7.05

1.2

1.4

8.72

9.23

u/l

0.22

120

836

Poisoning by narcotics and psychodysleptics [hallucinogens]

274

2.23

7.05

1.5

10.62

6.75

u/l

0.91

232

Other disorders of white blood cells

449

1.91

7.04

1.6

1.4

9.83

9.33

u/l

0.10

359

Statin medication

1271

6054

1.18

7.03

1.4

9.18

11.01

u/l

4.88

1016

4997

Heart failure and antihypertensive medication

268

1238

1.44

7.02

1.4

1.3

11.43

9.39

u/l

1.18

210

1000

Renal failure

417

2886

1.33

7.02

1.5

1.4

13.23

9.20

u/l

4.07

328

2301

Nephropathy related operations

181

1189

1.54

7.00

1.6

1.5

12.63

7.63

u/l

2.90

146

938

Mental retardation, excluding more controls

514

1.85

7.00

2.5

1.7

7.35

7.33

u/l

0.01

374

Urticaria

570

4515

1.27

6.97

1.5

1.4

10.51

10.16

u/l

0.25

482

3636

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

233

2.27

6.96

1.5

1.3

15.05

7.22

u/l

2.19

196

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

147

2.62

6.96

1.4

1.3

18.06

9.90

u/l

1.78

120

Familial hypercholesterolemia

141

874

1.63

6.94

1.4

10.26

10.06

u/l

0.06

116

715

Ventral hernia

259

1826

1.43

6.94

1.3

10.53

11.37

u/l

0.48

214

1487

Calculus of kidney and ureter

379

2846

1.34

6.90

1.4

9.19

9.37

u/l

0.10

318

2312

Dermatitis due to substances taken internally

554

1.80

6.89

1.6

1.5

12.66

9.63

u/l

1.23

448

Purpura and other haemorrhagic conditions

200

1347

1.50

6.87

1.5

11.22

9.04

u/l

1.31

157

1083

Mixed specific developmental disorders

493

1.87

6.86

2.5

2.1

6.15

5.81

u/l

0.18

327

Skin changes due to chronic exposure to nonionizing radiation

225

1461

1.46

6.86

1.4

1.3

13.09

13.07

u/l

0.00

174

1155

Injuries to the knee and lower leg

2307

11727

1.13

6.86

1.4

9.87

9.58

u/l

0.46

1886

9551

Other and unspecified disorders of white blood cells

328

2.06

6.85

1.6

1.4

9.65

9.63

u/l

0.00

262

Other systemic involvement of connective tissue

319

2335

1.38

6.85

1.3

12.94

12.38

u/l

0.25

267

1901

Benign neoplasm: Brain, supratentorial

156

2.61

6.83

2.6

1.4

7.68

9.50

u/l

0.31

123

Wilms' tumor, excluding all cancers (controls excluding all cancers)

4.72

6.83

2.8

1.5

16.77

5.03

u/l

—

Melanoma in situ

179

2.45

6.82

1.1

1.2

11.59

11.40

u/l

0.03

137

Conduction disorders

312

1885

1.38

6.81

1.4

1.5

10.53

9.61

u/l

0.55

243

1511

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

137

812

1.63

6.81

1.2

21.17

18.67

u/l

0.92

121

644

Injuries to the shoulder and upper arm

1334

9609

1.17

6.79

1.5

1.4

8.76

9.48

u/l

1.39

1117

7809

Acute myeloid leukaemia and myelodysplastic syndromes

3.58

6.77

3.0

1.3

15.80

8.57

u/l

0.60

Varicose veins of other sites

112

661

1.73

6.77

1.7

1.5

7.57

6.82

u/l

0.23

533

Fracture of lumbar spine and pelvis

219

1503

1.47

6.74

1.4

11.83

9.80

u/l

1.19

171

1215

Other systemic involvement of connective tissue (FG)

308

2234

1.38

6.72

1.3

13.19

12.57

u/l

0.27

257

1831

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

139

2.66

6.70

1.4

10.34

6.00

u/l

1.51

119

Other and unspecified types of non-Hodgkin lymphoma, hilmo

212

2.31

6.68

1.4

1.3

11.22

9.75

u/l

0.32

166

Presbycusis

321

2.03

6.66

1.2

1.3

11.81

12.31

u/l

0.10

253

Benign neoplasm of other and unspecified sites

200

2.35

6.65

1.5

1.3

12.51

10.16

u/l

0.41

165

Complications of internal orthopaedic prosthetic devices, implants and grafts

172

1128

1.53

6.64

1.4

1.3

11.03

11.96

u/l

0.38

133

906

Iron deficiency anaemia secondary to blood loss (chronic)

159

1027

1.56

6.61

1.3

1.4

12.28

11.51

u/l

0.24

127

831

6-mercaptopurine

454

1.89

6.61

2.1

1.5

8.06

7.66

u/l

0.11

368

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

134

2.66

6.60

1.3

9.01

16.32

u/l

1.67

106

Pneumocystosis

101

2.98

6.58

1.8

1.5

11.04

7.54

u/l

0.50

Benign neoplasm: Adrenal gland

423

1.89

6.58

1.5

1.3

10.85

11.66

u/l

0.21

339

Other and unspecified rosacea

111

658

1.71

6.58

1.4

1.3

8.80

12.57

u/l

2.16

545

Other and unspecified disorders of skin and subcutaneous tissue

460

1.85

6.53

1.4

1.3

11.78

10.78

u/l

0.28

376

Adjustment and management of implanted device

156

1006

1.56

6.52

1.3

1.4

11.73

9.36

u/l

1.01

109

805

Atrial fibrillation and flutter

419

2083

1.32

6.51

1.4

9.63

9.77

u/l

0.07

333

1729

Atopic dermatitis, strict definition with reimbursement

778

6231

1.22

6.50

1.6

1.4

9.24

9.26

u/l

0.02

618

5052

255

1704

1.41

6.48

1.4

1.3

12.77

13.03

u/l

0.10

198

1354

Postviral fatigue syndrome

132

2.78

6.47

1.4

1.3

8.55

11.06

u/l

0.56

107

Hypertrophic scar

114

687

1.70

6.44

1.4

10.12

10.08

u/l

0.01

553

Mental and behavioural disorders due to tobacco

129

801

1.64

6.42

1.4

1.3

11.06

9.82

u/l

0.48

653

AV-block

154

901

1.56

6.38

1.4

10.32

9.49

u/l

0.27

118

734

Family history of malignant neoplasm

174

1159

1.52

6.36

1.4

1.3

16.28

12.19

u/l

2.48

155

966

Other disorders of nervous system

421

1.88

6.36

1.6

1.3

12.56

9.36

u/l

1.02

335

Fall on same level

2366

11812

1.12

6.35

1.4

9.70

9.48

u/l

0.34

1895

9642

Acute laryngitis and tracheitis

339

2505

1.35

6.35

1.7

1.5

7.31

7.66

u/l

0.28

276

1987

Other bursopathies

146

935

1.58

6.33

1.3

11.55

10.60

u/l

0.34

123

760

Thrombocytopenia, unspecified

546

1.77

6.32

1.5

1.4

11.97

8.93

u/l

1.08

445

Gastric ulcer

155

1006

1.55

6.31

1.3

1.4

12.57

10.77

u/l

0.66

129

802

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

106

628

1.71

6.31

2.0

1.5

13.68

10.84

u/l

1.01

512

Flat foot [pes planus] (acquired)

112

673

1.68

6.31

1.4

12.15

13.98

u/l

0.51

542

Other disorders starting during childhood or adolescence

197

1348

1.49

6.26

1.8

6.19

7.05

u/l

1.06

142

1021

Hypertrophic disorders of skin

121

746

1.66

6.26

1.4

10.53

9.97

u/l

0.15

602

Persons encountering health services for specific procedures, not carried out

145

933

1.58

6.25

1.4

10.25

8.75

u/l

0.52

761

Sudden idiopathic hearing loss

113

683

1.67

6.23

1.7

1.3

10.68

10.07

u/l

0.18

568

Amblyopia ex anopsia

103

611

1.73

6.23

1.8

1.7

9.11

7.71

u/l

0.48

472

Hidradenitis suppurativa

492

1.82

6.22

1.3

1.4

11.50

9.57

u/l

0.70

412

Diseases of the myoneural junction and muscle

146

940

1.57

6.22

1.7

1.4

9.00

9.13

u/l

0.04

113

760

Benign neoplasm of eye and adnexa

100

585

1.73

6.22

1.4

10.71

10.24

u/l

0.12

484

Other and unspecified effects of external causes

555

4448

1.26

6.21

1.5

1.4

9.73

9.32

u/l

0.29

454

3627

Fall on and from stairs and steps

358

2712

1.33

6.20

1.4

10.61

10.05

u/l

0.30

277

2201

Benign neoplasm: Tongue

169

2.42

6.20

1.4

12.90

10.54

u/l

0.40

133

Smoking dependency

129

809

1.62

6.18

1.4

1.3

11.06

9.83

u/l

0.47

656

Benign neoplasm: Rectum, anus and anal canal

174

1164

1.51

6.17

1.4

1.3

11.98

11.10

u/l

0.32

142

943

Other benign neoplasms of skin

420

3253

1.30

6.15

1.5

1.4

12.10

11.38

u/l

0.41

323

2651

Otitis externa

359

2726

1.33

6.15

1.5

1.4

9.71

9.68

u/l

0.02

294

2197

Alcohol dependence

402

3099

1.31

6.14

1.4

9.38

7.98

u/l

1.57

309

2540

Melanocytic naevi of lower limb, including hip

428

1.86

6.11

1.4

11.44

10.22

u/l

0.25

346

Squamous cell neoplasms and carcinomas of the skin

412

1.86

6.07

1.2

1.3

14.80

10.39

u/l

1.51

322

Galactorrhea

136

2.65

6.05

1.2

14.64

12.68

u/l

0.25

109

Postmenopausal osteoporosis with pathological fracture

3.10

6.04

1.3

1.2

26.01

24.59

u/l

0.13

Vasomotor rhinitis (mode)

105

629

1.69

6.03

1.3

11.98

11.27

u/l

0.18

513

Embedded and impacted teeth

840

5984

1.21

6.03

1.5

1.4

8.30

7.80

u/l

0.40

701

4914

Recurring oral aphthae, including avohilmo

207

1443

1.45

6.03

1.4

1.5

11.80

9.70

u/l

1.19

163

1161

Malignant neoplasm, without specification of site

100

2.84

6.02

1.4

1.2

20.24

9.71

u/l

1.84

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

346

2625

1.33

6.02

1.2

1.3

10.69

10.98

u/l

0.15

278

2186

Melanocytic naevi, other sites/unspecified

129

815

1.61

6.02

1.4

1.3

10.28

10.14

u/l

0.04

111

664

Actinic keratosis

210

1388

1.44

6.01

1.4

1.3

13.39

12.85

u/l

0.21

163

1093

Single spontaneous delivery

471

3183

0.78

6.01

1.2

1.3

11.45

11.38

u/l

0.04

395

2512

Ethmoidectomy

202

1403

1.46

6.00

1.4

1.3

10.70

9.62

u/l

0.48

168

1154

Atrial fibrillation and flutter with reimbursement

280

1302

1.39

6.00

1.4

1.3

10.44

9.72

u/l

0.35

224

1075

Achilles tendinitis

131

830

1.60

5.99

1.4

1.3

8.14

11.33

u/l

2.65

104

672

Insulin, intermediate and long-acting

798

6526

1.20

5.99

1.3

1.5

9.52

8.54

u/l

1.42

617

5272

Blepharochalasis

194

1334

1.46

5.99

1.2

1.3

13.89

15.55

u/l

0.72

146

1071

COPD

394

2496

1.31

5.97

1.3

1.4

10.04

10.09

u/l

0.02

295

1989

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.49

5.96

1.9

1.5

11.37

7.64

u/l

—

Gastroduodenal ulcer

226

1596

1.42

5.96

1.3

1.4

12.50

10.24

u/l

1.25

186

1282

Ocular pain

141

912

1.57

5.96

1.4

11.29

10.02

u/l

0.60

116

744

Unspecified fall

748

6157

1.21

5.94

1.5

9.51

9.22

u/l

0.26

594

4950

Benign neoplasm of ovary

123

768

1.61

5.94

1.2

18.41

16.51

u/l

0.61

100

614

Fibroblastic disorders

238

1704

1.41

5.91

1.4

1.3

10.64

11.25

u/l

0.26

191

1377

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1013

8492

1.18

5.90

1.4

10.40

10.54

u/l

0.08

832

6970

Obstructive hydrocephalus

125

2.66

5.90

3.4

1.7

4.60

7.61

u/l

2.28

Other blood glucose lowering drugs, excl. Insulins

141

911

1.56

5.90

1.2

1.3

8.87

11.35

u/l

1.85

114

740

Pneumonia due to other infectious organisms, not elsewhere classified

238

2.15

5.87

1.5

9.11

9.07

u/l

0.01

197

Status epilepticus

258

2.10

5.86

1.8

1.6

10.26

8.67

u/l

0.29

198

Deep endometriosis

153

1012

1.53

5.83

1.2

10.60

12.81

u/l

1.42

130

846

Visual impairment including blindness (binocular or monocular)

470

1.79

5.83

2.2

1.5

7.67

9.35

u/l

0.91

377

Acute bronchiolitis

200

1257

1.46

5.82

2.1

1.9

6.29

6.80

u/l

0.34

144

934

Faecal incontinence

397

1.86

5.81

1.2

1.3

12.87

14.23

u/l

0.32

320

Oral leukoplakia and related diseases, including avohilmo

575

1.71

5.79

1.3

1.4

12.38

9.81

u/l

0.74

475

Rosacea

152

1005

1.53

5.78

1.3

9.80

12.04

u/l

1.16

119

835

FESS (DNB20)

195

1356

1.45

5.78

1.4

10.83

9.53

u/l

0.60

164

1120

Anorexia

176

2.37

5.77

1.6

1.5

8.56

10.31

u/l

0.37

141

Other and unspecified immunodeficiencies with predominantly antibody defects

133

2.60

5.76

2.4

1.7

9.33

9.95

u/l

0.07

106

Motor neuron disease (with DMD)

3.40

5.76

2.0

1.2

5.97

9.84

u/l

0.78

Injuries to the thorax

618

5050

1.23

5.74

1.4

8.78

u/l

0.00

484

4147

Other chronic obstructive pulmonary disease, including avohilmo

480

3163

1.27

5.73

1.3

1.4

10.48

10.37

u/l

0.06

368

2547

Chronic periodontitis, including avohilmo

1311

8430

1.15

5.72

1.4

11.17

10.34

u/l

1.23

1046

6933

Benign neoplasm: Ascending colon

109

668

1.65

5.71

1.5

1.3

12.37

11.35

u/l

0.25

542

Malignant neoplasm of bone and articular cartilage

3.09

5.71

1.9

1.8

9.87

7.63

u/l

0.28

Unknown and unspecified causes of morbidity

107

654

1.66

5.70

1.5

1.3

9.77

9.69

u/l

0.02

100

538

Soft tissue disorders related to use, overuse and pressure

301

2254

1.34

5.67

1.3

10.49

11.18

u/l

0.37

248

1829

Somnolence, stupor and coma

359

1.90

5.66

1.3

1.4

11.98

8.31

u/l

0.84

297

Congenital malformations of breast

278

2.07

5.65

1.3

1.4

10.50

10.43

u/l

0.01

229

ILD medications: azathioprine

281

2088

1.36

5.65

1.6

1.5

8.67

8.78

u/l

0.06

237

1694

Other diseases of the respiratory system

180

1236

1.47

5.64

1.5

10.11

9.84

u/l

0.11

143

989

Other respiratory disorders and diseases

180

1236

1.47

5.64

1.5

10.11

9.84

u/l

0.11

143

989

Other and unspecified erythematous conditions

222

2.17

5.64

1.4

1.5

9.84

10.45

u/l

0.10

174

Benign neoplasm: Stomach

489

1.76

5.64

1.3

13.58

13.30

u/l

0.05

387

L02BA Anti-estrogens

138

897

1.55

5.64

1.4

1.2

17.96

20.02

u/l

0.71

114

722

Use of disulfiram, acamprosate or naltrexone

164

1110

1.50

5.64

1.3

1.4

7.90

7.41

u/l

0.26

126

912

Malignant neoplasm of breast, HER-positive

209

1454

1.42

5.63

1.2

23.94

22.36

u/l

0.62

173

1175

Diabetes, insulin treatment (Kela reimbursement)

1606

8651

1.14

5.61

1.4

9.04

10.33

u/l

4.00

1275

7075

Autism

488

1.79

5.60

1.6

1.7

8.16

6.86

u/l

0.52

389

Hemiplegia

403

1.84

5.60

1.9

1.4

11.42

10.69

u/l

0.17

320

Algoneurodystrophy

340

1.93

5.59

1.5

1.3

9.65

10.76

u/l

0.28

278

Hydrocele

143

940

1.54

5.58

1.6

1.5

6.88

6.09

u/l

0.49

109

765

Other disorders of glucose regulation and pancreatic internal secretion

140

918

1.55

5.58

1.5

11.19

8.24

u/l

1.33

111

729

Explicit bacterial Sepsis

135

877

1.56

5.57

1.6

1.4

12.03

8.25

u/l

2.49

103

706

Allergic conjunctivitis

1056

8937

1.17

5.57

1.4

10.55

10.52

u/l

0.02

869

7324

Adhesive capsulitis of shoulder

170

1158

1.48

5.57

1.4

1.3

11.72

12.44

u/l

0.25

136

936

Deep bite

268

1732

1.37

5.57

1.9

1.7

7.49

8.19

u/l

0.51

211

1334

Viral infections of the central nervous system

124

792

1.59

5.56

1.5

1.4

9.00

9.49

u/l

0.16

102

647

Parodontitis

1314

8437

1.15

5.56

1.4

11.17

10.35

u/l

1.21

1047

6938

Parodontitis or operation codes

1316

8444

1.15

5.56

1.4

11.16

10.35

u/l

1.18

1049

6943

Carcinoma in situ of other and unspecified sites

165

2.35

5.56

1.3

9.12

7.79

u/l

0.36

129

Abscess of anal and rectal regions

148

984

1.53

5.53

1.4

10.11

7.72

u/l

1.22

120

792

Fungal Sepsis

237

2.11

5.53

1.4

1.3

12.73

9.31

u/l

0.75

190

Malignant neoplasm of prostate

241

2086

0.73

5.52

1.5

1.3

8.56

7.41

u/l

0.94

179

1681

Benign lipomatous neoplasm of other sites/unspecified

448

1.78

5.51

1.4

1.3

9.27

9.69

u/l

0.11

361

Mental and behavioural disorders due to cannabinoids

101

619

1.69

5.51

1.5

6.04

6.70

u/l

0.37

521

Cytomegalovirus infection, IBD co-morbidity

192

2.26

5.51

1.7

1.5

10.23

8.73

u/l

0.34

157

Torsion of ovary, ovarian pedicle and fallopian tube

135

2.50

5.50

1.3

1.4

12.06

14.32

u/l

0.42

106

Third [oculomotor] nerve palsy

100

2.78

5.50

2.2

1.3

5.76

10.72

u/l

1.71

Other viral diseases, not elsewhere classified

375

2908

1.30

5.47

1.6

1.5

9.47

8.81

u/l

0.45

305

2283

Female genital prolapse

207

834

1.44

5.44

1.1

1.2

18.03

20.01

u/l

0.82

155

664

Nasal polyp

243

1774

1.38

5.44

1.4

9.61

9.49

u/l

0.05

208

1464

Acute pancreatitis

234

1699

1.39

5.41

1.5

1.4

9.75

9.19

u/l

0.25

180

1379

Certain conditions originating in the perinatal period

285

1899

1.35

5.37

1.9

1.7

7.40

7.43

u/l

0.02

222

1468

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

506

1.73

5.36

1.4

8.96

9.12

u/l

0.05

420

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

855

7249

1.19

5.35

1.4

9.69

8.92

u/l

0.97

702

5921

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

277

2.04

5.34

2.3

1.9

6.25

8.26

u/l

0.79

195

Acute generalized exanthematous pustulosis

410

1.82

5.34

1.5

13.03

10.21

u/l

0.80

331

Chronic kidney disease

262

1930

1.36

5.34

1.5

1.4

14.21

8.92

u/l

4.02

215

1537

Familial hypercholesterolemia, with ischemic heart disease

431

1.78

5.32

1.3

1.4

9.24

8.70

u/l

0.13

348

Autonomic disorders

169

2.31

5.31

1.7

1.4

11.39

8.24

u/l

0.52

139

Wilms' tumor

3.85

5.31

2.8

1.8

16.77

7.53

u/l

—

Strabismus

493

3967

1.25

5.31

1.7

1.5

9.45

9.46

u/l

0.00

404

3155

Other disorders of kidney and ureter

137

903

1.53

5.31

1.5

1.4

11.45

9.65

u/l

0.77

116

719

Pacemaker

236

1671

1.38

5.29

1.4

11.37

10.10

u/l

0.64

181

1334

Thyrotoxicosis with diffuse goitre

187

1313

1.44

5.28

1.4

1.3

11.68

12.48

u/l

0.31

155

1088

Other diseases of stomach and duodenum

353

1.86

5.26

1.3

13.60

11.02

u/l

0.50

282

Diffuse brain injury

304

1.94

5.26

1.4

1.3

9.41

7.74

u/l

0.57

256

Otitis media, unspecified

301

2105

1.33

5.25

1.8

1.6

7.39

8.06

u/l

0.67

248

1650

Other erythematous conditions

249

2.05

5.25

1.4

1.5

10.97

10.52

u/l

0.07

196

Vestibular neuronitis

104

646

1.63

5.23

1.4

1.3

11.13

10.63

u/l

0.12

523

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

509

1.71

5.21

1.4

1.3

12.05

10.05

u/l

0.71

410

Insulin, fast-acting

602

4960

1.22

5.21

1.4

1.5

9.65

8.17

u/l

2.22

472

4008

Appendectomy

1215

10218

1.15

5.20

1.4

10.05

9.91

u/l

0.14

1025

8400

Disorders of muscles

147

989

1.50

5.20

1.6

1.4

9.16

9.65

u/l

0.20

113

807

Other specified/unspecified dorsopathies

243

2.05

5.19

1.8

1.3

10.39

11.07

u/l

0.13

199

Premature rupture of membranes

578

3484

1.23

5.17

1.2

1.3

10.70

11.31

u/l

0.49

503

2824

258

2.03

5.16

1.3

1.4

11.00

10.37

u/l

0.12

209

Azathioprine

281

2119

1.34

5.16

1.6

1.5

8.67

8.75

u/l

0.04

237

1730

Osteonecrosis

363

1.84

5.15

1.7

1.3

8.64

9.71

u/l

0.32

298

Hernia

1481

8864

1.14

5.15

1.4

9.20

10.02

u/l

1.62

1197

7242

Other chronic obstructive pulmonary disease

368

2381

1.29

5.13

1.3

1.4

10.08

10.13

u/l

0.02

276

1902

Cytomegaloviral disease

218

2.13

5.13

1.7

1.5

9.82

9.54

u/l

0.05

177

Spinal instabilities

204

2.15

5.13

1.5

1.3

12.41

11.04

u/l

0.18

167

Maternal care related to the fetus and amniotic cavity and possible delivery problems

902

4518

1.18

5.13

1.2

1.3

13.05

12.66

u/l

0.32

781

3661

Assault by bodily force

189

1343

1.43

5.11

1.5

8.79

7.65

u/l

0.59

146

1079

Benign neoplasm: Skin of ear and external auricular canal

198

2.15

5.07

1.3

6.70

9.70

u/l

1.29

162

Autoimmune thyroiditis

186

2.22

5.07

1.7

1.3

15.69

10.53

u/l

0.89

149

Other disorders of bone density and structure

274

1.99

5.06

1.6

1.4

9.44

9.36

u/l

0.01

223

Campylobacter enteritis

260

2.01

5.06

1.4

1.3

10.00

9.51

u/l

0.08

209

Any dementia

988

0.60

5.06

1.3

14.19

12.03

u/l

0.51

780

Disorders of sclera, cornea, iris and ciliary body

851

7256

1.18

5.05

1.4

10.12

9.78

u/l

0.28

711

5924

Corns and callosities

514

1.70

5.05

1.5

1.4

10.89

9.99

u/l

0.23

423

Exclusion endpoint for clefts

384

1.85

5.04

2.4

1.9

5.78

7.49

u/l

1.10

291

Hypoglycaemia, other or unspecified

116

749

1.57

5.01

1.6

1.5

11.05

8.26

u/l

0.99

597

Oral lichen ruber planus wide, hypothyreosis or thyroxin

219

2.08

5.00

1.3

1.2

13.82

15.77

u/l

0.25

175

Benign neoplasm of male genital organs

161

2.30

4.99

1.7

1.4

6.26

6.04

u/l

0.05

129

Benign neoplasm: Appendix

3.77

4.98

1.1

1.2

11.00

6.85

u/l

—

Benign neoplasm of other and unspecified sites

227

2.07

4.97

1.5

1.3

12.51

10.80

u/l

0.28

181

Acute pancreatitis (for exclusion)

234

1726

1.37

4.95

1.5

1.4

9.75

9.08

u/l

0.32

180

1400

Malignant neoplasm of eye, brain and central nervous system

376

1.82

4.94

2.3

1.6

7.64

7.81

u/l

0.04

301

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

234

2.04

4.94

1.7

1.4

11.21

8.99

u/l

0.47

190

Cyst of kidney

361

1.82

4.92

1.4

1.3

10.08

9.36

u/l

0.15

287

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

467

3777

1.24

4.90

1.4

8.66

8.65

u/l

0.01

396

3100

Sequelae of other external causes

436

1.75

4.90

1.4

10.02

9.70

u/l

0.07

350

TMD muscular pain linked with fibromyalgia

2.87

4.89

1.4

1.2

14.51

15.27

u/l

0.07

Insulin medication

889

6512

1.17

4.88

1.4

1.5

9.65

8.88

u/l

1.07

692

5278

Acute renal failure

189

1349

1.41

4.87

1.4

11.38

8.78

u/l

1.37

135

1091

Nummular dermatitis

102

643

1.61

4.87

1.6

1.4

10.24

9.11

u/l

0.40

510

Carcinoma in situ, bladder

156

2.29

4.86

1.3

8.87

7.60

u/l

0.32

121

Follicular cysts of skin and subcutaneous tissue

256

1921

1.34

4.86

1.5

1.4

10.50

9.37

u/l

0.64

209

1573

Sequelae of injuries of head

575

1.65

4.85

1.3

1.4

8.25

7.66

u/l

0.21

479

Striking against or struck by other objects

669

5613

1.20

4.84

1.5

8.32

7.78

u/l

0.53

537

4548

Plantar fascial fibromatosis

115

746

1.56

4.84

1.3

12.01

13.28

u/l

0.36

618

Benign neoplasm: Rectum

151

1036

1.47

4.83

1.4

1.3

10.99

10.56

u/l

0.15

124

841

Hypertensive Heart Disease

174

997

1.43

4.83

1.3

8.90

9.92

u/l

0.49

126

795

Pneumothorax

536

1.66

4.82

1.3

1.4

9.59

7.90

u/l

0.67

443

Lichen ruber planus, wide definition including periferal and oral lichen planus

197

1420

1.40

4.80

1.3

11.28

12.34

u/l

0.47

160

1144

Other heart diseases, wide

1761

9779

1.12

4.80

1.4

10.66

9.65

u/l

2.08

1421

7983

Malignant neoplasm of other connective and soft tissue

132

2.40

4.79

1.4

1.3

10.36

9.25

u/l

0.17

100

Other and unspecified diseases of blood and blood-forming organs

177

2.20

4.78

1.7

1.3

7.99

9.61

u/l

0.34

146

Early lumbar disc prolapse operation

256

1931

1.34

4.78

1.4

8.65

8.77

u/l

0.06

212

1603

Viral warts

190

1367

1.41

4.77

1.5

8.21

9.07

u/l

0.41

159

1098

Artrosis, including avohilmo

1379

6669

1.14

4.77

1.4

10.03

10.59

u/l

0.77

1128

5465

Wide developmental disorders

111

724

1.58

4.75

1.9

1.8

7.51

6.52

u/l

0.47

545

Viral meningitis

480

1.71

4.73

1.6

1.4

10.82

9.12

u/l

0.49

393

Pilonidal cyst

209

1532

1.38

4.72

1.6

1.4

5.97

7.53

u/l

2.81

178

1250

Focal epilepsy, strict definition

290

2225

1.31

4.72

1.5

10.44

8.96

u/l

1.01

233

1748

Suppurative and unspecified otitis media

959

7360

1.16

4.71

1.5

1.4

8.90

8.12

u/l

1.16

775

6003

Diseases of arteries, arterioles and capillaries (FINNGEN)

278

1471

1.33

4.70

1.3

1.4

10.48

9.33

u/l

0.64

226

1219

Pervasive developmental disorders excl. Autism + Asperger

255

2.02

4.69

2.2

2.0

6.97

5.99

u/l

0.31

176

Generalized skin eruption due to drugs and medicaments

368

1.80

4.69

1.6

1.5

12.77

10.00

u/l

0.77

294

Leukaemia of unspecified cell type

3.34

4.69

2.4

1.8

9.38

6.45

u/l

0.50

Effects of foreign body entering through natural orifice

441

3566

1.25

4.68

1.5

9.42

7.66

u/l

1.96

358

2895

Lichen simplex chronicus and prurigo

434

1.73

4.68

1.7

1.3

14.15

10.48

u/l

1.06

354

Maltreatment syndromes

137

934

1.50

4.68

1.4

9.20

8.16

u/l

0.49

115

769

Gout, FINNGEN

256

1931

1.33

4.67

1.5

1.4

9.09

8.46

u/l

0.39

199

1548

Manic episode

347

1.83

4.67

1.3

1.4

9.06

9.00

u/l

0.01

288

Autism spe

500

1.70

4.66

1.6

1.8

8.31

6.83

u/l

0.60

404

Degenerative diseases of the nervous system

909

0.59

4.65

1.3

13.31

11.72

u/l

0.35

719

Vitamin deficiency, wide

376

1.78

4.64

1.6

1.4

9.85

9.59

u/l

0.05

298

Vitamin deficiency

376

1.78

4.64

1.6

1.4

9.85

9.59

u/l

0.05

298

Benign neoplasm: Caecum

427

1.72

4.64

1.3

13.05

9.93

u/l

0.90

352

Extreme obesity with alveolar hypoventilation

254

1.96

4.63

1.3

10.47

10.37

u/l

0.02

207

Insulin, fast-acting or short human

602

5022

1.20

4.63

1.4

1.5

9.65

8.22

u/l

2.09

472

4047

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

134

2.35

4.62

2.5

1.5

17.34

7.83

u/l

1.21

114

Other congenital malformations of male genital organs

150

2.37

4.60

2.6

2.2

4.77

4.03

u/l

0.35

Unspecific neurodegenerative disorder

1028

0.64

4.60

1.3

11.80

12.58

u/l

0.19

818

Malignant neoplasm of oral cavity

193

2.11

4.60

1.3

1.4

15.06

7.99

u/l

1.45

153

Atopic dermatitis, strict definition

748

6246

1.18

4.60

1.5

1.4

9.26

9.06

u/l

0.14

590

5072

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

122

2.42

4.60

1.3

1.4

8.56

6.52

u/l

0.78

100

Other and unspecified myopathies

582

1.62

4.59

1.6

1.4

8.57

8.35

u/l

0.05

477

Carbimazole or st.post thyroidectomy, condition for graves disease

278

2130

1.31

4.58

1.4

1.3

12.45

12.30

u/l

0.05

223

1737

Other otitis externa (chronic)

599

1.61

4.57

1.6

1.4

11.07

9.58

u/l

0.61

485

Other specified congenital malformation syndromes affecting multiple systems

330

1.87

4.57

2.3

2.0

5.62

7.47

u/l

1.05

245

Ganglion

326

2552

1.29

4.56

1.3

10.89

10.97

u/l

0.04

281

2083

Heartburn

145

1001

1.46

4.56

1.4

9.27

9.98

u/l

0.28

119

812

Disorders of vitreous body

401

3145

1.25

4.55

1.3

12.84

12.91

u/l

0.03

316

2551

Fracture of lower leg, including ankle

807

6887

1.17

4.54

1.5

1.4

10.19

9.78

u/l

0.37

654

5627

Melanocytic naevi of other and unspecified parts of face

538

1.64

4.54

1.5

1.3

8.46

10.62

u/l

1.10

440

Ptosis of eyelid

576

1.61

4.52

1.5

1.3

9.20

12.03

u/l

1.39

460

Other and unspecified coagulation defects

563

1.63

4.52

1.3

1.4

11.10

10.35

u/l

0.18

457

Other disorders of pigmentation

285

1.89

4.50

1.3

1.4

13.58

9.47

u/l

1.16

224

Excessive vomiting in pregnancy

173

1240

1.42

4.48

1.2

1.3

13.55

11.34

u/l

1.05

143

1015

Other and unspecified urticaria

353

2800

1.27

4.47

1.5

1.4

10.19

10.02

u/l

0.09

301

2251

Mental disorders, not otherwise specified

180

1300

1.40

4.46

1.4

1.3

9.73

9.23

u/l

0.19

146

1077

Specific development disorders of speech and language

160

1091

1.44

4.46

1.9

1.8

6.35

6.84

u/l

0.36

109

824

Carcinoma in situ of skin

243

1.95

4.45

1.4

1.3

10.10

10.50

u/l

0.08

198

Open wound of wrist and hand

849

7250

1.17

4.44

1.4

8.43

8.13

u/l

0.32

686

5932

Car occupant injured in other and unspecified transport accidents

382

3062

1.26

4.44

1.4

8.41

8.87

u/l

0.38

314

2537

Open wound of lower leg

221

1648

1.35

4.43

1.5

10.24

8.31

u/l

1.18

179

1321

Insulin, combination of fast acting with intermediate-acting or long-acting

889

7084

1.16

4.43

1.4

1.5

9.65

8.69

u/l

1.51

692

5725

Respiratory insufficiency

307

1.83

4.41

1.7

1.5

10.16

9.19

u/l

0.28

246

Maternal care for other known or suspected fetal problems

698

3793

1.19

4.40

1.2

1.3

10.33

11.35

u/l

1.31

599

3075

Other epidermal thickening

353

1.79

4.40

1.5

1.4

12.77

8.51

u/l

1.05

280

Benign neoplasm: Skin of eyelid, including canthus

122

819

1.50

4.39

1.3

13.47

10.84

u/l

1.05

663

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

162

1150

1.42

4.38

1.4

1.3

12.12

11.15

u/l

0.36

137

946

Lesion of radial nerve

274

1.89

4.36

1.5

1.3

11.91

10.39

u/l

0.27

227

Other specified/unspecified inflammatory spondylopathies

568

1.61

4.36

1.3

13.67

10.02

u/l

1.15

466

Conjunctivitis (acute, non atopic)

500

4116

1.22

4.35

1.5

1.4

9.92

9.49

u/l

0.34

392

3294

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

107

2.48

4.34

1.5

1.4

13.77

6.23

u/l

1.98

Slow fetal growth and fetal malnutrition

167

2.28

4.34

2.8

2.5

4.63

5.52

u/l

0.45

Postpartum hemorraghe, parous women as controls

543

3958

1.21

4.31

1.2

11.06

12.61

u/l

2.18

478

3355

Other osteochondrodysplasias

134

2.37

4.31

1.6

1.5

12.91

8.66

u/l

0.56

Disorders of speech understanding and production

108

701

1.55

4.31

2.0

1.9

6.06

6.56

u/l

0.30

504

Intestinal malabsorption

446

1.69

4.30

1.5

1.4

11.13

8.21

u/l

0.75

356

Left bundle-branch block

325

1.80

4.30

1.2

1.4

12.16

12.09

u/l

0.01

268

Other benign neoplasms of connective and other soft tissue

116

776

1.51

4.29

1.5

1.3

9.06

10.09

u/l

0.42

102

633

Separation of retinal layers (serosa)

349

1.78

4.27

1.4

6.41

7.28

u/l

0.28

288

Early onset COPD

238

1803

1.33

4.27

1.4

9.44

9.70

u/l

0.12

179

1455

Congenital malformations of the nervous system

389

1.75

4.26

1.6

1.8

7.80

8.44

u/l

0.18

299

Fracture of skull and facial bones

359

2871

1.26

4.25

1.5

8.24

8.14

u/l

0.06

290

2340

Other keratitis

186

1361

1.38

4.25

1.5

1.4

8.81

9.04

u/l

0.09

157

1102

Superficial injury of head

344

2736

1.27

4.25

1.4

9.79

9.18

u/l

0.38

264

2196

Other female pelvic inflammatory diseases

191

1402

1.37

4.24

1.3

1.2

15.48

14.56

u/l

0.29

161

1152

Intussusception

140

2.26

4.23

1.3

14.91

13.64

u/l

0.15

110

Other strabismus

427

3475

1.23

4.22

1.7

1.5

9.49

9.22

u/l

0.16

351

2762

Benign neoplasm: Transverse colon

470

1.65

4.22

1.4

1.3

10.65

8.98

u/l

0.48

382

Benign neoplasm of breast

116

779

1.50

4.20

1.3

1.2

16.91

13.70

u/l

1.23

632

Other specified/unspecified soft tissue disorders

277

1.86

4.20

1.2

1.4

13.60

11.17

u/l

0.48

221

Paralytic strabismus

502

1.63

4.20

2.1

1.4

9.07

9.48

u/l

0.10

401

Benign neoplasm of eye and adnexa

100

651

1.55

4.20

1.4

10.71

10.93

u/l

0.05

537

Crohn disease

247

1890

1.32

4.19

1.4

8.74

8.84

u/l

0.04

212

1530

Benign neoplasm: Rectosigmoid junction

160

2.15

4.17

1.5

1.3

11.62

9.19

u/l

0.30

135

Disorders of orbit

352

1.76

4.15

1.3

13.77

10.95

u/l

0.61

284

Inflammatory diseases of the central nervous system

127

873

1.47

4.14

1.7

1.4

9.84

9.19

u/l

0.22

106

709

Cholecystectomy

832

6359

1.16

4.13

1.3

12.72

12.54

u/l

0.12

672

5184

Hallux rigidus

110

733

1.51

4.13

1.3

13.09

14.14

u/l

0.30

585

Other coagulation defects

117

793

1.50

4.11

1.4

11.48

10.38

u/l

0.29

643

Benign leiomyoma with endometriosis

646

1.54

4.09

1.2

21.72

17.06

u/l

1.46

519

Complications of other internal prosthetic devices, implants and grafts

216

1.97

4.09

2.2

1.3

8.82

10.74

u/l

0.55

172

Symptoms and signs involving emotional state

370

1.74

4.08

1.4

1.5

10.58

8.54

u/l

0.48

301

Infections with a predominantly sexual mode of transmission

701

6001

1.17

4.07

1.3

9.50

9.42

u/l

0.05

563

4994

DVT of lower extremities

185

1360

1.37

4.07

1.4

1.3

12.24

11.01

u/l

0.46

157

1104

Focal epilepsy

322

2556

1.27

4.07

1.5

10.23

9.06

u/l

0.81

262

2022

Fall on same level involving ice and snow

815

7056

1.16

4.07

1.4

10.38

10.22

u/l

0.13

682

5755

False labour

759

4093

1.17

4.06

1.2

1.3

11.47

11.97

u/l

0.44

663

3316

Disorders of vitreous body and globe

410

3256

1.23

4.06

1.3

12.64

12.83

u/l

0.08

324

2638

Other and unspecified nail disorders

156

2.17

4.06

1.5

1.4

9.71

10.18

u/l

0.08

128

Disorders of synovium and tendon in diseases classified elsewhere

156

2.17

4.05

1.4

1.3

8.62

8.14

u/l

0.09

125

Sequelae of injuries of neck and trunk

289

1.84

4.05

1.2

1.4

8.54

8.47

u/l

0.01

239

Superficial injury of abdomen, lower back and pelvis

262

2031

1.30

4.04

1.5

1.4

8.83

8.69

u/l

0.07

204

1663

Ulcer of vagina/vulva

239

1.93

4.04

1.2

1.3

14.81

11.79

u/l

0.43

196

Cysts of oral region, not elsewhere classified

370

1.73

4.04

1.4

10.51

8.33

u/l

0.52

296

Other and unspecified mononeuropathies, also in other diseases

176

2.08

4.04

1.2

1.4

13.94

10.35

u/l

0.50

147

Abnormal blood-pressure reading, without diagnosis

363

1.73

4.02

1.5

1.4

9.24

10.46

u/l

0.35

291

Superficial injury of lower leg

421

3449

1.23

4.01

1.4

9.62

9.29

u/l

0.20

340

2800

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

334

1729

1.27

4.00

1.2

22.54

18.62

u/l

3.51

284

1387

Combinations of oral blood glucose lowering drugs

276

2156

1.29

3.97

1.4

8.01

9.56

u/l

2.06

216

1750

Vitreous haemorrhage

110

741

1.50

3.96

1.4

10.69

9.05

u/l

0.58

597

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

334

1731

1.26

3.96

1.2

22.54

18.62

u/l

3.51

284

1388

Benign neoplasm: Choroid

261

1.86

3.96

1.6

1.3

10.61

10.40

u/l

0.03

211

Pregnancy with abortive outcome

1127

5199

1.14

3.93

1.2

1.3

12.54

12.16

u/l

0.36

949

4284

Sicca syndrome [Sjögren]

511

1.60

3.92

1.2

1.3

13.91

14.91

u/l

0.24

415

Implicit fungal Sepsis

220

1.94

3.91

1.5

1.3

14.03

9.67

u/l

0.90

174

Dipeptidyl peptidase 4 (DPP-4) inhibitors

630

1.54

3.90

1.4

1.3

9.87

10.01

u/l

0.04

501

Superficial injury of forearm

187

1391

1.36

3.90

1.5

9.80

8.53

u/l

0.61

156

1126

Cholecystitis

123

849

1.46

3.90

1.3

11.39

10.23

u/l

0.43

692

Hypertensive heart and/or renal disease

195

1122

1.35

3.90

1.3

9.75

9.82

u/l

0.02

144

887

Oesophageal varices

256

1.86

3.88

1.3

1.4

12.36

7.77

u/l

0.72

199

Seborrhoeic keratosis

165

1201

1.38

3.87

1.5

1.3

11.52

12.66

u/l

0.48

138

976

Other symptoms and signs involving the circulatory and respiratory systems

561

1.57

3.86

1.3

1.4

9.67

9.81

u/l

0.03

441

Budesonide

214

1625

1.33

3.86

1.4

9.18

9.57

u/l

0.19

172

1339

Other arrhythmias

938

6290

1.15

3.86

1.4

10.73

10.42

u/l

0.29

768

5174

Invasive ventilation

593

1.55

3.86

1.7

1.5

9.48

8.44

u/l

0.26

457

Carrier of infectious disease

265

1.86

3.85

1.5

1.3

7.69

9.11

u/l

0.43

212

Any dementia, excluding more controls

900

0.65

3.85

1.3

14.19

12.76

u/l

0.30

721

Mixed disorders of conduct and emotions, excluding more controls

510

1.62

3.85

1.6

1.5

5.99

6.71

u/l

0.53

415

Dementia

122

1209

0.69

3.85

1.3

12.35

12.36

u/l

0.00

959

Chronic ulcer of skin, not elsewhere classified

390

1.68

3.84

1.4

1.3

10.94

9.42

u/l

0.41

310

Melanoma in situ of trunk

3.14

3.84

1.1

1.3

8.86

6.99

u/l

—

Follow-up care involving plastic surgery

279

1.82

3.83

1.1

1.2

19.05

13.24

u/l

1.31

221

Maternal care for cervical incompetence

384

1.70

3.83

1.3

1.2

10.42

12.09

u/l

0.70

314

Iron deficiency

333

1.77

3.82

1.4

5.65

10.21

u/l

5.98

275

Benign neoplasm: Cranial nerves

153

2.13

3.82

1.6

1.3

13.29

9.84

u/l

0.39

129

L04AA Selective immunosuppressants

313

2499

1.26

3.81

1.6

1.4

10.99

10.28

u/l

0.40

261

2017

Cerebrovascular diseases (FINNGEN)

408

2387

1.23

3.78

1.4

1.3

10.92

10.70

u/l

0.10

330

1975

Behavioural disorders, excluding more controls

379

1.71

3.78

1.5

9.07

7.86

u/l

0.33

308

Fitting and adjustment of other devices

263

1909

1.29

3.78

1.4

11.59

10.83

u/l

0.42

226

1519

Cirrhosis of liver, NAS

273

1.82

3.77

1.5

1.4

12.82

8.73

u/l

0.65

223

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

251

1.85

3.76

1.3

1.5

10.51

7.13

u/l

1.47

205

Acute nasopharyngitis (common cold)

238

1831

1.30

3.76

1.4

1.5

6.57

6.30

u/l

0.19

210

1494

Postprocedural disorders of digestive system, not elsewhere classified

209

1.95

3.76

1.6

1.4

13.05

9.66

u/l

0.45

158

Haemorrhage, not elsewhere classified

181

2.02

3.75

1.8

1.4

10.39

7.57

u/l

0.51

144

Acute suppurative otitis media

749

6064

1.16

3.75

1.6

1.5

8.91

7.88

u/l

1.43

594

4942

Correction of physiology of bite - very demanding therapy visit

319

1.76

3.75

1.4

1.3

11.29

11.50

u/l

0.04

264

Total colectomy

433

1.65

3.74

1.5

1.4

10.38

7.87

u/l

0.58

353

Total colectomy operation

433

1.65

3.74

1.5

1.4

10.38

7.87

u/l

0.58

353

Bicipital tendinitis

341

1.72

3.72

1.6

1.4

8.26

9.03

u/l

0.20

270

Disturbances of smell and taste

267

1.82

3.72

1.4

1.3

12.36

11.93

u/l

0.06

211

Benign neoplasm of bone and articular cartilage

120

835

1.45

3.71

1.4

10.16

9.33

u/l

0.27

102

688

Lichen planus

108

735

1.48

3.71

1.3

12.81

12.56

u/l

0.05

594

Social disorders starting during childhood or adolecense, excluding more controls

164

2.13

3.71

1.9

1.7

5.18

6.71

u/l

0.79

127

Other specified disorders of external ear

275

1.81

3.71

1.8

1.4

7.93

8.76

u/l

0.17

220

Other enthesopathy of foot (+metatarsalgia)

125

876

1.44

3.70

1.3

1.4

10.41

12.35

u/l

0.80

105

716

Postprocedural musculoskeletal disorders, not elsewhere classified

357

1.70

3.68

1.5

1.3

11.85

11.27

u/l

0.11

288

Alzheimer disease, including avohilmo

740

0.61

3.67

1.3

13.02

12.91

u/l

0.02

571

Benign lipomatous neoplasm of other sites/unspecified

504

1.58

3.67

1.4

1.3

9.27

11.00

u/l

0.60

407

Otitis externa, unspecified

179

1336

1.35

3.67

1.6

1.4

9.39

9.49

u/l

0.04

154

1075

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

560

1.55

3.67

1.4

1.3

12.05

11.36

u/l

0.18

452

Benign neoplasm: Skin of other and unspecified parts of face

648

1.51

3.66

1.6

1.3

11.26

10.51

u/l

0.21

532

Other specified/unspecified bacterial intestinal infections

482

1.59

3.64

1.5

8.82

9.50

u/l

0.21

396

Nystagmus and other irregular eye movements

164

2.08

3.63

2.2

1.8

9.25

8.76

u/l

0.06

126

Other disorders of urethra and urinary system

1019

6752

1.13

3.63

1.3

12.93

11.51

u/l

1.98

818

5560

Other specified and unspecified disorders of eye and adnexa

299

1.77

3.63

1.4

1.3

13.04

10.27

u/l

0.52

236

Benign neoplasm: Appendix

3.03

3.62

1.1

1.2

11.00

8.08

u/l

—

Other gastritis (incl. Duodenitis)

226

1744

1.30

3.61

1.3

1.4

11.64

10.36

u/l

0.70

180

1417

Haemangioma, any site

100

675

1.50

3.61

1.4

9.25

10.11

u/l

0.28

552

Acute tubulo-interstitial nephritis

879

6842

1.14

3.60

1.4

11.07

10.64

u/l

0.36

705

5559

Heterophoria

155

1136

1.38

3.60

1.4

1.5

10.80

9.29

u/l

0.59

131

902

Nail disorders

127

899

1.43

3.60

1.4

1.5

10.78

8.59

u/l

1.13

105

738

Metatarsalgia

113

782

1.46

3.59

1.3

1.4

11.08

12.52

u/l

0.47

637

Event of undetermined intent

122

859

1.44

3.59

1.4

8.13

7.95

u/l

0.05

690

Family history of other conditions

179

2.03

3.58

1.5

8.61

8.43

u/l

0.03

141

Thyrotoxicosis with toxic single thyroid nodule

2.91

3.58

1.4

1.1

16.72

14.48

u/l

0.22

Other diseases of pericardium

278

1.79

3.57

1.4

1.5

9.75

8.48

u/l

0.29

226

Traumatic subdural haemorrhage

545

1.54

3.57

1.3

7.95

9.52

u/l

0.87

448

Acute pharyngitis

365

2970

1.23

3.57

1.4

1.5

7.51

7.60

u/l

0.06

295

2382

Other and unspecified nonscarring hair loss

2.74

3.56

1.2

7.64

12.60

u/l

1.07

Trochanteric bursitis

113

783

1.45

3.55

1.3

12.59

15.50

u/l

1.31

637

Leukaemia of unspecified cell type

2.80

3.55

2.4

2.0

9.38

7.57

u/l

0.28

Other and unspecified injuries of ankle and foot

607

1.53

3.55

1.4

1.5

10.07

8.22

u/l

0.71

480

Carcinoma in situ of breast, intraductal

256

1.81

3.54

1.1

1.2

21.44

19.17

u/l

0.39

197

Macular pucker

620

1.51

3.54

1.3

14.52

12.12

u/l

0.54

493

Other peripheral vertigo

573

1.53

3.53

1.3

9.72

12.30

u/l

1.28

464

Sequelae of injuries of upper limb

145

1054

1.39

3.52

1.4

10.28

8.75

u/l

0.54

121

854

Fracture of foot, except ankle

429

3573

1.21

3.52

1.4

9.55

8.99

u/l

0.40

355

2897

Haemangioma and lymphangioma, any site

110

761

1.46

3.52

1.4

9.42

9.89

u/l

0.14

620

Alzheimer’s disease, wide definition

516

0.52

3.52

1.2

1.3

15.93

13.04

u/l

0.43

396

Sensorineural hearing loss

789

4810

1.15

3.50

1.5

1.4

10.33

11.06

u/l

0.79

617

3878

Focal epilepsy, mode (most common among epilepsy diagnosis)

269

2133

1.27

3.50

1.5

10.62

9.00

u/l

1.06

219

1677

Cardiac murmurs and other cardiac sounds

180

1340

1.34

3.49

1.6

1.7

8.61

8.91

u/l

0.14

137

1037

Melanocytic naevi of other and unspecified parts of face

576

1.53

3.48

1.5

1.3

8.46

11.10

u/l

1.49

465

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

251

1.82

3.48

1.2

1.4

10.37

9.02

u/l

0.24

210

Streptococcal septicaemia

624

1.50

3.47

1.7

1.5

11.87

8.15

u/l

1.91

498

Lichen planus, including avohilmo

162

1200

1.36

3.47

1.3

11.42

12.12

u/l

0.24

132

966

Scissor bite

636

1.52

3.45

2.0

2.2

5.55

6.35

u/l

0.40

474

Toxic effects of substances chiefly nonmedicinal as to source

206

1585

1.31

3.44

1.5

8.33

8.25

u/l

0.03

166

1274

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

593

1.52

3.44

1.2

1.3

13.93

11.87

u/l

0.56

480

Acute and transient psychotic disorders

194

1482

1.32

3.41

1.3

1.4

9.95

9.25

u/l

0.31

137

1226

Other congenital malformations, not elsewhere classified

135

2.18

3.40

2.2

2.1

11.59

6.02

u/l

0.74

100

Other facial nerve disorders

203

1.90

3.38

1.2

7.95

11.27

u/l

0.90

167

Artificial joint re-operation

253

1.79

3.38

1.3

12.04

12.30

u/l

0.03

198

Nontoxic diffuse goitre

154

2.04

3.37

1.2

17.20

14.59

u/l

0.46

124

Other inflammatory liver diseases

572

1.52

3.37

1.6

1.4

8.89

9.50

u/l

0.19

458

Gonarthrosis [arthrosis of knee](FG)

915

4745

1.14

3.36

1.4

1.3

11.10

11.89

u/l

0.86

745

3871

Benign neoplasm: Skin of ear and external auricular canal

232

1.83

3.36

1.3

6.70

10.19

u/l

1.68

179

Need for other prophylactic measures

541

1.54

3.35

1.5

1.6

7.43

8.29

u/l

0.27

417

Dislocation, sprain and strain of joints and ligaments of thorax

330

1.70

3.34

1.4

7.84

8.73

u/l

0.30

271

COPD, hospital admissions

366

2546

1.22

3.34

1.3

1.4

10.05

10.38

u/l

0.18

274

2040

Dementia, including avohilmo

141

1327

0.73

3.34

1.3

11.81

11.92

u/l

0.03

106

1053

Focal brain injury

461

1.58

3.33

1.3

1.4

8.16

8.11

u/l

0.01

379

Diseases of tongue

422

1.60

3.33

1.3

1.4

12.41

11.15

u/l

0.26

340

COPD, early/later onset

368

2556

1.22

3.32

1.3

1.4

10.08

10.35

u/l

0.15

276

2048

Other and/or unspecified nontoxic goitre

368

1.64

3.30

1.1

1.2

16.52

16.45

u/l

0.01

293

Presence of other devices

171

1286

1.33

3.30

1.1

1.3

11.37

11.72

u/l

0.13

149

1050

Myeloproliferative diseases

478

1.56

3.30

1.6

1.3

12.73

10.32

u/l

0.80

385

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

315

1.69

3.29

1.6

1.4

10.31

9.72

u/l

0.12

258

Vertical strabismus

324

1.70

3.29

1.6

1.4

10.85

9.94

u/l

0.14

258

Impacted teeth

596

4786

1.17

3.28

1.5

1.4

7.99

7.79

u/l

0.19

495

3943

Trigger finger

152

1127

1.36

3.26

1.3

13.56

12.03

u/l

0.53

119

917

Superficial injury of wrist and hand

396

3302

1.21

3.26

1.5

8.42

8.65

u/l

0.16

320

2684

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

148

1096

1.37

3.26

1.2

11.06

13.58

u/l

1.31

125

902

malignant neoplasm of male genital organs

427

2262

1.20

3.24

2.2

1.3

7.94

7.09

u/l

1.09

343

1823

Stenosis and insufficiency of lacrimal passages

642

1.48

3.24

1.6

1.5

13.06

12.07

u/l

0.22

508

Other and unspecified vasculitis limited to skin

150

2.04

3.24

1.3

1.4

13.10

9.15

u/l

0.72

116

Paraplegia, diplegia of upper limbs

171

1.97

3.23

1.5

10.07

8.93

u/l

0.19

138

Fracture at wrist and hand level

610

5271

1.16

3.23

1.6

1.5

8.14

8.21

u/l

0.05

501

4286

Abnormal findings in nipple discharge synovial fluid wound secretions

151

2.04

3.21

1.3

1.4

8.79

10.22

u/l

0.24

124

Alzheimer’s disease (Late onset)

444

0.50

3.20

1.1

1.3

18.31

13.21

u/l

0.77

338

Transitory endocrine and metabolic disorders specific to fetus and newborn

361

1.68

3.20

2.3

4.20

5.72

u/l

1.32

223

Atrophic disorders of skin

148

1097

1.36

3.20

1.5

1.4

12.88

12.85

u/l

0.01

114

899

ILD, hospital admission 2, with pulmonary infections

466

1.56

3.19

1.5

1.4

9.16

9.17

u/l

0.01

368

Moderate visual impairment, binocular

151

2.01

3.17

2.6

1.6

7.47

9.44

u/l

0.48

122

Conductive and sensorineural hearing loss

896

5492

1.13

3.16

1.5

1.4

10.29

10.90

u/l

0.67

703

4435

!Aliquae complicationes praecoces traumatis

429

1.59

3.16

1.5

7.90

7.78

u/l

0.03

352

Early complications of trauma

429

1.59

3.16

1.5

7.89

7.78

u/l

0.03

352

Malignant neoplasm of brain

305

1.70

3.15

2.5

1.6

6.74

8.22

u/l

0.53

247

Ehlers-Danlos syndrome

153

2.05

3.15

1.3

10.16

10.89

u/l

0.11

125

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

348

1.68

3.15

2.1

2.3

4.14

5.78

u/l

1.44

216

Other disorders of the genitourinary system

564

1.50

3.14

1.2

16.71

17.27

u/l

0.10

448

Alzheimer disease

630

0.61

3.14

1.3

14.37

13.31

u/l

0.18

491

Injuries involving multiple body regions

446

1.57

3.14

1.3

1.4

10.49

8.10

u/l

0.72

369

Retinal breaks without detachment

138

1015

1.37

3.13

1.4

1.3

11.69

11.49

u/l

0.05

112

815

Dislocation, sprain and strain of joint and ligaments of hip

223

1.82

3.13

1.5

1.4

10.27

8.80

u/l

0.24

178

Hypoplasia of dental enamel, prenatal

3.28

3.13

2.8

2.5

3.17

2.92

u/l

—

Type 1 diabetes, wide definition, subgroup 1

419

3524

1.20

3.11

1.4

1.5

8.96

7.90

u/l

0.98

328

2842

Hydrocephalus

414

1.58

3.10

2.7

1.5

8.71

9.63

u/l

0.22

320

Congenital malformations of spine and bony thorax

107

2.29

3.09

1.4

2.0

8.06

9.22

u/l

0.17

Melanoma in situ of trunk

2.74

3.09

1.1

1.2

8.86

9.56

u/l

—

475

1.57

3.08

1.7

1.6

7.88

7.62

u/l

0.09

367

Hyperkalaemia

224

1.80

3.07

1.6

1.4

13.23

8.49

u/l

0.85

180

COPD related to multimorbidity

286

1948

1.24

3.07

1.3

1.4

10.75

10.47

u/l

0.12

213

1558

Other embolism and thrombosis

134

985

1.37

3.07

1.5

1.4

9.13

10.82

u/l

0.88

107

803

Benign neoplasm of major salivary glands

592

1.48

3.07

1.3

1.4

10.02

9.17

u/l

0.23

481

Von Willebrand disease

147

2.03

3.06

1.7

1.3

13.53

11.47

u/l

0.16

118

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

2.30

3.06

1.5

1.4

12.98

6.27

u/l

1.36

Ménière disease

569

1.49

3.03

1.5

1.3

11.90

12.81

u/l

0.26

455

Vasculitis limited to skin, not elsewhere classified

161

1.96

3.02

1.3

1.4

13.50

9.29

u/l

0.82

126

Injury of muscle and tendon at wrist and hand level

204

1597

1.29

3.02

1.5

1.4

9.92

8.19

u/l

1.10

165

1301

Spondyloarthritis

272

2203

1.24

3.00

1.4

10.26

9.68

u/l

0.27

225

1821

Panniculitis affecting regions of neck and back

294

1.69

2.99

1.4

1.3

10.68

10.39

u/l

0.05

237

Spontaneous rupture of synovium and tendon

498

1.52

2.99

1.2

1.4

12.19

11.01

u/l

0.29

406

Iridocyclitis

304

2493

1.23

2.98

1.4

11.04

9.89

u/l

0.69

252

2024

Arthropathies in other diseases classified elsewhere

287

1.70

2.98

1.5

1.3

12.00

9.81

u/l

0.41

225

Dermatophytosis

148

1112

1.34

2.96

1.6

1.4

9.70

8.90

u/l

0.35

124

893

Injury of muscle and tendon at hip and thigh level

125

916

1.38

2.95

1.4

10.38

9.18

u/l

0.44

742

Persistent delusional disorders

639

1.45

2.95

1.4

10.47

8.91

u/l

0.45

519

Crohn's disease of small intestine

129

952

1.37

2.95

1.4

8.31

8.53

u/l

0.08

110

773

Tobacco use

591

1.48

2.94

1.5

1.3

7.73

9.19

u/l

1.10

488

Polyarthrosis

113

779

1.40

2.93

1.3

16.25

17.28

u/l

0.20

620

Palmar fascial fibromatosis [Dupuytren]

122

890

1.38

2.93

1.4

1.3

9.41

9.01

u/l

0.12

725

Other bursal cyst

2.26

2.93

1.0

1.3

16.29

11.27

u/l

0.55

Lung diseases due to external agents

119

865

1.38

2.93

1.3

1.4

11.91

8.86

u/l

1.37

704

Other cataract

370

2390

1.20

2.92

1.4

11.53

11.19

u/l

0.17

296

1916

Preterm labour and delivery

343

2852

1.21

2.92

1.2

12.63

15.14

u/l

2.46

289

2322

Polymyalgia rheumatica

452

1.53

2.92

1.4

1.3

13.04

13.35

u/l

0.06

358

Fibrosis and cirrhosis of liver

445

1.54

2.91

1.5

1.3

12.70

10.50

u/l

0.40

355

LeFortI or BSSRO operation

585

1.48

2.91

1.2

1.4

10.75

10.50

u/l

0.06

482

Keratitis

526

4538

1.16

2.90

1.5

1.4

9.55

9.36

u/l

0.12

442

3701

Other and unspecified disorders of vitreous body

285

2315

1.23

2.89

1.3

13.16

14.09

u/l

0.43

221

1874

Scoliosis

163

1249

1.32

2.88

1.6

1.5

11.39

8.68

u/l

1.29

130

1008

Bruxism

223

1.79

2.88

1.6

1.2

14.47

11.23

u/l

0.47

178

Disorders of iron metabolism

116

2.12

2.87

1.7

1.2

3.51

7.30

u/l

3.42

Thyrotoxicosis with toxic multinodular goitre

244

1.74

2.87

1.1

1.2

16.94

14.55

u/l

0.38

190

Right bundle-branch block

200

1.82

2.87

1.4

9.57

9.38

u/l

0.03

164

Dystonia

439

1.54

2.87

1.4

8.01

10.76

u/l

1.23

354

COPD-related respiratory insufficiency

535

1.48

2.87

1.2

1.3

8.59

10.08

u/l

0.58

433

Other nonscarring hair loss

2.30

2.86

1.2

7.79

11.51

u/l

0.88

Hypermobility syndrome

112

813

1.40

2.86

1.3

11.54

11.03

u/l

0.11

661

Second line medication for Crohn's disease

867

7737

1.12

2.86

1.5

1.4

10.79

10.17

u/l

0.64

717

6295

Dementia in Alzheimer disease

368

0.49

2.85

1.3

17.99

12.41

u/l

0.74

280

Haemolytic anaemias

299

1.66

2.84

1.5

10.47

9.13

u/l

0.29

242

Malignant neoplasm of endocrine gland

562

1.47

2.83

1.7

1.4

14.16

11.59

u/l

0.73

449

Other and unspecified paralytic syndromes

110

2.14

2.83

1.5

12.86

9.45

u/l

0.40

Anaemia in chronic diseases classified elsewhere

144

1.98

2.83

1.6

1.4

16.50

8.10

u/l

1.07

110

Gout, idiopatic and unspecified

206

1628

1.27

2.83

1.5

1.4

8.82

8.15

u/l

0.36

158

1313

Other surgical follow-up care

370

1.59

2.82

1.4

9.10

9.07

u/l

0.01

301

Gluteal tendinitis

216

1.78

2.82

1.1

1.3

13.19

14.39

u/l

0.18

168

Heart failure and coronary heart disease

126

1264

0.74

2.82

1.2

1.4

13.94

9.32

u/l

2.02

1006

Prolonged pregnancy

285

3153

0.82

2.81

1.1

1.3

12.42

10.74

u/l

1.03

252

2561

Other disorders of the musculoskeletal system and connective tissue

147

1113

1.33

2.81

1.3

1.4

11.67

10.70

u/l

0.34

116

907

Congenital malformations of the musculoskeletal system, not elsewhere classified

218

1.80

2.80

1.5

1.6

9.54

10.35

u/l

0.15

182

Recurrent dislocation of patella

134

1005

1.35

2.80

1.4

10.65

9.24

u/l

0.50

104

835

Benign neoplasm: Cranial nerves

173

1.88

2.79

1.6

1.3

13.29

10.48

u/l

0.30

141

Other specified/unspecified systemic involvement of connective tissue

442

1.53

2.79

1.3

1.4

11.94

12.24

u/l

0.06

356

Residual foreign body in soft tissue

549

1.48

2.77

1.3

1.5

6.72

7.59

u/l

0.46

452

Care involving dialysis

681

1.42

2.77

1.7

1.5

12.60

7.95

u/l

1.62

530

Drug-induced hypopituitarism

4.89

2.77

3.3

1.9

8.53

5.16

u/l

—

Monoplegia

111

2.12

2.77

1.3

1.2

15.11

9.98

u/l

0.63

Mental retardation, wide definition

683

1.43

2.77

2.4

1.8

7.61

7.04

u/l

0.22

496

Congenital deformities of feet

373

1.59

2.76

1.6

8.96

8.21

u/l

0.15

296

Postpartum haemorrhage

543

4104

1.16

2.76

1.2

11.06

12.34

u/l

1.58

478

3325

Other neurotic disorders

340

1.60

2.75

1.5

1.3

10.26

9.69

u/l

0.10

278

Phlebitis and thrombophlebitis (not including DVT)

239

1930

1.24

2.74

1.5

1.3

12.29

11.15

u/l

0.50

189

1587

Mental retardation

668

1.43

2.73

2.5

1.8

7.35

6.97

u/l

0.14

484

ILD, hospital admissions 3, with pneumonia sepsis

364

1.58

2.73

1.4

9.36

9.76

u/l

0.12

291

Anxious personality disorder

296

1.66

2.73

1.3

1.4

6.65

8.27

u/l

0.65

245

Asthma mixed form (mode)

485

1.50

2.72

1.6

1.4

8.85

8.83

u/l

0.00

394

Other specified/unspecified arthritis

359

3021

1.19

2.71

1.3

1.4

11.27

10.46

u/l

0.51

292

2421

Foreign body on external eye

258

2106

1.23

2.71

1.4

1.5

7.59

6.56

u/l

0.80

207

1726

Benign neoplasm of middle ear and respiratory system

526

1.48

2.71

1.2

1.4

9.87

8.38

u/l

0.41

431

Unspecified urinary incontinence

485

1.49

2.71

1.4

14.79

13.07

u/l

0.25

382

Gout, unspecified

165

1276

1.30

2.71

1.5

1.4

9.01

8.08

u/l

0.44

127

1021

Chondropathies

255

2079

1.24

2.71

1.5

1.4

8.77

9.19

u/l

0.23

200

1699

Delivery

526

3214

0.86

2.70

1.2

1.3

12.50

11.37

u/l

1.01

448

2535

Calcific tendinitis of shoulder

389

1.56

2.70

1.2

1.3

14.83

13.77

u/l

0.18

322

Benign neoplasm of ovary

123

912

1.35

2.70

1.2

1.3

18.41

18.32

u/l

0.02

100

736

Injuries to the hip and thigh

528

4192

1.16

2.69

1.4

9.37

9.60

u/l

0.17

426

3384

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

454

1.51

2.69

1.6

1.3

14.29

10.67

u/l

1.04

372

Chronic lymphocytic leukaemia, helper endpoint

2.20

2.68

1.2

1.3

15.67

6.37

u/l

1.92

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

2.20

2.68

1.2

1.3

15.67

6.37

u/l

1.92

Benign neoplasm: Rectosigmoid junction

190

1.81

2.68

1.5

1.2

11.62

10.29

u/l

0.14

149

Use of anticholinesterases

794

0.67

2.67

1.2

1.3

11.44

12.75

u/l

0.29

622

N06DA Anticholinesterases

794

0.67

2.67

1.2

1.3

11.44

12.75

u/l

0.29

622

Muscular dystrophy

2.34

2.67

2.4

1.8

7.82

8.33

u/l

0.06

Congenital malformations of eyelid, lacrimal apparatus and orbit

156

1.94

2.66

1.9

2.2

6.61

6.93

u/l

0.08

122

Otalgia

120

892

1.36

2.64

1.5

10.47

10.22

u/l

0.08

688

Other salmonella infections

305

1.63

2.64

1.4

1.3

10.61

8.95

u/l

0.24

249

Gout, strict definition

141

1072

1.32

2.63

1.4

8.43

7.74

u/l

0.31

110

861

Tooth agenesis EXCLUDE clefts and syndromes

114

845

1.38

2.62

2.0

1.7

6.56

7.88

u/l

1.15

672

Primary gonarthrosis, bilateral

358

2638

1.19

2.62

1.3

11.79

13.33

u/l

1.17

287

2114

Agoraphobia

549

1.47

2.62

1.5

1.4

6.53

8.54

u/l

1.62

448

Extracorporeal dialysis

506

1.48

2.62

1.7

1.5

11.52

7.64

u/l

1.51

402

Acute alcohol intoxication

376

3189

1.18

2.62

1.4

9.04

8.06

u/l

0.96

289

2608

Congenital malformations of uterus and cervix

355

1.59

2.61

1.0

1.3

7.92

11.12

u/l

1.97

290

Adverse effects, not elsewhere classified

338

2843

1.20

2.61

1.5

1.4

10.53

9.98

u/l

0.27

274

2301

Other disorders of prostate

177

1.83

2.61

1.5

1.3

5.42

6.36

u/l

0.41

149

Fracture of femur

185

1330

1.27

2.61

1.5

1.4

9.30

9.70

u/l

0.17

150

1071

Asthma mixed form (mode), excluding more controls

490

1.48

2.60

1.6

1.4

8.85

8.68

u/l

0.05

399

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

531

1.46

2.60

1.5

1.3

14.04

10.96

u/l

0.93

436

Ischaemic heart disease, wide definition

786

4376

1.13

2.60

1.4

10.27

10.18

u/l

0.06

635

3559

630

1.43

2.60

2.3

2.2

5.77

5.83

u/l

0.02

413

Complications of labour and delivery

1012

5090

1.11

2.59

1.2

1.3

12.51

13.10

u/l

0.62

887

4124

Monosomies and deletions from the autosomes, not elsewhere classified

2.72

2.59

3.0

2.8

9.18

4.81

u/l

—

Opening and dilatation of root channel of tooth

110

810

1.37

2.59

1.4

9.27

u/l

0.00

665

Sixth [abducent] nerve palsy

215

1.74

2.58

2.4

1.4

11.96

9.83

u/l

0.35

166

Allergic urticaria

141

1078

1.32

2.58

1.5

10.85

9.70

u/l

0.42

116

855

Examination and encounter for administrative purposes

307

1.61

2.57

1.7

1.3

9.14

7.92

u/l

0.29

254

Lesion of plantar nerve

268

1.65

2.57

1.2

1.3

12.36

16.50

u/l

1.03

220

ILD, hospital admissions 1, main diag only

682

1.40

2.57

1.4

10.39

10.71

u/l

0.09

550

Overjet

559

1.46

2.56

2.0

2.1

6.27

6.93

u/l

0.27

407

Post-traumatic wound infection, not elsewhere classified

254

1.68

2.56

1.5

1.4

8.90

7.92

u/l

0.17

209

Motorcycle rider injured in other and unspecified transport accidents

135

1029

1.33

2.55

1.4

1.5

6.61

6.78

u/l

0.09

111

841

Secondary malignant neoplasm of other and unspecified sites

2.65

2.55

1.5

1.1

22.75

12.06

u/l

1.11

Other chromosome abnormalities, not elsewhere classified

2.39

2.55

2.9

2.1

8.94

7.95

u/l

—

Benign neoplasm: Caecum

500

1.47

2.55

1.3

13.05

11.20

u/l

0.44

399

Abnormal serum enzyme levels

316

2611

1.20

2.55

1.4

7.93

8.22

u/l

0.18

252

2091

Other vitreous opacities

231

1.71

2.54

1.5

1.2

17.21

9.92

u/l

1.03

175

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

158

1.89

2.54

1.7

1.4

11.53

9.16

u/l

0.25

132

Autoimmune diseases excluding thyroid diseases

1960

10116

1.08

2.52

1.4

10.17

8.95

u/l

3.63

1606

8212

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

278

1.64

2.51

1.2

1.4

10.37

9.10

u/l

0.22

225

Carcinoma in situ of skin

293

1.61

2.51

1.4

1.2

10.10

11.76

u/l

0.40

228

Type 1 diabetes

472

4087

1.16

2.51

1.4

1.5

8.72

7.99

u/l

0.66

373

3301

Major anomalies of jaw size

342

1.58

2.50

1.7

1.6

11.84

9.07

u/l

0.59

279

Benign neoplasm: Parotid gland

486

1.47

2.50

1.3

9.86

8.89

u/l

0.24

399

Other and unspecified epidermal thickening

248

1.68

2.50

1.5

1.4

11.89

8.33

u/l

0.54

198

Other benign neoplasms of connective and other soft tissue

116

866

1.35

2.49

1.5

1.3

9.06

11.26

u/l

1.20

102

706

Single delivery by caesarean section

514

2585

1.16

2.49

1.2

1.3

11.21

10.69

u/l

0.34

453

2039

L04AX Other immunosuppressants

825

7410

1.12

2.48

1.5

1.4

10.94

10.24

u/l

0.71

686

6027

Appendicitis, broad definition

1303

10936

1.09

2.48

1.4

9.29

9.78

u/l

0.68

1077

9002

Other/unspecified synovitis and tenosynovitis

142

1092

1.31

2.48

1.3

9.99

10.63

u/l

0.25

116

901

Dermatographic urticaria

107

791

1.37

2.47

1.6

1.3

11.75

10.90

u/l

0.22

649

Other mental disorders due to brain damage and dysfunction and to physical disease

620

1.41

2.47

1.4

10.34

9.87

u/l

0.12

501

Ischemic heart diseases

809

4531

1.12

2.47

1.4

10.29

10.22

u/l

0.05

658

3680

Striae atrophicae

124

2.00

2.46

1.2

1.3

13.79

10.47

u/l

0.41

Other abnormal findings of blood chemistry

359

1.55

2.45

1.6

1.3

11.47

9.36

u/l

0.38

291

Other/unspecified enthesopathies of lower limb, excluding foot

673

1.39

2.44

1.5

1.4

10.36

10.61

u/l

0.06

552

Dementia due to Parkinson's disease

0.00

2.43

0.0

1.2

—

9.33

—

Congenital malformations of eye, ear, face and neck

145

1125

1.30

2.42

1.7

1.6

9.05

8.40

u/l

0.22

114

879

Abrasion of teeth

406

2559

1.17

2.42

1.3

11.34

10.23

u/l

0.74

329

2137

Type 1 diabetes, wide definition

424

3656

1.16

2.41

1.4

1.5

8.97

7.98

u/l

0.90

331

2938

Defects in the complement system

2.23

2.41

1.2

1.5

10.43

10.78

u/l

0.03

Meralgia paraesthetica

235

1.68

2.41

1.4

1.2

9.57

10.21

u/l

0.11

198

Degenerative macular diseases

531

1.44

2.41

1.4

13.61

11.28

u/l

0.47

431

Follicular lymphoma

182

1.77

2.40

1.6

1.3

8.53

9.06

u/l

0.11

151

Bilateral sagittal split ramus osteotomy operation

451

1.49

2.40

1.2

1.3

11.35

10.59

u/l

0.17

371

Suggestive for eosinophilic asthma

700

1.38

2.40

1.5

1.4

10.90

9.20

u/l

0.51

572

Spirochaetal infections, other/unspecified

633

1.40

2.39

1.5

1.4

9.22

11.21

u/l

0.80

511

Superficial injury of ankle and foot

243

2003

1.22

2.38

1.6

1.5

9.30

8.24

u/l

0.88

208

1601

Benign neoplasm of breast

116

872

1.34

2.38

1.3

16.91

15.69

u/l

0.32

715

Diabetic nephropathy, excluding more controls

131

1419

0.76

2.38

1.3

1.4

10.32

8.24

u/l

1.23

100

1163

Infective dermatitis

137

1055

1.31

2.38

1.4

9.73

9.89

u/l

0.05

112

857

Benign neoplasm: Transverse colon

541

1.43

2.38

1.4

1.3

10.65

10.51

u/l

0.03

435

Myopia

260

2158

1.21

2.38

1.5

1.4

10.18

9.07

u/l

0.57

214

1768

Other congenital malformations of circulatory system

221

1.70

2.38

2.0

1.3

11.00

9.51

u/l

0.21

178

Acute appendicitis

1234

10689

1.09

2.37

1.4

9.17

9.75

u/l

0.85

1021

8800

Contraceptive management

742

4663

1.12

2.37

1.3

1.4

11.69

9.40

u/l

4.21

613

3770

Antenatal screening

505

2477

1.15

2.37

1.2

1.3

12.50

12.41

u/l

0.05

432

1962

Diseases of appendix

1307

10960

1.09

2.37

1.4

9.31

9.78

u/l

0.65

1080

9016

Other retinal disorders

658

4694

1.13

2.37

1.4

11.06

9.94

u/l

1.14

513

3796

Tongue abnormality

370

1.53

2.36

1.3

13.73

11.64

u/l

0.42

290

Tooth eruption problems

428

3673

1.16

2.36

1.7

1.5

7.90

7.76

u/l

0.05

348

2979

Other disorders of veins

391

3355

1.17

2.36

1.3

12.89

13.69

u/l

0.46

302

2756

Other necrotizing vasculopathies (FG)

322

1.57

2.36

1.4

13.57

11.09

u/l

0.43

260

Other specified/unspecified disorders of bone/cartilage

229

1.68

2.36

1.5

1.4

6.76

9.11

u/l

0.89

188

Pleural plaque

435

1.48

2.35

1.4

1.3

11.42

8.55

u/l

1.26

345

Angina pectoris

517

3050

1.15

2.34

1.4

9.56

10.10

u/l

0.44

419

2439

Open wound of head

760

6720

1.12

2.33

1.5

8.52

8.36

u/l

0.14

581

5407

Hyperkinetic disorders (excl. ADHD)

403

1.52

2.33

1.5

2.0

6.63

6.38

u/l

0.06

295

Disorder of the sleep-wake schedule

262

1.64

2.33

1.5

1.7

5.00

8.02

u/l

2.53

214

Lesion of lateral popliteal nerve

388

1.51

2.32

1.4

1.3

10.02

9.12

u/l

0.23

325

Myocarditis

478

1.46

2.32

1.7

1.4

11.07

7.72

u/l

0.84

394

Benign neoplasm: Other and unspecified parts of mouth

207

1.71

2.32

1.4

11.28

9.17

u/l

0.46

174

Spondylopathies (FG)

235

1936

1.22

2.31

1.4

9.62

9.50

u/l

0.05

196

1605

Viral pneumonia

167

1325

1.27

2.31

1.6

1.5

9.20

8.49

u/l

0.31

131

1057

Abnormal spermatozoa

110

825

1.34

2.31

1.4

8.95

7.09

u/l

0.58

667

Other necrotizing vasculopathies

388

1.51

2.31

1.4

15.57

10.29

u/l

1.10

313

Radial styloid tenosynovitis [de Quervain]

537

1.43

2.31

1.2

1.3

11.34

11.94

u/l

0.14

444

Bacterial pneumonia (organism specified)

528

4224

1.14

2.31

1.5

1.4

10.02

9.32

u/l

0.62

434

3432

Alcohol abuse, main dg

259

2155

1.21

2.30

1.4

8.64

7.66

u/l

0.71

198

1757

Contact with other sharp object(s)

134

1037

1.31

2.30

1.4

1.5

7.27

8.13

u/l

0.48

107

843

Injury of nerves and spinal cord at neck level

193

1.74

2.30

1.5

8.28

7.47

u/l

0.20

156

Benign neoplasm: Skin of trunk

309

1.57

2.29

1.8

1.4

15.78

8.85

u/l

1.42

250

Unspecified event, undetermined intent

302

1.59

2.29

1.3

1.4

7.69

8.46

u/l

0.15

252

Complications predominantly related to the puerperium

454

3957

1.15

2.29

1.2

12.58

12.02

u/l

0.33

377

3294

Benign neoplasm: Skin of eyelid, including canthus

122

930

1.32

2.29

1.3

1.4

13.47

12.58

u/l

0.25

757

Other other unspecified disorders of the circulatory system

208

1.70

2.28

1.2

1.4

19.04

11.35

u/l

1.44

158

Benign neoplasm: Skin of other and unspecified parts of face

715

1.36

2.28

1.6

1.3

11.26

11.37

u/l

0.02

580

Papulosquamous disorders

469

4095

1.15

2.28

1.4

10.46

10.48

u/l

0.01

382

3316

Ulcerative ileocolitis

523

1.43

2.27

1.6

1.4

8.38

8.75

u/l

0.09

433

Other disorders of ear

1273

7800

1.09

2.26

1.5

1.4

10.21

10.55

u/l

0.37

999

6331

Maxillary retrognathism

328

1.56

2.26

1.7

1.8

8.22

7.95

u/l

0.05

253

Episcleritis

498

1.44

2.26

1.4

1.3

10.36

10.78

u/l

0.06

409

Antepartum haemorrhage, not elsewhere classified

194

1574

1.25

2.25

1.2

1.3

12.95

11.55

u/l

0.61

167

1282

Glomerular diseases

225

1851

1.22

2.24

1.5

1.4

11.68

8.45

u/l

2.48

181

1490

Conductive hearing loss, unspecified

107

804

1.34

2.24

1.5

9.68

9.97

u/l

0.07

643

COPD, hospital admission 2, with asthma infections

237

1667

1.22

2.24

1.3

1.4

10.64

10.05

u/l

0.27

183

1340

Benign neoplasm: Skin of scalp and neck

187

1.74

2.23

1.7

1.4

12.62

10.31

u/l

0.31

149

Oral leukoplakia and related diseases

295

1.57

2.23

1.2

1.4

17.61

10.25

u/l

1.33

238

Supplementary factors related to causes of morbidity and mortality classified elsewhere

484

4246

1.14

2.22

1.4

1.5

9.96

8.88

u/l

1.09

400

3456

Flatulence and related conditions

2.18

2.22

1.5

1.4

8.53

8.92

u/l

0.04

Fasciculation

122

1.94

2.21

1.3

1.2

7.66

10.98

u/l

0.81

Graves disease, strict definition

145

1139

1.28

2.21

1.4

1.3

11.35

12.13

u/l

0.27

121

956

Mild mental retardation

411

1.49

2.20

2.4

1.8

6.86

7.41

u/l

0.20

314

Emphysema

320

1.54

2.19

1.2

1.3

7.65

9.37

u/l

0.64

255

Acute and subacute iridocyclitis

252

2102

1.20

2.19

1.4

11.67

9.88

u/l

1.05

208

1714

Melanocytic naevi of scalp and neck

258

1.62

2.19

1.4

10.48

8.65

u/l

0.35

218

Acute alcohol intoxication, ICD10

324

2764

1.18

2.19

1.4

8.83

7.77

u/l

0.97

247

2263

Ulcerative enterocolitis

362

1.51

2.18

1.2

1.3

6.91

8.52

u/l

0.72

294

Dependent personality disorder

166

1.78

2.18

1.3

1.2

8.59

10.75

u/l

0.47

135

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

197

1.72

2.18

1.3

1.5

7.51

7.54

u/l

0.01

165

Oral lichen ruber planus, including avohilmo

337

1.53

2.17

1.3

11.66

13.30

u/l

0.31

267

Other arthritis (FG)

414

3598

1.15

2.17

1.3

1.4

11.16

10.43

u/l

0.50

336

2919

Other articular cartilage disorders

166

1.77

2.17

1.3

1.4

8.32

9.72

u/l

0.27

131

Other specified and unspecified retinal disorders

219

1.66

2.17

1.6

1.4

7.50

8.95

u/l

0.35

170

Benign neoplasm of bone and articular cartilage

120

922

1.31

2.17

1.4

10.16

9.69

u/l

0.14

102

761

ILD, hospital admissions

103

773

1.34

2.17

1.4

10.11

10.49

u/l

0.11

625

Carcinoma in situ of skin of other and unspecified parts of face

173

1.74

2.17

1.5

1.3

12.49

9.68

u/l

0.33

135

Family history of certain disabilities and chronic diseases leading to disablement

707

1.36

2.16

1.5

1.4

9.23

9.11

u/l

0.03

574

Intracranial and intraspinal abscess and granuloma

2.15

2.16

1.5

1.3

6.36

8.93

u/l

0.59

Acute inflammation of orbit

2.29

2.16

1.5

11.55

7.45

u/l

—

Gonarthrosis,primary

889

5069

1.10

2.15

1.3

11.34

12.51

u/l

1.52

724

4113

Volvulus

137

1.85

2.15

1.8

1.2

9.34

11.65

u/l

0.48

107

Open wound of ankle and foot

163

1304

1.26

2.14

1.3

1.5

8.64

7.94

u/l

0.36

134

1042

Benign neoplasm: Descending colon

290

1.56

2.14

1.5

1.4

12.60

9.19

u/l

0.69

240

Bacterial pneumonia, not elsewhere classified

454

3514

1.15

2.14

1.5

1.4

10.13

9.41

u/l

0.58

375

2877

Scleritis and episcleritis

571

1.40

2.14

1.4

1.3

9.99

10.84

u/l

0.15

469

Alzheimer’s disease (Late onset), excluding more controls

268

0.55

2.13

1.0

1.2

18.30

14.32

u/l

0.50

213

Other disorders of binocular movement

316

1.55

2.13

1.4

16.79

9.16

u/l

0.45

260

Other fall from one level to another

395

3428

1.16

2.13

1.6

1.5

9.22

7.94

u/l

1.31

316

2734

Social disorders starting during childhood or adolescence

200

1.73

2.12

1.9

5.18

7.01

u/l

0.97

151

Other/unspecified enthesopathies, not elsewhere classified

622

1.38

2.12

1.3

9.47

10.75

u/l

0.52

510

Intermittent heterotropia

136

1068

1.29

2.12

2.2

1.6

5.72

8.01

u/l

3.04

106

807

Benign neoplasm: Choroid

315

1.54

2.12

1.6

1.3

10.62

12.30

u/l

0.35

251

Alzheimer’s disease, wide definition, excluding more controls

324

0.59

2.11

1.2

1.3

15.69

13.81

u/l

0.23

259

Cerebral aneurysm, nonruptured

555

1.40

2.10

1.6

1.3

10.97

12.23

u/l

0.29

452

Puerperal sepsis

118

908

1.31

2.10

1.3

1.2

15.88

16.75

u/l

0.22

756

Special screening examination for neoplasms

221

1.64

2.09

1.7

1.2

11.98

10.25

u/l

0.27

177

D07AA Corticosteroids, weak (group I)

308

2626

1.18

2.09

1.5

9.14

9.04

u/l

0.06

243

2094

Coeliac disease

179

1451

1.24

2.09

1.5

10.86

9.88

u/l

0.35

142

1147

Other and unspecified mononeuropathies of upper limb

245

1.61

2.09

1.4

8.43

9.65

u/l

0.22

207

Other congenital malformations of brain

2.16

2.09

2.3

2.1

7.86

7.74

u/l

—

Interstitial lung disease endpoints

103

778

1.33

2.09

1.4

10.11

10.50

u/l

0.12

629

Interstitial lung disease

103

778

1.33

2.09

1.4

10.11

10.50

u/l

0.12

629

Diabetic retinopathy

298

2213

0.85

2.09

1.3

1.4

11.12

9.05

u/l

1.65

231

1794

Colectomy operation

143

1129

1.27

2.08

1.4

12.97

10.07

u/l

1.10

115

916

5-aminosalicylic acid

373

3231

1.16

2.08

1.4

8.47

8.64

u/l

0.11

311

2659

Tubulo-interstitial nephritis, not specified as acute or chronic

523

1.41

2.07

1.3

11.37

11.46

u/l

0.02

411

Unspecified privation

139

1096

1.28

2.07

1.2

1.4

8.54

8.96

u/l

0.16

106

888

Dental pulpitis 3

508

3236

1.14

2.07

1.6

7.58

7.30

u/l

0.32

409

2575

Other disorders of conjunctiva

118

911

1.30

2.05

1.4

12.68

11.21

u/l

0.48

103

742

Other and unspecified intracranial injuries

278

1.57

2.05

1.4

11.56

8.44

u/l

0.65

222

Presence of other functional implants

437

2702

1.15

2.05

1.4

13.41

11.46

u/l

1.45

354

2155

Disorders resulting from impaired renal tubular function

270

1.57

2.05

1.9

1.6

10.73

8.70

u/l

0.42

209

Peroneal tendinitis

125

1.87

2.05

1.2

1.3

9.54

12.72

u/l

0.56

Disorders of breast

612

5073

1.12

2.05

1.3

1.2

15.15

14.22

u/l

0.74

526

4180

Olecranon bursitis

508

1.41

2.04

1.3

1.4

7.77

6.63

u/l

0.50

412

Superficial injuries involving multiple body regions

311

1.54

2.04

1.3

1.4

9.88

8.27

u/l

0.29

252

Osteomyelitis

500

1.41

2.04

1.5

9.94

8.03

u/l

0.70

405

Mesial bite

171

1.76

2.04

1.9

1.8

7.26

8.21

u/l

0.24

140

Mumps

271

1.57

2.03

1.2

1.3

14.11

9.00

u/l

0.69

223

Chondrocostal junction syndrome [Tietze]

327

1.52

2.03

1.4

1.3

11.53

10.73

u/l

0.15

264

Foreign body in alimentary tract

543

1.40

2.03

1.6

10.60

8.57

u/l

0.45

432

Traumatic subarachnoid haemorrhage

162

1.74

2.03

1.3

8.91

8.17

u/l

0.19

133

Pathological resorption of teeth

287

1.55

2.03

1.7

1.4

11.44

9.13

u/l

0.40

236

Hepatic failure, not elsewhere classified

247

1.60

2.03

1.4

1.5

7.34

9.39

u/l

0.54

200

Other interstitial pulmonary diseases

103

782

1.32

2.02

1.4

10.11

10.47

u/l

0.11

631

Benign neoplasm: other/unspecified salivary gland

104

1.94

2.01

1.3

9.53

10.13

u/l

0.08

Decubitus ulcer and pressure area

287

1.54

2.01

1.1

1.3

10.69

7.83

u/l

0.93

226

Other obstetric trauma

939

0.72

2.01

1.1

1.2

11.00

11.29

u/l

0.05

751

Diseases of peritoneum

732

1.33

2.00

1.3

1.4

13.23

10.75

u/l

0.63

596

Bacterial pneumoniae

492

3850

1.13

2.00

1.5

1.4

10.00

9.26

u/l

0.65

406

3150

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

139

1102

1.27

2.00

1.3

1.4

8.22

9.51

u/l

0.71

114

904

Burns and corrosions

241

2024

1.20

2.00

1.4

1.5

8.85

7.85

u/l

0.84

185

1627

Other infective otitis externa

562

1.38

1.99

1.3

1.4

11.07

9.82

u/l

0.38

449

Postmenopausal atrophic vaginitis

117

540

1.31

1.99

1.1

1.3

26.46

24.74

u/l

0.38

429

Retinoschisis and retinal cysts

119

1.87

1.98

1.2

1.3

14.16

8.67

u/l

0.71

Type of accident

433

3805

1.14

1.98

1.4

9.69

8.93

u/l

0.67

359

3080

Open wound of hip and thigh

437

1.44

1.98

1.5

7.51

7.39

u/l

0.04

355

Calculus of lower urinary tract

329

1.50

1.97

1.4

11.54

8.34

u/l

1.04

267

Cholangitis (primary sclerosing, PSC)

470

1.42

1.96

1.3

1.5

8.68

8.19

u/l

0.08

370

Peripheral arterial reconstruction

751

1.32

1.96

1.3

14.83

9.61

u/l

2.00

599

Autoimmune diseases excluding thyroid diseases, strict definition

1840

9613

1.07

1.96

1.4

10.18

8.96

u/l

3.45

1516

7813

Other inflammation of vagina/vulva

497

1.41

1.95

1.2

1.3

11.37

11.41

u/l

0.01

413

Inflammatory bowel disease

539

4807

1.13

1.95

1.4

8.99

8.96

u/l

0.02

448

3932

Degeneration of macula and posterior pole

263

1832

1.19

1.95

1.3

1.4

13.35

12.29

u/l

0.45

201

1472

Overexertion and strenuous or repetitive movements

149

1195

1.26

1.95

1.4

8.37

8.84

u/l

0.20

120

965

Meningitis

522

1.39

1.94

1.8

1.4

10.25

8.82

u/l

0.40

427

Crohn's disease NAS

114

886

1.30

1.94

1.3

1.5

8.43

8.46

u/l

0.01

712

Chalazion

154

1240

1.25

1.94

1.6

1.4

8.92

9.67

u/l

0.29

116

1008

Barrett oesophagus

306

1.52

1.94

1.6

1.4

6.93

8.54

u/l

0.67

252

Helminthiases

173

1.71

1.93

1.2

1.6

11.87

9.70

u/l

0.35

140

Contusion of other and unspecified parts of foot

103

792

1.32

1.92

1.7

1.5

7.94

8.13

u/l

0.08

630

Hypertrophy of breast

202

1675

1.21

1.91

1.2

1.3

15.09

15.93

u/l

0.32

172

1367

SLE (Finngen)

275

1.54

1.91

1.4

1.3

11.77

11.83

u/l

0.01

223

Failed attempted abortion

213

1.64

1.91

1.2

11.40

12.68

u/l

0.18

180

Somnolence

151

1.76

1.91

1.3

6.86

8.65

u/l

0.71

126

Sacroiliitis, not elsewhere classified

705

1.33

1.91

1.5

1.4

9.40

8.93

u/l

0.13

582

Rheumatoid arthritis, including avohilmo

282

3294

0.85

1.91

1.3

14.35

12.17

u/l

1.46

237

2674

Renal tubulo-interstitial diseases

1307

9310

1.08

1.91

1.4

11.73

10.16

u/l

2.89

1056

7578

Other respiratory diseases principally affecting the interstitium

122

957

1.28

1.90

1.4

10.97

10.31

u/l

0.19

100

768

Alzheimer disease, excluding more controls

374

0.64

1.89

1.3

14.37

13.11

u/l

0.17

300

Disorders in reading

360

1.49

1.89

1.9

5.52

6.76

u/l

0.92

282

Perforation of oesophagus

2.95

1.88

1.3

17.55

6.80

u/l

—

Ankylosis of joint

2.93

1.88

1.4

1.2

6.65

6.39

u/l

—

Effects of other external causes

434

1.43

1.87

1.5

7.82

7.04

u/l

0.23

357

Haemangioma, any site

100

767

1.31

1.87

1.4

9.25

11.10

u/l

0.78

622

Acute lymphadenitis

105

812

1.31

1.87

1.7

1.5

8.36

8.79

u/l

0.13

657

Other acute viral hepatitis

160

1.73

1.86

1.6

1.4

10.34

8.98

u/l

0.16

129

Erythema nodosum

253

1.56

1.86

1.5

1.3

13.13

10.60

u/l

0.52

206

Type1 diabetes, definitions combined, early onset

148

1813

0.80

1.85

1.5

1.7

7.12

7.05

u/l

0.03

115

1404

Toxic liver disease

115

1.86

1.85

1.6

1.2

12.77

9.61

u/l

0.39

Myocardial infarction, unclassifiable

932

0.74

1.85

1.3

1.4

14.37

9.52

u/l

1.03

741

Other complications of labour and delivery, not elsewhere classified

343

2881

1.16

1.84

1.2

1.3

9.13

9.30

u/l

0.09

302

2348

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

135

1078

1.26

1.84

1.4

10.71

8.22

u/l

1.02

872

Unspecified visual impairment (binocular)

123

1.82

1.83

2.0

1.8

7.85

8.20

u/l

0.06

severe traumatic brain injury, does not include concussion

201

1674

1.20

1.82

1.3

1.4

7.94

8.78

u/l

0.52

161

1346

Acute gastritis

528

1.37

1.82

1.2

1.4

11.35

10.09

u/l

0.22

435

Other and unspecified injuries of lower leg

120

948

1.28

1.81

1.4

9.28

9.05

u/l

0.07

106

773

Ankylosing spondylitis

125

992

1.27

1.81

1.3

1.4

8.11

8.98

u/l

0.37

102

807

Other diseases of oesophagus

640

1.33

1.81

1.5

1.4

10.99

9.80

u/l

0.29

520

Impetigo

677

1.33

1.81

2.0

1.5

9.56

8.29

u/l

0.36

522

Artificial joint operation, meniscal resection

1088

6690

1.08

1.80

1.3

1.4

10.09

10.59

u/l

0.61

887

5464

Conduct disorder

447

1.42

1.80

1.5

1.7

9.07

6.95

u/l

0.71

355

Other diseases of gallbladder

223

1.58

1.80

1.3

1.2

12.24

10.46

u/l

0.35

171

Myotonic disorders

1.95

1.79

1.9

1.4

8.63

9.37

u/l

0.12

Chronic pancreatitis

128

1020

1.26

1.79

1.3

1.4

9.76

7.48

u/l

1.31

103

821

Long labour

496

3866

1.13

1.79

1.2

12.62

12.41

u/l

0.11

424

3141

Crowding of teeth, including avohilmo

270

1910

1.18

1.78

2.0

1.7

6.72

7.86

u/l

1.39

206

1495

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

161

1.69

1.78

1.1

1.3

10.28

8.85

u/l

0.22

131

Other noninflammatory disorders of cervix uteri

146

1.72

1.78

1.1

1.3

22.11

22.94

u/l

0.07

112

Benign neoplasm of major salivary glands

660

1.33

1.77

1.3

10.02

10.52

u/l

0.13

541

Behavioural disorders

457

1.41

1.77

1.5

1.6

9.07

7.18

u/l

0.61

363

Procedures for purposes other than remedying health state

185

1.64

1.77

1.2

1.3

16.33

13.02

u/l

0.39

148

Myositis

185

1.64

1.77

1.9

1.5

7.53

8.94

u/l

0.39

144

Multiple myeloma, excluding all cancers (controls excluding all cancers)

177

1.65

1.76

1.9

1.3

11.93

9.16

u/l

0.44

144

Allergic contact dermatitis

196

1637

1.20

1.76

1.3

11.42

11.54

u/l

0.04

159

1352

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1178

0.77

1.76

1.3

1.2

11.44

11.84

u/l

0.11

1016

Other immunodeficiencies

125

1.80

1.76

1.4

9.89

11.00

u/l

0.15

Acute peritonitis

464

1.39

1.75

1.3

1.4

13.75

9.01

u/l

1.00

376

Corneal ulcer

267

2291

1.17

1.75

1.5

1.4

10.59

9.19

u/l

0.87

227

1877

Diabetic retinopathy, excluding more controls

267

1756

0.85

1.74

1.3

1.4

11.42

8.90

u/l

1.96

208

1441

Injuries to unspecified part of trunk, limb or body region

129

1033

1.26

1.74

1.6

1.5

7.68

9.12

u/l

0.95

102

830

Anterior Iridocyclitis

262

2245

1.17

1.74

1.4

11.70

9.89

u/l

1.09

215

1823

Idiopathic gout

541

1.36

1.74

1.4

8.92

7.45

u/l

0.44

437

Simple and mucopurulent chronic bronchitis

225

1.57

1.74

1.5

8.01

9.00

u/l

0.22

175

Palindromic rheumatism

2.17

1.73

1.3

1.2

12.33

12.15

u/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

117

927

1.27

1.73

1.4

11.87

8.75

u/l

1.37

760

Other symptoms and signs involving general sensations and perceptions

323

1.47

1.73

1.3

1.5

7.73

8.33

u/l

0.18

257

Haemangioma and lymphangioma, any site

110

865

1.28

1.73

1.4

1.5

9.42

10.80

u/l

0.52

698

Dermatitis due to ingested food

113

862

1.28

1.73

2.0

1.9

5.97

6.83

u/l

0.93

629

Nonsuppurative otitis media

613

4796

1.11

1.72

1.6

1.5

7.51

7.89

u/l

0.45

489

3873

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

2.04

1.72

1.8

15.63

7.24

u/l

—

Follicular lymphoma, hilmo

202

1.60

1.72

1.6

1.3

8.53

10.22

u/l

0.44

159

Xerosis cutis

1.94

1.72

1.2

15.25

7.40

u/l

1.08

Autoimmune hyperthyroidism

586

1.34

1.72

1.4

1.3

12.83

12.40

u/l

0.09

488

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

728

1.31

1.71

1.7

1.6

7.87

7.86

u/l

0.00

550

Other osteochondropathies

111

876

1.28

1.71

1.5

1.4

9.13

9.12

u/l

0.00

719

Dementia due to Parkinsons disease, excluding more controls

0.00

1.71

0.0

1.2

—

9.19

—

Crohn's disease of large intestine

683

1.32

1.71

1.4

8.31

8.79

u/l

0.15

560

Benign neoplasm: Skin of scalp and neck

203

1.60

1.70

1.7

1.4

12.62

10.48

u/l

0.29

159

Viral pneumonia (unknown virus, not influenza)

771

1.29

1.70

1.5

7.14

7.93

u/l

0.33

626

Disorders of optic nerve, not elsewhere classified

126

1.77

1.69

2.2

1.2

13.05

8.61

u/l

0.45

Noninfective disorders of pinna

3.33

1.69

1.2

5.63

5.89

u/l

—

Carcinoma in situ of breast, intraductal

316

1.46

1.68

1.1

1.2

21.44

21.84

u/l

0.05

253

Other interventions on the root canals of the tooth

228

1.56

1.68

1.5

1.4

6.75

9.23

u/l

0.85

184

Syphilis

260

1.52

1.68

1.4

1.5

7.38

6.81

u/l

0.13

220

Bacterial, viral and other infectious agents

149

1219

1.23

1.68

1.5

1.4

8.13

7.67

u/l

0.15

113

992

Polyarthritis, unspecified

284

1.49

1.68

1.4

12.03

10.32

u/l

0.31

226

Cardiovascular disorders originating in the perinatal period

106

1.92

1.68

2.2

2.6

9.67

5.11

u/l

0.47

Personality and behavioural disorders due to brain disease, damage and dysfunction

134

1.75

1.68

1.7

1.3

5.87

8.21

u/l

0.61

103

Ulcer of lower limb, not elsewhere classified

104

815

1.28

1.68

1.3

10.47

8.89

u/l

0.64

670

Bronchiectasis

333

1.45

1.68

1.4

1.3

14.10

11.66

u/l

0.37

268

Foreign body in respiratory tract

572

1.34

1.67

1.8

1.6

12.79

9.24

u/l

1.18

445

Malignant neoplasm of breast, HER2-negative

311

1984

1.15

1.67

1.2

22.94

21.04

u/l

1.05

264

1613

Open bite that required surgery (Lefort1 or BSSRO)

166

1.68

1.67

1.4

9.74

9.83

u/l

0.01

138

Scar conditions and fibrosis of skin

402

1.41

1.65

1.6

1.4

12.16

10.20

u/l

0.35

324

Maternal care for known or suspected abnormality of pelvic organs

545

3387

1.11

1.65

1.2

12.30

12.24

u/l

0.03

473

2755

Maternal care for known or suspected fetal abnormality and damage

380

2989

1.14

1.65

1.2

1.3

10.66

11.15

u/l

0.27

311

2428

Mixed connective tissue disease

504

1.36

1.64

1.3

11.70

12.86

u/l

0.28

408

Intrahepatic Cholestasis of Pregnancy (ICP)

1165

0.77

1.63

1.3

1.2

11.44

11.88

u/l

0.12

971

Open wound of abdomen, lower back and pelvis

412

1.40

1.63

1.4

1.5

7.71

7.55

u/l

0.04

341

Other disorders originating in the perinatal period

248

1.55

1.63

1.9

2.2

5.94

6.89

u/l

0.28

142

Mixed disorders of conduct and emotions

612

1.33

1.63

1.6

1.7

5.99

6.82

u/l

0.62

488

Duodenal ulcer

582

1.33

1.63

1.3

12.12

9.26

u/l

0.84

471

Eustachian salpingitis and obstruction

168

1398

1.21

1.62

1.4

8.23

8.40

u/l

0.07

133

1146

Myeloproliferative diseases (CML excluded)

420

1.39

1.61

1.4

1.3

12.88

10.28

u/l

0.89

335

Other specified/unspecified necrotizing vasculopathies

1.94

1.61

1.3

1.2

14.58

9.74

u/l

—

Vitamin B12 deficiency anaemia

488

1.36

1.61

1.5

1.3

15.98

11.47

u/l

1.34

387

Malignant neoplasm of breast, HER-negative

102

801

1.28

1.61

1.2

21.03

20.72

u/l

0.06

647

Other infectious diseases

601

1.32

1.61

1.4

11.18

9.12

u/l

0.67

485

561

1.34

1.61

2.4

2.2

5.92

6.02

u/l

0.04

361

Benign neoplasm of middle ear and respiratory system

584

1.33

1.60

1.2

1.4

9.87

9.30

u/l

0.13

471

Other specified/unspecified hearing loss

489

1.36

1.60

1.4

10.15

10.29

u/l

0.03

397

Presbyopia

490

1.36

1.59

1.3

15.63

11.88

u/l

0.59

393

Ulcerative colitis, NAS

228

1951

1.17

1.59

1.4

1.5

8.96

8.95

u/l

0.00

189

1586

Birth trauma

115

1.81

1.58

1.8

2.1

5.03

6.99

u/l

1.48

Hypoplasia of dental enamel, prenatal , including avohilmo

116

1.83

1.57

2.5

5.14

5.53

u/l

—

Infections specific to the perinatal period

291

1.49

1.57

2.1

2.4

6.61

5.44

u/l

0.69

188

Traumatic ischaemia of muscle

145

1.69

1.57

1.4

1.5

6.33

8.80

u/l

0.91

118

L02BB Anti-androgens

435

0.64

1.57

2.8

1.3

8.45

8.33

u/l

0.02

350

Other melanin hyperpigmentation

1.87

1.57

1.1

1.2

17.48

11.38

u/l

0.83

Glomerulonephritis

123

994

1.24

1.57

1.6

1.5

12.27

8.48

u/l

1.65

107

793

Other and unspecified haemorrhagic conditions

122

1.75

1.56

1.1

1.4

14.90

10.47

u/l

0.66

Other and unspecified psoriasis

509

1.35

1.56

1.5

1.3

12.97

9.94

u/l

0.77

406

Sequelae of injuries of lower limb

125

1013

1.24

1.55

1.4

8.71

9.28

u/l

0.21

833

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

295

1766

1.15

1.54

1.3

13.07

10.75

u/l

1.75

235

1401

Pneumonia due to Streptococcus pneumoniae

365

1.41

1.54

1.4

1.5

11.08

8.11

u/l

0.77

302

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

633

1.31

1.54

2.1

1.8

6.17

7.24

u/l

0.66

480

Other congenital malformations of the digestive system

682

1.30

1.53

1.7

1.9

7.91

7.57

u/l

0.10

477

Failed induction of labour

150

1244

1.22

1.53

1.2

1.3

9.55

9.95

u/l

0.19

129

1007

Melanocytic naevi of scalp and neck

283

1.47

1.52

1.4

10.48

9.23

u/l

0.22

240

Hydronephrosis

107

854

1.26

1.52

1.7

1.4

14.20

9.75

u/l

1.57

101

692

Benign neoplasm: Skin of trunk

341

1.42

1.52

1.8

1.4

15.78

9.88

u/l

1.12

274

conjunctival haemorrhage

417

1.37

1.51

1.5

1.3

14.32

10.30

u/l

1.16

336

Kidney transplant status

591

1.32

1.51

1.9

1.6

10.56

7.21

u/l

1.25

470

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

443

1.36

1.51

1.3

1.4

9.30

8.11

u/l

0.31

363

Chronic iridocyclitis

478

1.35

1.50

1.2

1.5

13.56

9.59

u/l

0.93

379

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1207

0.79

1.50

1.3

1.2

12.36

12.17

u/l

0.04

1039

Acute appendicitis, no complications

1005

9338

1.08

1.50

1.4

9.24

9.70

u/l

0.53

838

7689

Chronic lymphocytic leukaemia

116

1.74

1.49

1.2

15.67

7.85

u/l

1.50

Other or ill-defined heart diseases

487

1.34

1.49

1.3

1.5

8.66

7.44

u/l

0.36

408

Multiple myeloma and malignant plasma cell neoplasms

178

1.58

1.49

1.9

1.3

12.34

9.16

u/l

0.51

145

Contact with nonpowered hand tool

514

1.34

1.49

1.5

6.49

6.77

u/l

0.13

425

Other noninfective disorders of lymphatic vessels and lymph nodes

251

1.49

1.5

1.3

12.07

10.76

u/l

0.23

201

Early syphilis

140

1.68

1.48

1.6

1.5

6.64

6.33

u/l

0.05

120

Crohn disease (strict definition, require KELA)

117

949

1.24

1.48

1.4

1.5

7.05

8.23

u/l

0.69

782

Phakomatoses, not elsewhere classified

156

1.64

1.47

2.4

1.7

7.21

7.67

u/l

0.09

120

Rheumatoid arthritis

243

2548

0.86

1.47

1.3

14.92

12.31

u/l

1.66

204

2068

Perioral dermatitis

228

1.51

1.46

1.2

1.3

17.50

10.35

u/l

0.94

190

Dialysis

395

1.38

1.46

1.6

1.7

13.18

7.79

u/l

1.04

317

Recurrent dislocation and subluxation of joint

123

1004

1.23

1.46

1.3

1.4

7.84

9.50

u/l

0.98

826

Other predominantly sexually transmitted diseases, not elsewhere classified

366

3261

1.13

1.46

1.4

1.3

9.61

9.24

u/l

0.19

295

2722

Nephrotic syndrome

353

1.41

1.46

1.6

1.7

9.86

7.56

u/l

0.46

270

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

752

4389

1.09

1.45

1.4

1.3

12.23

10.91

u/l

1.45

612

3621

Superficial injury of hip and thigh

147

1220

1.21

1.45

1.3

1.4

9.86

9.37

u/l

0.20

124

997

Benign neoplasm: Other and unspecified parts of mouth

236

1.50

1.45

1.4

11.28

9.91

u/l

0.27

187

Chronic hepatitis, not elsewhere classified

269

1.46

1.45

1.5

1.3

9.51

10.34

u/l

0.18

213

Transient ischemic attack

391

2891

1.12

1.45

1.4

1.3

11.55

11.38

u/l

0.08

309

2338

Feeding problems of newborn

135

1.73

1.45

1.6

2.1

5.81

6.59

u/l

0.24

Covid-19 suspected case

398

3564

1.12

1.45

1.3

1.4

11.14

9.35

u/l

1.53

317

2917

Herpesviral [herpes simplex] infections

146

1213

1.21

1.45

1.5

1.3

11.63

10.64

u/l

0.32

112

998

Benign neoplasm: Conjunctiva

220

1.51

1.45

1.3

1.4

10.34

9.57

u/l

0.12

184

Complications of genitourinary prosthetic devices, implants and grafts

164

1.60

1.44

1.2

1.3

10.31

12.07

u/l

0.28

137

Viral haemorrhagic fevers, not elsewhere classified/unspecified

763

1.27

1.44

1.4

12.47

8.86

u/l

1.42

629

Other orthopaedic follow-up care

473

1.34

1.44

1.5

1.4

11.18

10.03

u/l

0.23

387

Coronary atherosclerosis

619

3643

1.10

1.44

1.4

9.66

9.76

u/l

0.07

504

2939

Abdominal aortic aneurysm (AAA)

426

1.35

1.43

1.4

1.3

9.66

9.18

u/l

0.09

342

Melanocytic naevi of upper limb, including shoulder

221

1.51

1.43

1.3

10.42

9.91

u/l

0.08

180

Aortic aneurysm

180

1498

1.18

1.43

1.4

10.24

8.05

u/l

1.16

144

1208

Cardiodefibrillation

277

2421

1.14

1.43

1.4

9.57

9.10

u/l

0.23

220

1944

Medical abortion

869

5095

0.93

1.42

1.2

1.3

14.43

12.27

u/l

3.33

702

4198

Anisometropia and aniseikonia

287

1.44

1.42

1.6

9.17

9.85

u/l

0.14

215

Hirsprung

2.87

1.42

2.0

1.9

11.02

3.59

u/l

—

Assault by other specified means

142

1.66

1.42

1.2

1.5

10.82

7.85

u/l

0.57

119

Disorders of lacrimal system and orbit in diseases classified elsewhere

157

1.61

1.41

1.3

1.2

17.06

12.77

u/l

0.53

125

Anogenital herpesviral [herpes simplex] infection

135

1118

1.22

1.41

1.4

1.3

8.03

9.34

u/l

0.78

107

942

Muscle strain

338

1.41

1.8

1.4

8.47

8.20

u/l

0.06

282

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

307

1851

1.14

1.41

1.3

13.31

10.62

u/l

2.21

243

1465

Chronic Coagulation defects

288

1.44

1.41

1.6

1.4

13.47

9.66

u/l

0.53

232

Mandibular hypoplasia

1.86

1.41

1.3

1.4

8.33

8.90

u/l

0.07

Additional codes for the location of defect, injury or illness

536

1.32

1.41

1.5

9.03

9.52

u/l

0.15

435

Impacted maxillary molar

165

1395

1.20

1.40

1.4

7.60

8.13

u/l

0.37

141

1153

SLE, ICD10

288

1.44

1.40

1.4

1.3

11.77

12.00

u/l

0.03

227

SLE, strict definition

288

1.44

1.40

1.4

1.3

11.77

12.00

u/l

0.03

227

Synovial cyst of popliteal space [Baker]

406

1.36

1.40

1.3

1.4

16.22

11.21

u/l

1.20

328

Postpartum haemorrhage due to retained placenta

242

2106

1.16

1.40

1.2

11.78

12.21

u/l

0.20

218

1809

Hepatocellular carcinoma

1.79

1.40

1.3

10.56

7.78

u/l

—

Carcinoma in situ of other and unspecified digestive organs

1.79

1.39

1.7

1.2

9.92

7.44

u/l

0.30

Gastrojejunal ulcer

1.97

1.39

1.2

10.46

9.87

u/l

0.06

Other congenital malformations of nervous system

191

1.56

1.39

1.3

1.8

8.09

9.51

u/l

0.28

152

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

284

1716

1.14

1.39

1.3

13.13

10.63

u/l

1.88

226

1359

Other maltreatment syndromes

495

1.33

1.38

1.4

6.56

7.02

u/l

0.13

419

Intentional self-harm by unspecified means

191

1.55

1.38

1.2

1.6

7.32

8.39

u/l

0.43

160

Oral leukoplakia, including avohilmo

174

1.57

1.38

1.4

1.3

14.27

9.24

u/l

0.60

139

Leisure time condition

252

2200

1.15

1.38

1.4

1.5

9.24

9.00

u/l

0.12

209

1789

Supervision of normal pregnancy

466

2404

1.11

1.38

1.2

1.3

13.16

12.43

u/l

0.47

403

1900

Personal history of risk-factors, not elsewhere classified

175

1.57

1.37

1.6

1.4

5.57

7.67

u/l

1.29

140

Scabies

574

1.30

1.37

1.8

1.5

8.07

7.78

u/l

0.10

465

Malignant neoplasm of breast

326

2082

1.13

1.37

1.2

22.83

20.69

u/l

1.32

278

1685

Congenital malformations of the circulatory system

252

2133

1.15

1.37

2.1

1.6

8.17

8.10

u/l

0.03

189

1631

Childhood allergy (age < 16)

557

4195

1.10

1.37

1.6

1.5

6.70

7.37

u/l

1.43

442

3382

Benign neoplasm: Parotid gland

547

1.31

1.37

1.3

9.86

10.17

u/l

0.06

447

IgA nephropathy (IgA glomerulonephritis)

265

1.45

1.36

1.8

1.4

10.19

7.91

u/l

0.48

217

Personal history of certain other diseases

333

1.41

1.36

1.6

1.3

7.79

8.64

u/l

0.23

273

Varicose veins

444

3714

0.90

1.36

1.3

14.52

14.17

u/l

0.17

367

3030

Gonarthrosis, primary, with knee surgery

364

2653

1.12

1.36

1.3

11.84

13.14

u/l

0.95

288

2120

Desensitization to allergens

131

1087

1.22

1.36

1.5

7.38

8.74

u/l

1.03

105

888

Outcome of delivery

378

2093

1.12

1.36

1.2

1.3

11.30

12.29

u/l

0.60

302

1655

Crohn disease (strict definition, require KELA, min 2 HDR)

114

932

1.23

1.36

1.4

1.5

7.14

8.11

u/l

0.51

769

Asthma/COPD (KELA code 203)

1719

11501

1.05

1.36

1.4

10.00

9.53

u/l

0.76

1407

9382

Burns and corrosions of external body surface, specified by site

180

1535

1.18

1.36

1.4

1.5

8.84

7.87

u/l

0.64

141

1223

Exophthalmic conditions

1.90

1.36

1.3

9.00

8.73

u/l

—

Other diseases of arteries and capillaries

618

1.28

1.35

1.3

1.4

14.95

10.34

u/l

1.29

501

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1189

0.80

1.35

1.3

1.2

12.36

12.12

u/l

0.06

990

Retinal detachments and breaks

273

2400

1.14

1.34

1.3

1.4

12.53

10.93

u/l

0.78

211

1952

Other Crohn's disease

120

989

1.22

1.33

1.4

1.5

9.25

8.29

u/l

0.33

104

813

Struck by thrown, projected or falling objec

648

1.28

1.33

1.3

1.5

6.06

7.29

u/l

1.02

529

Type 1 diabetes, strict definition

168

1963

0.85

1.32

1.4

1.6

6.95

7.07

u/l

0.06

127

1538

Burn and corrosion confined to eye and adnexa

309

1.41

1.32

1.5

1.4

7.13

8.11

u/l

0.39

259

Later onset COPD

131

851

1.21

1.32

1.2

1.3

11.27

11.77

u/l

0.15

666

Thoracic aortic aneurysm

120

988

1.22

1.32

1.4

10.13

7.53

u/l

1.12

803

Unattended death

0.00

1.32

0.0

1.4

—

5.87

—

Myocardial infarction, strict

324

2657

0.89

1.32

1.3

1.4

10.19

9.05

u/l

0.80

256

2119

Fracture of neck

446

1.33

1.31

1.4

1.3

9.00

8.11

u/l

0.24

360

Parkinson's disease, strict definition, excluding more controls

445

1.33

1.31

1.1

1.3

10.44

12.04

u/l

0.56

359

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lutropin [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS